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Functional near infrared spectroscopy (fNIRS) is a non-ionising, non-invasive, portable
and relatively inexpensive method of measuring cerebral oxygen saturation. It has been
suggested as a monitoring modality for patients with traumatic brain injury (TBI) in
order to guide therapy in both the emergency and clinical settings. Despite its potential
for use in TBI, current literature describes it as a ’work in progress’ and is currently not
suitable as a standalone technique to replace x-ray computerised tomography or invasive
intracranial pressure monitors, due to uncertainty in signal origins (superficial contami-
nation).
This thesis examined the viability of existing fNIRS devices, Atlas-based reconstruc-
tion algorithms, and a prototype, high-density near infrared spectroscopy probe, for quan-
titative assessment of TBI, which is investigated and presented.
Healthy volunteer investigations and simulations with existing fNIRS devices con-
firmed the ability for the imaging modality to measure relative changes in cerebral oxygen
saturation in the presence of signal contamination from superficial tissues such as skin
and bone. However, these superficial signals confounded the quantitative accuracy of
the cerebral saturation data and therefore confirmed that fNIRS devices, in their current
form, are insufficient to be used for monitoring TBI in isolation.
Simulations using a high-density fNIRS probe, providing a 3-wavelength, 168 channel
measurement set over a 18 cm2 region of interest (ROI), and a 4-point registered Atlas
model (ICBM152) for accurate spatial prior information, was sufficient to recover cere-
bral saturation values with greater quantitative accuracy than standard fNIRS devices;
mapping the simulated values to within 10 ± 2 %.
This concept was extended to healthy volunteer studies, using a high-density probe
at 2-wavelengths and 96 channels, over a 16 cm2 ROI. Results showed that although
there was a clear improvement in terms of the magnitude of recovered saturation changes,
the quantitative accuracy of the recovered parameters was still not sufficient to progress
fNIRS into the clinic at this stage. The source of the limitations in quantitative accuracy
is suggested to be due to tissue thickness mismatches between the subject and the Atlas
model used, as well as the choice of scattering parameters in the reconstruction model.
A prototype version of the 3-wavelength, 196 channel high-density probe, controlled by
an Arduino Due, was constructed for less than £300, and was capable of data collection at
1.3 Hz. The probe was shown to be able to track qualitative changes in oxygen saturation
in both arm cuff occlusion and Valsalva Manoeuvre studies. The cost and portability of
the probe make it an attractive option for large scale monitoring of TBI patients.
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The primary focus of this research is to explore the application of near infrared (NIR)
technology to the clinical field of Traumatic Brain Injury (TBI) monitoring; assessing its
current role, its limitations and how best to drive development towards its use as a clinical
monitoring tool.
Worldwide, TBI is one of the leading causes of death in young people who are otherwise
healthy [1], with up to 20,000 people sustaining a serious head injury annually [2]. The
main cause of the high mortality rate (20-40%) [3] in TBI is not due to the initial insult
to the brain, instead it is the variety of hypoxic, ischaemic and cytotoxic events that can
lead to a profound secondary insult, occurring minutes to hours after the primary event,
which poses additional risk to patients [4]. Therefore an important facet of improving
the care of TBI patients is the prediction and prevention of secondary injuries through
continuous monitoring in pre-clinical and clinical locations, so cerebral perfusion can be
tightly manipulated externally.
There is currently a niche in the TBI monitoring domain as all the current modalities,
such as x-ray computerised tomography (CT) and intracranial pressure (ICP) monitors
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(further details of TBI monitoring modalities provided in Section 1.2.2), are only appli-
cable in the clinical environment and are ionising, invasive or high cost. Therefore it
has been suggested that NIR devices could fill this gap in TBI monitoring, with current
research showing the potential of NIR devices in other areas such as cardiac and vascular
surgery, where clinical studies illustrated that a 13-20% drop in blood oxygen saturation
is an indicator of post-operative brain tissue damage [5, 6]. However, within the context
of TBI they have been found to not yet be a viable substitute for conventional monitoring
being described as a work in progress [7, 8, 9].
1.1.2 Introduction to Near Infrared Techniques
Near infrared light has long been a desirable form of non-invasive imaging and spec-
troscopy since its first reported use by Jobisis in 1977 [10]. As well as being non-invasive,
NIR devices use non-ionising radiation, so they can be used for continuous monitoring.
They can be made portable [11, 12] and can be relatively cheap in comparison to other
TBI monitoring modalities; therefore they could provide significant advantages to the
monitoring of TBI patients, both in and out of clinical settings [13]. Basic forms of the
technology, such as pulse oximeters, are well established in the clinical setting for mea-
suring the arterial phase oxygen saturation of blood from a probe on the finger. More
complex near infrared technology, such as functional near infrared spectroscopy (fNIRS)
and diffuse optical tomography (DOT), have been used in many medical research areas
ranging from breast cancer [14, 15] to epilepsy [16, 17].
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Figure 1.1: Absorption spectra for oxyhaemoglobin, deoxyhaemoglobin, and water show-
ing the relatively low absorption levels in the NIR region [18].
Near infrared light is within the range of 650-1000 nm and can exploit a biological window
(Figure 1.1) of relatively low absorption in biological tissue [19, 20, 21]. The main absorp-
tion sources are haemoglobin, separated into oxygenated (HbO) and deoxygenated (HHb)
components, and water; these are known as chromophores. The low absorption means
that scatter is the dominant interaction mechanism significantly altering the light path
(examples shown in Figure 1.2). Figure 1.2 shows two different source-detector setups for
NIR instrumentation, reflectance (A) and transmittance (B). Reflectance setups (Figure
1.2A) are used for cerebral monitors and the scatter dominated interaction process allows
NIR photons to follow a ’banana-shaped’ path back to the detector; this provides the abil-
ity to probe deeper into tissue than optical techniques operating at visible wavelengths.
As NIR photons travel a non-linear path from source to detector data cannot be recon-
3
structed through simple back projection, as it is in computerised tomography (CT) x-ray
imaging, where the light path is linear. For this reason a fundamental principle of NIR
technology is that photon diffusion in tissue must be predicted in order to reconstruct a
usable parameter from the detected intensity data. Some devices, known as continuous
wave instruments, assume a pathlength for NIR photons within a given medium in order
to estimate its optical properties. The diffuse (high scattering) nature of the NIR light
limits the lateral spatial resolution to approximately 1 cm (depending on the probe and
reconstruction methods used) [22]. In terms of spatial resolution and depth penetration,
near infrared techniques do not compare to the likes of x-ray and magnetic resonance
imaging (MRI), the advantage comes in the form of safe, non-ionising radiation (unlike
x-rays) and low cost and portability (unlike MRI). Given that photon diffusion can be
predicted, differences in detected light intensity can be attributed to absorption by the
aforementioned chromophores. A combination of blood flow and metabolism compete
to alter the oxygen saturation of blood [23], changing the concentration HbO and HHb.
Then as the absorption spectra for each of the chromophores shown in Figure 1.1 is unique,
the individual contributions of each one to the overall detector signal can be unmixed to
obtain the relative contribution and concentration from each. This unmixing requires the
use of multiple wavelengths in order to obtain chromophore concentrations.
Figure 1.2: Examples of reflectance (A) and transmission (B) NIR measurements
NIR devices can be separated into a variety of categories based on their setup and re-
construction techniques (Full details in Chapter 2.1). For the most part they fall into
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two categories; fNIRS (Figure 1.3A) gives single, global values for the chromophores in
a target medium using 1 or 2 source-detector pairs, and DOT (Figure 1.3B) uses a large
array of sources and detectors, at multiple wavelengths, to produce a spatial resolved
map/functional image of the chromophore concentrations in the target medium. The
chromophore maps are similar to those produced by positron emission tomography (PET)
scanners yet without the need for radionuclide tracers. The observed chromophores HbO,
HHb and water are all abundant in the body and are good indicators of patient condition
in the context of TBI. Hence no external contrast agents are required, although there
are some available (like Cyanine dyes which, can also be used to measure flow rates [24])
depending on the application [25].
Figure 1.3: Examples of NIRS (A) and DOT (B) probe geometries, positioned on the
forehead.
The question remains, with all its potential advantages and current uses in the clinic
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and research environments, why has NIR technology not made the leap into TBI monitor-
ing? The main reason is that there are concerns within the NIR field generally about the
levels of contamination from superficial layers (i.e., skin and skull) and whether this con-
tamination could confound the neurological NIRS measures which could have a significant
impact on TBI monitoring [26, 27, 8, 28, 29]. Thus far investigations into the use of NIR
devices in TBI have found results to be highly variable with one of the most prominent
issues being the quantitative accuracy of the NIRS data being produced [28, 29, 7]. In
a setting where a normal reference baseline can be observed, as in cardiac surgery, this
can be used to index relative changes in cerebral haemodynamics and thus be indicative
of prognostic clinical outcome (e.g., oxygen saturation decrease from baseline). However,
when no normative index baseline is available, as is the case with an acute TBI, the
interpretation of changes in NIRS data is problematic as there is a large inter-subject
variability in cerebral oxygen saturation. Therefore, improving the quantitative accuracy
of NIRS is required to improve its clinical application in TBI.
1.2 Traumatic Brain Injury
Traumatic brain injury is described as an insult to the brain caused by an external me-
chanical force leading to an alteration or impairment in brain function [30, 31, 32]. The
source of the external force ranges from rapid deceleration to blast waves. TBI can be
categorised by its severity using the Glasgow Coma Scale (GCS) based on patient re-
sponse. A mild TBI could be a concussion caused by a sport injury where the patient is
awake and responsive. At the other end of the continuum, and the primary focus of this
research, a severe TBI would be from a more significant impact, such as a motor vehicle
collision, where the patient may be unconscious.
The initial impact of a TBI is likely to cause shearing of white matter tracts and
rupturing of blood vessels leading to both intra and extracranial haematomas [33]. This
often results in inflammation and swelling, and is referred to as the primary insult to the
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brain. While these are significant injuries, in themselves they are not fatal, it is instead
the repercussions of these injuries further down the line that are the main source of
patient morality; these repercussions are known as secondary insults to the brain [4]. The
main issues in the secondary insult process are hypoxia (lack of oxygen) and intracranial
hypotension (abnormally low blood pressure) [34, 32], which along with the impaired
brain’s intrinsic blood regulatory mechanism (cerebral autoregulation), compromise the
delivery of oxygen and nutrients to cerebral tissue. Furthermore the swelling in the
brain from the initial insult increases intracranial pressure (ICP), which in turn decreases
cerebral perfusion pressure (CPP), meaning that adequate cerebral tissue perfusion is
further compromised causing further impairment of the brain’s intrinsic autoregulation
abilities [35]. As these secondary injuries can take place at anytime post injury, the ability
to continuously monitor patients from the moment emergency care arrives is essential for
securing positive patient outcomes [32].
1.2.1 Treatment of Traumatic Brain Injury
Standard practice for the treatment of most trauma victims (recommended by the Na-
tional institute for health and care excellence and other bodies) is Permissive Hypotensive
Resuscitation (PHR), which helps to reduce the risk of a secondary haemorrhage, lung
injury or tissue oedema. PHR is a procedure, which involves gentle fluid infusion in order
to increase systemic blood pressure to just below normal levels. The notable exception to
this is in the case of TBI. This is due to concerns that PHR will cause an ischaemic insult
to the brain, resulting in further damage by reducing blood pressure in a brain that is
potentially already hypotensive, a topic which is still controversial. Currently the main
goal in pre-hospital treatments is to use fluid therapy to avoid hypoxia and hypotension
until the patient can be fully assessed in a hospital. However the information available
to emergency medics at this point in order to guide the therapy is limited to blood pres-
sure and systemic blood saturation measurements. It is only on arrival at a hospital
that more informative monitoring and assessment modalities (detailed in Section 1.2.2)
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can be utilised. More accurate information then allows clinicians to manipulate ICP and
CPP safely through fluid and pharmaceutical intervention with surgical techniques also
available, such as a decompressive craniectomy [33].
1.2.2 Monitoring Modalities in Traumatic Brain Injury
Currently there are very few monitoring modalities available for pre-hospital management
of TBI, which is a key driving force behind this research. Pulse oximetry and blood
pressure monitoring are the main modalities available with both only giving a systemic
overview of patient health (i.e., not brain specific). The concern with these modalities is
that in TBI, the oxygenation and blood pressure in other tissue is not necessarily indicative
of that in the brain and could therefore lead to the incorrect therapy. Despite this it has
been shown in the literature that maintaining an acceptable peripheral saturation and
blood pressure does correlate with positive TBI outcomes [36, 37].
There are several methods of patient monitoring currently used in the clinic, including
x-ray computerised tomography (CT), magnetic resonance imaging (MRI), intracranial
pressure (ICP) monitors, transcranial Doppler (TCD) and electroencephalography (EEG)
[31]; CT and pressure monitors are the most common. There are also invasive monitors like
the ICP probes which can measure brain tissue oxygenation (PbtO2) and provide positive
outcomes when used with ICP [38]. CT scans are standard practice for TBI patients and
when used with contrast agents can accurately show the position of haematomas in the
brain and can guide surgical procedures (Figure 1.4). It is however only useable once
the patient arrives in hospital and due to the ionising nature and risk of moving critical
patients it is not useful as a continuous monitoring tool. Similarly, ICP and PbtO2
monitors can only be installed in the hospital by a surgeon.
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Figure 1.4: Example CT of a subject with a TBI used to calculate ideal monitoring
depth in TBI patients. A Corpus Callosum, B Contact Point to start measurement, C
Haematoma and D Third Ventricle (axis origin).
The pressure monitors are invasive and are screwed into the skull in order to give a
long-term assessment of intracranial pressure and tissue oxygenation (Figure 1.5). They
also have their own associated risks with the implantation, specifically a 0.5 % risk of
causing a haemorrhage and a 2 % risk of becoming infected [33]. In some literature reviews
ICP monitors were not found to have any significant advantage over other imaging and
clinical examination [39], although this is a topic of debate [40]. TCD can show blood
flow velocity in the brain and has been found useful in guiding therapy to restore cerebral
perfusion [41], however the results can be inconclusive and interpretation varies between
users.
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Figure 1.5: Example of ICP monitor surgically implanted in the skull of a TBI patient
(indicated by red circle).
As there is currently no accepted modality/technique for guiding both hospital and
pre-hospital therapies, this leaves a gap which could potentially be filled by fNIRS as it
has the depth penetration ability to assess the cortex (reaching the ideal TBI monitoring
depth of 21 ± 4 mm (Figure 1.4) [42]). The application of fNIRS for assessment of haemo-
dynamics is widely used in clinical research [43] due to its versatility and ease of use. Also
as it is non-ionising and significantly cheaper to purchase and run than CT/MRI scanners,
it can be used to continuously monitor TBI patients, from the moment emergency medics
start treatment. As cerebral oxygen saturation is one of the key parameters clinicians are
concerned with when it comes to monitoring TBI patients, the ability to use fNIRS would
be advantageous. Evidence indicates that changes in tissue oxygenation index (TOI) and
tissue haemoglobin index (THI) as measured by fNIRS can be used as an indicator of ICP
[44, 45]. However, other reviews have stated that despite its potential in its current state,
fNIRS cannot be relied upon to predict ICP consistently [7]. On balance, research to date
indicates that NIRS has the ability to supplement current TBI assessment methods but
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it not good enough to replace them [46, 8, 47].
1.2.3 Application of Near Infrared Spectroscopy to Traumatic
Brain Injury
The ability to use fNIRS devices to detected changes in cerebral haemodynamics like
cerebral oxygen saturation or total haemoglobin concentration is very appealing in TBI
monitoring. These parameters potentially give a much more direct measure of whether
the brain is hypoxic or under perfused whereas ICP only provides pressure changes from
which it can be inferred that the brain may be under perfused. To date there has been
a very limited number of studies applying fNIRS to TBI monitoring [8]. The clinical
application of fNIRS in TBI have been mainly focused around comparison to current
monitoring modalities such as ICP and PbtO2, which showed that while fNIRS parame-
ters mapped changes well there was a lack of specificity in the output parameters making
it difficult to guide therapy choices [48, 7]. The primary reason for this is that despite
the apparent advantages and potential of NIRS in this clinical context, there still remains
doubt as to the physical origins of the obtained oxygen saturation values from externally
measured optical signals, a debate common to the entire fNIRS and DOT field. With the
rich vascular nature of facial somatic tissue, questions have been raised about the levels
of signal contamination that will occur due to haemodynamic changes in these superficial
tissues, and thus obscuring cerebral observations [26, 49, 50]. Due to the diffuse nature of
near infrared light and the reflection geometry used by fNIRS devices, it is impossible to
avoid all influence from the superficial tissues as the light must physically pass through
these regions. A multitude of different approaches to reduce and/or eliminate superficial
contamination have been suggested, ranging from probe design to reconstruction algo-
rithms (discussed in detail in Chapter 2). Another limitation of the NIRS approach is
that the presence of a sub-dural or extracranial haemorrhage can severely obscure the
assessment of cerebral saturation as essentially the probe will be sampling a large pool of
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blood, which will slowly desaturate [51]. Interestingly this limitation has actually been
adapted to form fNIRS devices, which are designed specifically to locate haemorrhages in
TBI patients [52, 53].
As a result of the signal contamination from superficial tissue, the quantitative accu-
racy of NIRS is limited. The principle of fNIRS is that it provides a global representation
of the optical properties of a target tissue, which makes a quantitative assessment of cere-
bral oxygenation difficult. Additionally there is a distinct lack of standardisation between
different fNIRS devices due to the different setups and algorithms used [21], resulting in
fNIRS experiments reporting only changes in baseline measurements. While limiting, this
approach is applicable in specific situations such as cardiac surgery and cognitive studies
where it can be confidently assumed that the patients brains are well perfused. However
in the context of the injured brain, no normative baseline measurements are available, as
the state of the brain is unknown. A study which used fNIRS devices to measure cerebral
oxygenation during a controlled hypoxic event showed that even with a healthy baseline
measurement the variation between subjects was too high to put a firm number of what
saturation level was indicative of a healthy brain [54]. Thus, a more quantitatively ac-
curate measurement of cerebral oxygenation is required in order to gauge the condition
of a patient. The main limiting factor is the measurement of a global saturation value in
the target tissue, which effectively averages the saturation changes over all layers (tissue
type) of the head, obscuring the true brain changes.
The progression of fNIRS towards a more quantitative assessment of cerebral oxygenation
can come in one of two ways. The first is to move to a time domain (TD) fNIRS system,
which maintains the real-time and portable advantages of standard fNIRS; however it uses
significantly more expensive components capable of individual photon counting. By mea-
suring both intensity and arrival time of the photons, TD fNIRS has intrinsic information
about photon flight path, which enables deep and shallow photons to be selected allowing
greater quantitative accuracy and increased depth resolution (although still global in the
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lateral plane) [55]. The increased cost is a limiting factor when considering large number
of devices would be needed.
An alternative method is an adaptation and use of diffuse optical tomography (DOT),
mentioned in Section 1.1. DOT differs to conventional fNIRS in both system design and
reconstruction, where instead of the linear probe designs used in NIRS systems consisting
of one or two sources and detectors (Figure 1.3A), a DOT probe will have a larger array
(Figure 1.3B) allowing use of multiple sets of overlapping measurements which can im-
prove both the spatial resolution and quantitative accuracy [22]. Most reconstructions in
DOT are model-based, typically using finite element models (FEM) where spatial priors
and initial optical property estimates can be used to increase the accuracy of derived
optical properties. The limitation of DOT systems is their size and parameter recovery
time, which makes them less practical for TBI monitoring. Although relative changes
in chromophore concentrations from a baseline can be measured in real time, the quan-
titatively accurate results (of oxygen saturation, for example) require a non-linear and
iterative reconstruction approach to hone in on the best solution. To date, however, truly
quantitative results have only been obtained in DOT of the breast [56] and the lack of
known baseline optical properties in the brain is currently a limiting factor in achieving
quantitative results.
Providing spatial priors regarding the tissue layers of the head, namely the skin, bone
and brain in a reconstruction algorithm has shown to help constrain the ill-posed nature
of the problem and improve parameter recovery accuracy [57]. Such spatial priors can be
obtained from patient MRI or CT scans that can be segmented and formed into subject-
specific models, however in the clinical and pre-clinical setting this is not always a feasible
option [22, 57, 58]. Alternatively, the use of Atlas-based models has shown good promise
to overcome cases where subject-specific MRI/CT data are not available [57, 58, 59].
Although the application of a DOT-based system can produce the data required to
monitor TBI patients, in its current format it is not ideal. The first issue is size and
expense of the equipment, which may have a relatively simple solution; the sampled area
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could be scaled down. Although this would imply a smaller region of interest from which
spatially varying parameters would be recovered, such small target regions would be suit-
able if the results were quantitative. It is worth noting that the invasive ICP probe only
target a small volume of the brain also. Therefore, if a small DOT probe is used to give
overlapping, multi-distant measurements over a small area, it could be used to recon-
struct depth-resolved spectroscopic parameters. A smaller probe is also more portable
and cheaper to produce and will also help with the second issue of reconstruction time.
Specifically, smaller the number of voxels (spatially varying locations) being reconstructed,
the faster the iterative reconstruction will complete [58]. Also having multiple overlap-
ping measurements obtained over a smaller sample area will improve the ill-posed nature
of the inverse problem [60]. It is also worth noting that a smaller target area is more
likely to avoid clots/haematomas in the brain, which may obscure recovered parameters.
With parallel computing and GPU acceleration becoming more prevalent, reconstruction
times will only get faster [61], providing additional benefits. The final obstacle in the
way of quantitatively accurate DOT reconstructions is the availability of spatial priors.
A subject-specific reconstruction model will not typically be available in clinical and pre-
clinical TBI cases, hence the utilisation of an Atlas model, using the average spatial priors
over a multitude of segmented heads, could be registered to match a patient head and
used as a substitute for specific priors [57, 58].
Finally, while portable high-density NIRS system designs are already available and
routinely used (e.g., NIRSport, NIRx Medical Technologies and fNIRS300B, BIOPAC
System, Inc), the key feature that is currently lacking is the non-trivial base-line pa-
rameter recovery needed to obtain information with a reasonable degree of quantitative
accuracy (reconstruction methods will be discussed in Chapter 2). At the other extreme,
systems such as the Washington University DOT array [62] uses a large-scale probe de-
sign, focusing on mapping cerebral activation and connectivity, which incorporate Atlas
guided recovery into their reconstruction routines. Thus, there are already system designs
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available that are suitable in terms of hardware. A near infrared system suitable for the
monitoring of TBI lies somewhere between these aforementioned designs, hybridising the
portability of the smaller DOT arrays with the more enhanced reconstruction algorithms
of the large scale probes. While this is something that has been explored [59], there has
been limited expansion of the Atlas-guided techniques to produce quantitatively accurate
results. Therefore this research was aimed to investigate the suitability of a small scale
fNIRS/DOT hybrid probe, designed for use on the forehead, for producing quantitatively
accurate cerebral oxygen saturation values, using a registered Atlas model for spatial
priors to address the limitation of fNIRS in the TBI setting.
1.3 Research Aims
Given the current position on NIR technology in the TBI field the aim of this research is
to address the following hypotheses:
1. Signals from superficial tissues are not preventing fNIRS from measuring haemody-
namic changes in the brain that would be necessary for guiding TBI patient therapy.
2. Contamination from superficial tissues is limiting the quantitative accuracy of fNIRS
measurements and thus it cannot currently by used as a standalone TBI monitoring
modality when no normative baseline measurements are available.
3. A small scale hybrid fNIRS/DOT probe and Atlas-based reconstruction algorithm
can be used to recover superficial and cerebral haemodynamics simultaneously and
thus produce quantitatively accurate results.
4. A low cost, portable, fNIRS device capable of producing these measurements can
be built using off-the-shelf components.
By understanding how superficial signals are influencing the NIR parameter recovery,
it will potentially allow for improvements to be made. In order to make this technology
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a viable option for use in the clinical and pre-clinical environments it needs to be low
cost and as simple as possible. Therefore finding ways to improve upon existing fNIRS
technology is more desirable than moving to more complex and large-scale DOT devices.
The proposed compromise is that a hybrid probe between that of fNIRS and DOT is built.
The idea being that the probe would obtain a large number of measurements over a small
target area that will allow for more complex parameter recovery without decreasing the
portability or affordability of the technology.
Chapter 2 and 3 explains the physical principles behind NIR technology and the different
reconstruction techniques that are used to reduce the influence of superficial contamina-
tion. It also includes a review of the most commonly used NIR devices and their areas
of use. Chapter 4 investigates existing fNIRS devices in both simulation and healthy
volunteer studies to work out their pitfalls and also what attributes help in reducing su-
perficial contamination or increasing quantitative accuracy. The idea of this chapter is to
provide the foundations for the next stage of research into improving the fNIRS probes
and reconstruction to move towards quantitative parameter recovery.
Chapter 5 examines how the quantitative accuracy of NIR reconstructions can be
improved by using Atlas models, registered to a subject head, in order to provide prior
structural information to guide the parameter recover. A small-scale diffuse optical to-
mography device, referred to as a high-density near infrared spectroscopy (HD-NIRS)
probe is outlined to provide the additional data required for the new reconstruction pro-
cess. This is assessed in both simulations and healthy volunteer studies using an existing
DOT system. Finally Chapters 6 & 7 outline the design, development and testing of the




This chapter has laid out the background and motivation for the research into applying
NIR techniques as a monitoring modality for patients with TBI. The literature so far has
shown that NIR modalities have the potential for use in TBI monitoring both in and
out of the clinic, however due to uncertainties about the quantitative accuracy and con-
tamination in the recovery data they cannot currently be used other than to supplement
current monitoring tools such as CT and ICP probes. The following chapter looks at the




NEAR INFRARED IMAGING AND
SPECTROSCOPY - TISSUE OPTICS
A brief introduction to the use of near infrared light is given in Chapter 1, here this is
expanded upon and the physical principles, which underpin diffuse optics (near infrared)
as an imaging and spectroscopy modality are explored.
The use of high-energy light (x-rays and gamma rays) to image inside biological tis-
sue is well established within the clinical setting, with Computerised Tomography (CT)
x-ray and Positron Emission Tomography (PET) being used routinely in hospitals. In-
cident light can be assumed to travel in a straight line through a medium with contrast
coming from any drop in intensity of the detected light due to absorption. However the
propagation of NIR light in biological tissue, as previously mentioned, is a more complex
phenomenon. Unlike x-rays, NIR light cannot be assumed to travel in a straight line, as
absorption is no longer the dominant interaction process; scattering now plays a major
role and light which originates from a point source becomes dispersed as shown in Figures
1.2 and 2.1.
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Figure 2.1: A High energy photon transport through biological tissue. B NIR photon
transport through biological tissue. C Example of scattered light from a single source.
Therefore, in order to predict or reconstruct the path of NIR light in tissue, and hence its
optical properties, computational methods and modelling are required. Modelling can be
done using the Radiative Transfer Equation (RTE) or simplifications of the RTE, which
will be discussed in Section 2.2.
2.1 Physical Principles
2.1.1 Light Interactions in Biological Tissue
The prediction of photon migration in tissue is based on our understanding of how light
interacts with biological media. The main interaction methods of a photon with tissue are
scatter and absorption; this section aims to described how these interactions take place
and why they cause changes in detected intensity at a given measurement point. Figure
2.2 shows examples of changes in absorption and scattering coefficients over a range of
wavelengths, where the area of high scattering and lower absorption in the NIR range can
be seen.
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Figure 2.2: Example spectra for reduced scattering [63] and absorption coefficients [64]
to show the area of high scattering and relatively low absorption in the NIR region.
A photon is the name given to a ’packet’ of energy, with the energy of the photon
being directly related to its frequency or wavelength (Planck-Einstein relation); as shown
in Equation 2.1, where E is the photon energy, f its frequency, λ its wavelength, c is the
speed of light in the medium and h is Planck’s constant.





The process of absorption occurs when a photon transfers its energy to molecules inside the
medium being traversed. The transfer of energy takes place via excitation of an electron
moving it from a lower energy, or ground state, to a higher energy level (illustrated in
Figure 2.3). Once the excitation has taken place the electron can return to its original, or
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intermediate, state by releasing some or all of the absorbed energy. This can take place
through a variety of mechanisms, which can be generalised under luminescence or thermal
energy. NIR light is described as ’non ionising’ as its photons do not have sufficient energy
to excite an electron to a level where it can break free of its parent nucleus, a process
which can cause tissue damage.
Figure 2.3: Jablonski energy diagram showing an example set of energy transitions for an
electron. The energy of the transition is denoted by h ν where h is Plancks constant and
ν is the frequency of the photon (referred to as f in Equation 2.1). The letters A, F, p
and R represent absorption, fluorescence, phosphorescence, and Raman respectively [65].
Luminescence is a form of photon emission sub divided into fluorescence and phospho-
rescence. The process involves relaxation of the excited electron to a lower energy state
(Figure 2.3) through the emission of a photon with an energy equal to that of the energy
gap traversed. While both involve emission of a photon, fluorescence drops first to an
intermediate vibration state while phosphorescence drops first to an excited triple state
through inter-system cooling shown in Figure 2.3 [65]. Due to the internal transitions
before the emission of the photon, the energy of the new photon is lower than the one
initially absorbed.
In terms of thermal energy the photon of light raises the electron into a vibrational
energy state where the energy can be dissipated through transfer of heat to surrounding
atoms. This absorption process is non-radiative as no photon is released.
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The energy levels (Figure 2.3) for electrons in different molecules are specific and as
the energy of a photon is directly related to the wavelength of the light there is a wave-
length dependence of the amount of absorption by a specific molecule, a principle that is
essential for fNIRS.
The probability of a photon, of a particular wavelength, being absorbed within a medium
per unit of distance travelled is defined as its absorption coefficient (µa). This is a mea-
sure of total absorption probability from all absorbing species. The relationship between
intensity (I) change over a distance (L) travelled through a non-scattering medium with
absorption coefficient µa, is exponential and is defined by Equation 2.2 which is referred
to as the Lambert-Bouguer Law [66, 67].
I(L) = I0e
−µaL (2.2)
The relationship between the absorption coefficient and the concentrations of the con-
stituent absorbing species is defined in Equation 2.3 which was built on by August Beer
[68] to become the Beer-Lambert Law (substituting Equation 2.3 into Equation 2.2). The
relationship is designed for measuring the transmission through an absorbing, but non-
scattering, species dissolved in a non-absorbing medium. The molar extinction coefficient
(ε) is the probability of light interacting with the species per unit path length. The ex-
tinction coefficient is wavelength (λ) specific and accounts for the interaction probability
due to absorption in terms of concentration of the absorbing species (C) and the distance
travelled (L). For biological tissues scattering is the dominant interaction (which is the
reason NIR light can probe deeper into biological tissue than visible light) and to account
for this, the modified Beer-Lambert law, discussed in Section 2.2.1 must be used. Equa-
tion 2.3 allows the absorption coefficient to be defined in terms the concentration of its
absorbing species (oxygenated and deoxygenated haemoglobin in this example).
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µa(λ) = ε(λ)HbOCHbO + ε(λ)HHbCHHb + ε(λ)H20CH20 (2.3)
The main absorption species in biological tissue are Haemoglobin (split into oxy-
genated (HbO) and deoxygenated (HHb) components), Water (H2O), and others such
as cytochrome oxidase and melanin [69]. Recovering concentrations of HbO and HHb
can also provide measures of blood oxygen saturation (SO2) (Equation 2.5) and total
Haemoglobin concentration (HbT) (Equation 2.4). The saturation of the blood is an
overall value covering both the venous and arterial components of blood, which are usu-
ally in the ratio of 75:25 so the venous contributions are stronger [70].







By measuring the absorption of light as several wavelengths in the NIR region, com-
bined with the extinction coefficients (for each chromophore at each source wavelength)
it is possible to calculate the concentration of each chromophore within a sample.
Scattering
Scattering is the process by which the direction of a photon is changed. It can be mod-
elled as a series of interactions between spherical particles and photons (Mie and Rayleigh
Theory) which, in the context of NIR light, are elastic meaning no energy is transferred
from the photons during the interaction process [65, 71]. There are other forms of scat-
tering which are non elastic and results in the reduction in incident photon energy, such
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as Raman scattering (seen on Figure 2.3); but are less likely in the NIR region due to
the associated energy level transitions. Elastic scattering dominates when the size of the
particles is similar to that of the optical wavelength (NIR), which is the case in biological
tissue where cell membranes, nuclei and mitochondria are key scatterers [72]. A mismatch
in refractive indices between constituent particles and the background medium can also
cause a significant amount of scattering, as governed by Snell’s Law.
Just like absorption there is a scattering coefficient (µs) that defines the probability of
a scattering event per unit length. The reciprocal of the scattering coefficient gives the
average distance a photon will travel in a medium before undergoing a scattering event
[65]. Another factor to consider with scattering is the angle of direction of the scattered
light, known as anisotropy. This is important as the probability of light being scattered
in all direction is not equal, so there is often a preference for forward or backward scatter.
Therefore, to account for this a reduced scattering coefficient can be used that incorpo-
rates an anisotropy factor, g, which can range from -1 (for back scatter) through to 1 (for
forward scatter) as shown in Equation 2.6. The anisotropy factor can be estimated ex-
perimentally and a typical value for biological tissue is 0.9, indicating forward scattering.
µ
′
s = (1− g)µs = Aλ−B (2.6)
The empirical approximation of the Mie scattering theory (Equation 2.6) has shown a
good fit to the reduced scatter coefficient of a tissue (µ
′
s) [63, 73]. The scatter amplitude,
A and the scatter power B are related to the particle sizes and number density of scatters
in a tissue, representing the changes in scatter at different wavelengths (λ), due to different
organelles and cellular structures [74].
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2.2 The Radiative Transport Equation and the Dif-
fusion Approximation
Based on the scattering and absorption parameters outlined in Section 2.1 the path of
diffuse light can be predicted by looking at photon interactions within the medium. The
prediction of the light propagation implements the radiative transfer equation (RTE),
shown in Equation 2.7. The original basis for the RTE was developed by Boltzmann in
the form of the Boltzmann transport equation in 1872. The physical quantities shown in
the equation are as follows: −→r is the position; ŝ is the unit direction vector; t is time; c
is the speed of light in the medium; µt is the total attenuation coefficient (µs + µa); Ω is
the solid angle, L(−→r , ŝ, t) represents radiance; P (ŝ′.ŝ)dΩ′ represents the scattering phase
function and S(−→r , ŝ, t) represents photon energy.
1
c
∂L(−→r , ŝ, t)
∂t




L(−→r , ŝ, t)P (ŝ′.ŝ)dΩ′ + S(−→r , ŝ, t)
(2.7)
Given the complexity of the RTE equation it is most commonly simplified into the Dif-
fusion Approximation (DA), which is valid when the following assumptions are applicable
[63].
1. Scattering interactions are dominant over absorption.
2. The region of interest is far from the source and boundaries.
3. Light fluence is not changing rapidly with time.
The DA is based on Fick’s Law (Equation 2.8), which describes the diffusion of photons
in a scattering medium. J is the diffusion flux showing the amount of movement over
time, D is the diffusion coefficient defined in Equation 2.9 and Φ is the intensity. µ
′
s is
the reduced scattering coefficient incorporating the anisotropy factor g.
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Using these principles the RTE can be simplified into Equation 2.10. There are other
forms of the DA that can be selected based on the application, for example there is a
frequency domain version of the DA that would be used when phase measurements are




−→r , t)−∇.[D∇Φ(−→r , t)] = S(−→r , t) (2.10)
With fewer variables the diffusion approximation is a simpler equation to solve than the
RTE. The solution is usually done in one of two ways either analytically or numerically
depending on the instrument setup and application area [63].
2.2.1 Modified Beer-Lambert Law
Given that the propagation of photons within a medium can be predicted using the RTE
and DA it is also necessary to be able to translate the changes in detected intensity into
concentrations of chromophores in the medium. Modelling photon propagation allows the
differential path length at a given wavelength of light for the medium to be estimated.
The differential path length factor can also be obtained experimentally using the time
domain and frequency domain source modes described in Section 2.3.1. This path length
indicates the average distance each photon travels, once this is known then the modified
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Beer-Lambert Law (BLL) can be used to obtain the changes in chromophore concen-
trations. The modified BLL can be used directly with fNIRS measurements to obtain
changes in chromophore concentration and as in the later stages of DOT reconstruction,
which will be discussed later in Chapter 3.
The original BLL (Section 2.1.1) relates the change in intensity of source light across
a medium (optical density OD = ln I
I0
) to the concentration of absorbing species in the
medium. The theory is illustrated in Figure 2.4A, where I0 is the input intensity, and I
is the measured output light.
Figure 2.4: Illustration Beer-Lambert Law (A) and Modified Beer-Lambert Law (B).
However the BLL is not designed to take into account scattering effects, which, is
problematic for fNIRS measurements. To account for this the BLL was modified to
incorporate the differential path length factor (DPF) to calculate the mean photon path
and hence the ’thickness’ of the sample (Figure 2.4B). While the DPF can be estimated
using photon modelling or obtained experimentally [75], using time-domain or frequency-
domain methods (discussed in Section 2.3.1) the modified BLL can no longer be used to
directly measure chromophore concentration, however it can be used to calculate changes
in chromophore concentration ∆c. The modification of the BLL includes an additive
factor that is dependant on the medium and the geometry of the system which cannot be
directly obtained, therefore the factor is assumed to be constant, and hence the reason
only changes is chromophore concentrations are calculated [71]. The modified BLL which
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includes the DPF is shown in Equation 2.11, instead of using the intensity of input
light the modified BLL uses the change in intensity between a reference detector reading
(Iref ), usually a baseline measurement or the previous measured intensity, and the current
detector intensity (Imeas), this is used to give a change in optical density (∆OD). It is
possible to compute the chromophore changes without a value for the differential path
length, however the concentration changes recovered are offset by a constant factor [76].
∆OD = L×DPFε∆C (2.11)
As fNIRS measurements are taken at multiple wavelengths, the modified BLL can be
solved as a series of simultaneous equation, in matrix form, to calculate the concentrations











This example calculates the change in the concentration of oxy (HbO) and deoxy (HHb)
haemoglobin for a source and detector a distance L apart, the DPF is the differential
pathlength factor for the medium and the change in OD is measured at two wavelengths
λ1 and λ2.
2.3 NIR Instrumentation
The design and components that make up a given NIR instrument will vary based on
the application and the type of measurement that needs to be acquired for the data
reconstruction process (Section 3). In this section an overview of the common components,




There are three distinct types of NIR instruments, which are defined by the source light
modes. These are continuous wave (CW), frequency domain (FD) and time domain (TD)
modes [77, 78, 79, 80, 69]. A CW instrument is the most simplistic of the three types
consisting of Light emitting diodes of laser diode sources and photodiode or avalanche
photodiode (for higher sensitivity) detectors. It relies solely on measuring attenuation of
the input light (Figure 2.5A). It is thus a fast and relatively inexpensive method, however
they cannot give absolute chromophore concentration measurements as there is no way
of distinguishing between intensity changes due to scatter and changes due to absorption
[81].
Figure 2.5: NIR source modes - A - Continuous Wave, B - Frequency Domain and C -
Time Domain [72]
Frequency domain systems use a similar light source, however the intensity is modulated
at frequencies in the MHz range [55]. The high-frequency modulation in FD systems
allows measurement of both phase and intensity of light (Figure 2.5B) to provide a more
quantitative assessment of optical properties. The phase change of the light indicates the
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level of scattering the light has undergone and hence helps distinguish between intensity
changes from scatter and absorption sources. For this technique the detectors must be
high speed in order to sample at the Nyquist frequency, which in this case would be twice
the modulation frequency. These types of detectors, such as photomultiplier tubes, are
more expensive and therefore FD instruments to be more expensive to develope [82].
Time domain systems measure both intensity and photon flight time. This gives the
the greatest level of depth resolution in comparison to CW and FD instruments. For
TD systems both high-speed sources, such as picosecond lasers, and detectors, such as
specialised time-gated charge-couple devices (CCD) [83] or PMTs [84], are required. This
makes TD system significantly more expensive, which is a limiting factor if large number of
instruments were required for a hospital for example. As the detectors count photons from
a single laser pulse over time a temporal point spread function is recorded (Figure 2.5C).
The spread in the intensity indicates the amount of scattering the light has undergone, the
photons that reach the detector last are assumed to be the ones that have travelled the
longest path through the medium [55, 85]. It is in this manner that the depth resolution of
TD systems is produced. A longer path length implies the greatest scatter and hence the
deepest travelling photons. The low scatter photons give shallow signals and the highly
scattered photons give deep signals albeit with a poor signal to noise ratio (SNR). This is
of course an assumption as a longer flight time does not necessarily mean a deep travelling
photon, however it is the most probable path for the photons.
2.3.2 Probe Geometries
Further sub division of NIR instruments come in the form of the probe geometry, a topic
briefly explored in Chapter 1. The two main types of probe can be split into two categories,
fNIRS probes and DOT probes. Then within these two categories the instruments could
be further split based on the 3 sources modes from Section 2.3.1 and by the different
reconstruction regimes discussed later in Section 3.
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Figure 2.6: A NIRO-200NX (Hamamtsu, Japan) fNIRS probe. B Diffuse optical tomog-
raphy probe developed by Washing University in St Louis [62].
fNIRS Probe Geometries - An fNIRS probe will consist of a linear array of
sources and detectors like the example shown in Figure 2.6A, which is the NIRO-200NX
(Hamamatsu, Japan) (other examples in Figure 2.7). As there are only a small number of
sources and detectors the number of measurement channels (source-detector combination
multiplied by the number of wavelengths) is also small. This means the fNIRS instruments
are only suitable for simple reconstruction regimes probing a small target area. Therefore
fNIRS instruments will give a global set of recovered parameters representing the entire
sampled volume (although techniques are available to improve regional specificity). The
typical separation of the sources and detectors ranges from approximately 15 to 55mm
and is very dependant on the dynamic range of the detectors being used, as the intensity
drop off with increasing distance is exponential. When position on the forehead, the
short separations (∼15 mm) will probe more shallow tissues, for example the skin and
bone, while a longer separation of 30 mm upwards will start to probe brain tissue as well.
The choice of separation will also influence the maximum depth the probe is capable of





separation [86]. While continually increasing the separation of the source and detectors
will increase the sampling depth of the probe, the signal-to-noise ratio (SNR) is the
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limiting factor in moving beyond ∼60 mm, as the signal strength is so low; an effect
which is magnified by the need for an ever increasing dynamic range for the detectors.
Figure 2.7: Examples of other fNIRS probe geometries, Top - FORE-SIGHT (CAS Med-
ical Systems Inc; Branford, CT), Middle - INVOS 5100C-PB (Covidien; Boulder, CO)
and Bottom - EQUANOX Classic 7600 (Nonin Medical Inc; Plymouth, MN) [26]
The setup can be used with all three of the previously mentioned source modes, how-
ever the linear nature of the probe gives a very limited ability to locate the spatial origin
of any detected signals. Even in the situation where a TD system is being used and pho-
ton flight times can be used to work quantitative chromophore concentration by depth,
the lateral resolution of the data will be limited.
The advantage of fNIRS probes is that they are small and portable which is of par-
ticular interest when looking to move to the pre-clinical environment. They also cost less
due to the smaller number of components and the trivial nature of the parameter recovery
(see Section 3) means that results are produced in real-time.
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DOT Probe Geometries - Diffuse optical tomography probes are large arrays of
sources and detectors that provide overlapping measurements over a large region of inter-
est, allowing for more complex parameter recovery than fNIRS geometries. Examples of
a DOT probe shown in Figures 2.6B and 2.8, where the sources and detector grid extends
around the sides and back of the head to observe haemodynamic changes from different
areas of the brain. Having overlapping measures from a 2-dimensional array as opposed to
the 1-dimensional fNIRS array means that a 3-dimensional map of chromophore concen-
trations can be reconstructed with x, y and z dimensions, this is where the ’tomography’
comes into play. While DOT produces a spatial map of chromophores, due to the dif-
fuse nature of NIR light the resolution in all directions is limited to approximately 1 cm
[22], significantly lower than other functional imaging modalities such as functional MRI,
which has resolution in the order of 1mm [87].
Figure 2.8: Examples of different DOT geometries the square (Left) and Triangular (cen-
tre) are considered to be spare arrays usually used for topography measurements and the
high-density array (Right) is usually used for tomography [88].
As well as use in tomography, sparse DOT arrays (shown in Figure 2.8) can also be
used to create topography images, these are not depth resolved images and do not require
overlapping measurements, instead they are an interpolation of nearest neighbour source-
detector combinations, in essence a combination of fNIRS probes over a wide area. The
Hitachi ETG-4000 (Hitachi Medical Systems Europe) is an example of a sparse array
device.
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Figure 2.9: NIRSport portable NIR head cap [89].
Generally DOT systems are very bulky due to the large numbers of optical fibres as well
as the housing for all the sources and detectors, which is a limitation to the probability
of the instruments. Despite the large array, there systems like the NIRSport (NIRx Med-
ical Technologies) and fNIRS300B (BIOPAC System, Inc) that have been made portable
(NIRSport example shown in Figure 2.9).
Although portable versions of DOT probe geometries have been produced they are
still expensive in comparison to the fNIRS probes (typically £50k-100k), and therefore
are not currently a viable method for mass clinical and pre-clinical monitoring.
2.4 Summary
This chapter discussed the physical principles of absorption and scattering that underpin
tissue optics. Using these principles a model of photon transport in tissue, known as the
radiative transfer equation, is derived and simplified into the diffusion approximation,
which is used as a model of photon migration in a majority of NIR instruments. An un-
derstanding of photon migration in tissue and how intensity changes over a given distance
forms the basis of the modified Beer-Lambert law, which allows changes in chromophore
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concentrations over time to the calculated given a measurement of intensity change.
The different fNIRS and DOT setups were discussed along with their individual limita-
tions and advantages in terms of TBI monitoring. As well as the setup of the instruments,
the source modes (CW, FD and TD) were discussed to show the difference in information
each could provide. The subject of data reconstruction has been touched upon in this
chapter, however the next chapter will go into further detail of how the physical principles
discussed can be utilised to reconstruct NIR datasets.
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CHAPTER 3
NEAR INFRARED IMAGING AND
SPECTROSCOPY - RECONSTRUCTION AND
MODELLING
This chapter aims to explain how biologically relevant information is produced from a
set of NIR spectroscopy or tomography measurements through the implementation of
the diffusion approximation and the modified Beer-Lambert law from Chapter 2. Re-
construction and modelling methods will be grouped into the categories of analytical and
numerical reconstructions that can be implemented for both fNIRS and DOT datasets. In
general, unless measured intensity is used with the modified Beer-Lambert law to directly
calculate chromophore changes, reconstructing optical properties from a dataset will re-
quire minimisation of the error between measured and modelled intensity values, which
is where the analytical and numerical solutions to the DA come into practice. Modelling
intensity values for a given geometry and set of optical values is what is referred to as the
’Forward model’.
3.1 Analytical Methods
An analytical solution is a direct mathematical approach where an exact answer can
be found, in this case the equation being solved is the Diffusion Approximation (DA)
that is a partial differential equation (Equation 2.10). Depending on the geometry of a
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situation, solving the DA equation is not always possible using analytical methods. There
are however a series of simple or semi-complex geometries where analytical solutions
can be derived that will allow direct calculation of light intensity a given distance from
the source. An analytical solution is the fastest way to calculate light fluence in order
to reconstruct measurement data and is used in fNIRS systems where real time data
processing is required and the geometries are simple.
In a majority of cases a continuous wave fNIRS device would be used to measure
differential changes in chromophore concentrations from a single source-detector pair. In
this situation the change in detected intensity can directly be used with the modified BLL
equation and a value for differential path length (obtained analytically or experimentally)
in order to obtain a value of global chromophore changes in the target volume.
The analytical solution to the diffusion approximation can also be used to find more
accurate estimates of the absorption and scattering coefficients (depending on the mea-
surement type) to improve the accuracy of the recovered chromophore concentrations.
Analytical solutions to the diffusion approximation for various geometries (such as slabs
cylinders and spheres) have been derived using Green’s functions [75]: these models can
be used to provide estimations of the differential path length (DPL) or used for forward
modelling of data. These solutions tend to be based on a homogeneous medium although
there are analytical solutions to the DA, which are built on more complex heterogeneous
layered models such as layered slabs [90]. Even with more complex geometries, analytical
solutions can only provide accurate results in certain situations (e.g., Muscle oximetry).
Equation 3.1 shows the analytical solution to the diffusion approximation for a semi
infinite half-space geometry for an impulse delta function impulse. Where R give the
intensity of the reflected light at time (t) after the impulse, when the detector is a distance
ρ from the source, µa and µ
′
s are the absorption and reduced scattering coefficients, c is the
speed of light in the medium, and D is the diffusion coefficient [76]. The light attenuation
(A) at a distance from the source ρ is described as the negative log of the integral of R over
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all time. So by modelling a small change in absorption (δµa) to find the change in light
attenuation (δA), a value of the differential path length (DPL) can be estimated for the
medium (Equation 3.2). Here the attenuation, A, (or OD) is defined as log( I0
I
), the log
ratio of input to output intensity or, for δA, the intensity change between measurements.












In the situation where there are multiple source-detector pairs at different separations,
such as a DOT array, the approach for using an analytical solution to the DA is less
direct; this is where forward modelling of boundary data is used. Boundary data is simply
a simulation of the intensity measured at given points on the boundary of a medium, in
this case a semi infinite slab. The fitting routines do vary but a general methodology
for fitting measurement data to an analytical model in order to obtain optical property
estimates, µa and µ
′
s is outlined in Figure 3.1. Each time the simulated and measurement
dataset are compared the optical properties given to the analytical model are updated,
until the mismatch between the two datasets reaches a predefined level, or a set number
of iterations are reached. Due to the simplicity of analytical models this process is still
very fast even in the event of modelling large arrays of sources and detectors.
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Figure 3.1: Example routine for obtaining optical properties from forward modelling of
boundary data.
Using this generalised method to hone in on a set of absorption and reduced scattering
coefficients that best fit the measured data, the optical properties can be converted into
chromophore concentrations using Equation 2.3. The example shown below is an example
of how intensity and phase data can be fitted to an analytical model of an infinite slab,
in order to produce a set of global optical properties, this technique, often used for the
calibration of data for numerical reconstruction methods (e.g., in NIRFAST), discussed
later in this chapter [91, 63]. The iterative fitting algorithm is in itself technically a nu-
merical method however as it is using the analytical solution to generate forward data it
is included in this section. This is by no means an exhaustive list of the analytical solu-
tions, but rather an example of its potential applications (analytical solutions for different
geometries can be found in Arridge et al [75]).
In this example the measurement data contains both intensity and phase information
and therefore fitting forward data to a measured dataset is done with respect to two
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parameters. The first parameter ( δφ
δr
)) is the slope of phase (φ) versus source-detector
distance (r) and the second parameter is the slope of the log intensity (I) multiplied by
source-detector distance (r), versus source-detector distance ( δln(rI)
δr
) (Example shown in
figure 3.2). Both of these parameters can be found to be stable in the analytical solution
for an infinite medium [91].
Figure 3.2: Example of intensity (A) and phase (B) data produced in NIRFAST ready
for fitting to an analytical model [63].
The fitting is implemented using numerical approximation of the Newton-Raphson method
[92], and aims to find a solution for µa and µ
′
s where the following conditions in Equa-
tions 3.3 and 3.4 are met. The Newton-Raphson method requires an initial guess at the
suspected root, xn, (optical properties in this case), with n being the iteration of the fit.
A Taylor expansion of the function (f(xn)) up to first order is taken to give a tangent
to the function at a given point, xn, then the root of the tangent is found and used to
adjust the value of xn to a root, xn+1 is closer to the actual root of the function using
the formula xn+1 = xn − fxnf ′n . The functions being fitted in this situation are shown in
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Where I and φ are the intensity and phase at the measurement location for the simulated






For the infinite medium being modelled, the Equations for ( δln(rI)
δr
) and ( δφ
δr
) are shown















































In applying this to the fitting of optical properties the following ’update’ equations can
be produced, where ∆µ is the update to the absorption or reduced scattering coefficient
at each iteration and d is a small update to the optical properties (0.0001 in this case
[91]). µ represents the measurement data properties being calculated by perturbating the






















(µ0)− δφδr (µ0 + d)
(3.8)
This method has been shown to converge where the measurement data is good; how-
ever, in the situation where the data is noisy or the initial guess at the optical properties
is far from the solution, the Netwon-Raphson method can break down and give incorrect
results. This can also be an issue when the analytical model being used is not truly rep-
resentative of the measurement geometry or where the changes in optical properties are
expected to be large (i.e., the changes are not small enough to be linear). For more com-
plex geometry modelling of a layered head for example, numerical methods are required
to obtain more accurate results.
3.1.1 Numerical Methods
When looking at more complex geometries, analytical solution may be either unavailable
or inappropriate, instead numerical methods can be used to model forward data for re-
constructions. Whereas an analytical solution will most often be fully homogeneous or
nearly homogeneous in its interior values, a numerical solution can use fully heteroge-
neous models to give more accurate results, although the reconstruction time is longer.
Numerical solutions are often performed using finite element models (FEM), which are
utilised in the following chapters to reconstruct data and will be explained in detail in
Section 3.1.1.
Monte Carlo (MC) is another numerical method of modelling the RTE and is often
used as a gold standard for validation of other computer models with heterogeneous media
[93]. MC uses a statistical approach to modelling and simulates the paths of millions of
individual photons through a series of random walks until a set level of counting statistics
obtained. The MC techniques are highly versatile and have been implemented for multi-
layered tissues geometries, such as that of the human head [94, 95]. The computational
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time required to complete the simulations is the reason MC methods are not currently
as widely used as FEM-based approaches, however there have been many advances in
both parallel computing and utilisation of graphics processing units in order to reduce
this computational time [96, 97].
In the following section an outline of how optical properties can be reconstructed using
numerical methods will be shown, as a demonstration a FEM-based approach will be used
to produce forward data.
Reconstruction Routines
In this section two different types of reconstruction will be discussed, a linear single step
routine and an iterative non-linear routine. Linear reconstructions are for measuring small
perturbations in the optical proper/chromophore concentration of a medium based on a
small change in detected light intensity (δI = ln(Ianom) − ln(Iref )). A non-linear recon-
struction uses an iterative routine to make many small updates to the optical properties
until converging on a solution. This method is better suited for finding quantitatively ac-
curate chromophore concentrations and for situations where the changes in chromophore
concentration are large, as reconstruction can be done on a single set of intensity values
so no ’difference’ data is required. Both methods require the use of a forward model for
data simulation.
Finite Element Models - are a method of solving partial differential equations
such as the diffusion approximation by discretising a complex geometry (see example of
a head FEM in Figure 3.3), into a series of small tetrahedral, non-overlapping, elements
over which the optical properties can be considered constant (a method that has been
validated though MC methods) [98, 63, 99]. As the DA is non-linear with respect to
optical properties, breaking down an imaging domain into a series of small elements
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acts to create many small areas over which optical properties can be considered linear.
Therefore, finding the light fluence at any given point in a model becomes a system of
linear algebraic equations that can be solved in matrix form [63]. A tetrahedron is the
most common element shape for a 3D geometry, a 2D geometry would be represented
using triangles. For 3D geometries each element in the tetrahedron is represented by 4
nodes, apart from the surface of the mesh, which will have three nodes and a triangular
element. As the source modelled in the DA is isotropic, the source within a FEM is placed
one scattering distance ( 1
µ′s
) inside the outer boundary [63].
Figure 3.3: Example of a finite element model of a head [58].
The meshes used for FEM-based approaches can be produced in a variety of ways such
as segmentation of a 2D imaging stack from modalities like MRI or CT (which will be
covered in Chapter 5) or volumes obtained through surface capture. There are numerous
software packages available for mesh generation with two open-source examples being
iso2mesh [100] and NIRFAST [63], with the latter being the package used within this
thesis (see later chapters).
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The Jacobian Matrix - The Jacobian defines the relationship between the changes
boundary data of a particular model with respect to a small change in optical properties
over all nodes. For this reason it is often referred to as the ’sensitivity’ matrix. The changes
in optical properties can either be ’standard’ absorption and scatter coefficients (for single
wavelength cases) or chromophore concentrations for spectral (multiple wavelength) cases.
In the spectral cases a constrained fit to the modified BLL is used to translate optical
properties into chromophore concentrations, and Mie scattering theory is used to translate
scattering coefficients into a generalised scatter power and amplitude (from Section 2).
The structure of a standard and a spectral Jacobian matrix are shown in Figures 3.4 and
3.5, respectively.
Figure 3.4: Structure of Jacobian matrix for a single wavelength case. The optical prop-
erties µ are separated into absorption µa and the diffusion coefficient κ (referred to previ-




are sub-matrices showing the change in log intensity arising





are similar sub matrices corresponding to changes in phase data from
frequency domain measurements [19].
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Figure 3.5: Structure of the Jacobian matrix for a spectral, multi wavelength case. There
is a sub-matrix for each chromophore (c), the scatter amplitude (a) and scatter power (b)
for each measurement wavelength, each having dimensions of the number of mesh nodes
by the number of measurements [19]. NN is the number of unknown parameters and NM
is the number of boundary measurements.
The Jacobian matrix can be calculated in a number of ways, the method implemented in
NIRFAST and thus the reconstructions in later chapters is known as the adjoint method.
The adjoint theorem states that measurement of flux at a detector j on a mesh due
to a source at node i is equal to the measurement of photon density at node i that
can be attributed to a source at detector j [19]. There are other methods that are
more computational intensive, such as the perturbation method where forward data is
produced both before and after a small change in optical properties, or the direct method
that involves differentiation of the DA equation to obtain the values at each node.
Linear single step reconstructions - As mentioned previously, this reconstruc-
tion method is designed to use ’difference’ data in order to calculate small changes in
chromophore concentration/optical properties within a medium. This method relies on
the production of a Jacobian matrix from the forward model. As the Jacobian represents
the influence each node in a simulated volume has on the boundary data, by inverting
the Jacobian (J−1) and multiplying it be the change in measure boundary data (δI) the






) = Jδµ (3.9)
Where Iref represents a reference set of boundary measurements from which to measure
the change to the current time point Ianom. δµ represents the change in optical properties,
which depending on the format of the Jacobian (J) can be either absorption and scattering
coefficients or chromophore concentrations.
δµ = J−1δI (3.10)
Non-linear iterative reconstructions - Non-linear reconstruction use the same
approach of generating forward data based on an initial set of optical properties, however
this time an inverse model to update the optical properties is used to hone in on a
quantitatively accurate set of recovered parameters rather than just measuring changes
in optical properties. The general steps of the reconstruction routine are as follows [65].
1. Model probe and geometry of medium - initial guess at optical properties. Here the
input is a 3D mesh where each node is assigned a set of optical properties. The
coordinates of the sources and detectors on the mesh are defined.
2. Run Forward Model - FEM or MC approach. Using the models produced in the
previous step the light path from each of the sources is simulated to produce a set
of boundary data (i.e. a set of intensity measurements at each detector position),
and a Jacobian matrix for the model.
3. Calculate root mean squared error between the simulated boundary data, from the
previous step, and the inputted measurement data. This will produce a single error
value that can be check against a predefined tolerance value. If the error is within
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tolerance the reconstruction will end, if the error is above the tolerance then the
reconstruction will move to the next iteration.
4. Inverse problem is set up to update the optical properties of the model. Here the
Jacobian matrix is inverted and any regularisation applied before solving Equation
3.10.
5. The inverse problem, Equation 3.10, is solved producing an update for the optical
properties at each node in the model.
6. The optical properties of the model are updated and the loop returns to step 2. This
process will continue until a predefined error or number of iterations is reached.
The initial guess at optical properties can either be based on a calibration of ex-
perimentally derived parameters, which can then be used to produce a set of boundary
intensity measurements in the same format as the measurement data. Step 3 is usually
performed using a modified version of the Tikhonov minimisation, which looks at the least
squares error and is particularly suited to ill-posed problems [102]. The modified version











ΦM and ΦC are the measurement data and forward data respectively, with NM being
the number of measurements and NN being the number of nodes. λ is the Tikhonov
regularisation parameter, µj and µ0 are the calculated and initial guess at absorption
coefficient, with χ2 representing mismatch error between them. To minimise this function
the first order derivative is set to 0. λ is defined as the ratio of the variances between the
measured and the initial estimate of the optical properties. Generally, for a good estimate
large λ values are used in order to make small changes to the model properties. For poor
guesses small λ values are used to allow larger updates to the model properties. Step
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4 involves calculation of the Jacobian (from the forward model). Once the Jacobian is
calculated it is inverted using the Moore-Penrose generalised inverse [103] and regularised
to solve the inverse problem (Equation 3.12) to give the optical property value update
before starting the next iteration. As the Jacobian is a non-square matrix it must be
multiplied by its transpose before it can be inverted.
(JTJ + λI)δµ = JT δΦ− λ(µi − µ0) (3.12)
J and JT are the Jacobian matrix and its transpose, I is an identity matrix, δΦ is
the data mismatch and δµ is the update to the optical properties or chromophore con-
centration depend on whether standard or spectral reconstruction are being performed.
The iterative process will stop once a predefined number of iterations have passed or a
set projection error between modelled and measured data is reached.
Numerical methods offer a powerful tool in the accurate reconstruction of chromophore
concentrations. The limitation being that large datasets must be collected in order to
reconstruct the already ill-posed (meaning that there are more unknowns than there are
measurements [19]) problem and the iterative solutions take minutes-hours (unless using
single step reconstructions) to hone in on the correct set of values depending on the size
of the mesh. This method can also be used to perform dynamic imaging to speed up
reconstruction time by pre-calculating and inverting the Jacobian then using a single step
calculation rather then iterating through.
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3.2 Methods for reducing Superficial Signal Contam-
ination
As the topic of superficial contamination is a prominent issue within NIR imaging and
spectroscopy, this next section is designed to explore some to the methods that have be
devised to reduce its the effects. The methods range from system design to computational
processing.
System Design - While it is only necessary to have one source detector pair to
calculate changes in chromophore concentration in a medium, this one pair will sample
deep signals as well as superficial signals. Therefore, the first method for reducing su-
perficial contamination is the use of multi-distant source-detector combinations. A close
source-detector (SD) pair at around 15 mm apart will sample mainly superficial regions
and a SD pair at around 30 mm will sample both deep and superficial regions. Therefore
the short SD measurement can be used as a regressor to remove the superficial contribu-
tions [104, 105, 49]. This is a feature that is almost inherent in DOT devices where 3D
reconstructions of optical properties automatically separate contributions by layer [104],
also having multiple overlapping measurements obtained over a smaller sample area will
improve the ill-posed nature of the inverse problem that can improve reconstruction ac-
curacy [60]. Even though DOT systems reconstruct 3D properties, they still suffer from
hypersensitivity in the superficial regions (a side effect of the exponential decrease on
light intensity with distance) so the deep signals are still underestimated. To account for
this an extra form of regularisation can be added into the Jacobian matrix formation that
provides a depth-based weighting to reduced hypersensitivity to superficial changes [106].
Time Resolved Spectroscopy - Systems capable of preforming time resolved
measurements can also be used to reduced the amount of superficial signal contamination.
A time resolved system will use a laser source capable of producing an input pulse in the
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picosecond range. Then using a high-speed detector, the output intensity from a single
pulse can be measured over time (ns range) to produce a temporal point spread function
(example shown in Figure 3.6).
Figure 3.6: Illustration of time resolved spectroscopy.
The ’early’ photons have only traversed the shortest distance between the source and
detector and the ’late’ photons will have travelled the furthest. In the context of perform-
ing measurements on the head, the ’early’ photons represent shallow photons which have
passed mainly through the superficial skin and bone tissues, whereas the ’late’ photons
will have travelled into the deeper brain tissue. Therefore by using only the ’late’ photons
in the reconstruction process the influence of the superficial layers can be reduced.
Signal Filtering - Another method of reducing superficial contamination is fre-
quency domain filtering. While this method will not directly affect the quantitative ac-
curacy of recovered parameters, it can be used to remove variations in the signals that
are not due to deep tissue changes. The variations in question are physiological signals
that are present in superficial tissues such as cardiac pulsation, respiratory changes and
blood pressure (Mayer) waves (shown in Figure 3.7 [107] . These signals can be filtered
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out using band-pass or high-pass filter after performing a Fourier transform on the time
series data. The blood pressure and respiratory signals tend to be between 0.08 Hz and
0.12 Hz, with cardiac signals being at 1 Hz (60 beats per minute).
Figure 3.7: Example of physiological noise in fNIRS signals [107].
Reconstruction Models - Another method of reducing superficial contamination
and parameter recovery in general is to use more accurate models for forward data simu-
lation. If the model is a good match for the medium in terms of its internal and external
structure then this structural prior information can be used to inform the DOT recon-
struction process meaning better reconstruction accuracy. Realistic head models can be
produced through segmentation and meshing of MRI or CT data [58] . Functional MRI
data has also been used as a way to regress out superficial signals in a technique known
as extended superficial signal regression (ESSR), where Blood Oxygen Level Dependant
(BOLD) MRI changes in scalp voxels are used to inform reconstructions [108].
Spatially Resolved Spectroscopy - Another algorithm, which has been used
with fNIRS devices, is spatially resolved spectroscopy (SRS).
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Figure 3.8: Illustration of NIRO 300 (Hamamatsu, Japan) setup to obtain spatially re-
solved spectroscopy measurements [76].
Spatial resolved spectroscopy (SRS) was a technique developed in 1999 aimed at obtaining
a relative index measure of tissue oxygenation (TOI) and tissue haemoglobin (THI) in
deep tissues, without contamination from superficial layers by analysing the gradient over
a series of multi-distance detectors (see Figures 3.8 and 3.9) [76].
Figure 3.9: A - Illustration of the spatially resolved spectroscopy measurements of light
attenuation (A) at distance (ρ) from the source. B Plotting gradient of light attenuation
measurements (A) over distance (ρ) to give ( δA
δρ
)
SRS is a widely used algorithm (Equations 3.13 and 3.14) and was derived through differ-














k is an unknown constant, λ is wavelength, µa is the absorption coefficient, A is the detec-
tor measurement, ρ is the distance between detectors, and ε is the extinction coefficient.
From the relative concentrations of HbO and HHb the TOI (oxygen saturation equivalent)
and THI (HbT equivalent) can be produced. Using the technique requires measuring δA
δρ
;
this is change (gradient) in detected light that is attenuated over a series of multi-distance
detectors shown in Figure 3.9.
kHbO
kHHb






This method is not designed to improve quantitative accuracy of recovered parameters;
instead its primary focus is to simply map deep signal changes. It has been veried for
phantoms and been used for both muscle oximetry work and cerebral monitoring [76,
5, 109]. TOI and THI are calculated in the same way as SO2 and HbT respectively,
however, instead of using HbO and HHb values they use the relative kHbO and kHHb
values calculated in Equation 3.14.
3.3 Summary
This section has discussed the different methods that can be used to model NIR light prop-
agation through a medium for use in data reconstruction. With the exception of simple
fNIRS, which directly calculates chromophore concentration changes using the modified
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BLL, all other reconstructions required a model to produce forward data. Analytical so-
lutions to the DA can be made for simple, often homogeneous media, however numerical
methods are required to model more complex heterogeneous media. Numerical methods
take longer to produce forward data, however they are more versatile than analytical
models.
Reconstruction of small changes in optical parameters can be achieved using back
projection of ’difference’ data using the inverted Jacobian matrix (sensitivity matrix) in
a linear single step process. For a more quantitative reconstruction, a non-linear iterative
fitting routine is used to hone in on a more accurate set of optical parameters. All
reconstructions will inherently have hypersensitivity to shallow (superficial) signals and
therefore a multitude of techniques have been devised to reduce the effect. The use of short
SD separation and overlapping measurements are the most common forms of regressing or
reconstructing for superficial signals. Filtering of data in the frequency domain can also
be used to remove any signal variations due to physiological noise. The SRS technique can
also be used to weight reconstructed parameters towards deep tissue changes and hence
reduce superficial influence. Testing of the SRS method as well as other fNIRS devices
and probe geometries are performed in Chapter 4.
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CHAPTER 4
NEAR INFRARED SPECTROSCOPY - DEVICE
SIMULATION AND TESTING
4.1 Introduction and Aims
The main aim of this chapter is to address the concerns in the literature (outlined in
Chapter 1) that cerebral changes measured by fNIRS devices are obscured by variations
in superficial haemodynamics, which is limiting the use of fNIRS in TBI where no norma-
tive baseline measurements are available to reference chromophore changes. This is done
through a series of simulations and healthy volunteer studies, starting by going back to
basics and looking at the sensitivity of a number of commercial fNIRS probe geometries
to absorption changes in the brain, through model-based analysis using NIRFAST. Such
testing yields information about the desirable features of a fNIRS probe in order to fine
tune any future hardware developments and answers the fundamental question of whether
we are in fact capable of detecting cerebral signals. The aim of these studies was to con-
firm the validity of fNIRS signals and assess the accuracy of some of the commercially
employed algorithms designed to reduce the effects of superficial contamination.
In order to test fNIRS devices in both simulation and healthy volunteer investigations,
a testing protocol was required that would allow differentiation between superficial and
cerebral haemodynamics. For this the Valsalva Manoeuvre (VM), detailed in Section 4.3,
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was used as it can induced profoundly different changes in the superficial and cerebral
tissues and thus making the signal origins easier to trace. Using this protocol, two com-
mercial available probes were modelled. The first was the NIRO-200NX (Hamamatsu,
Japan), a CW system that uses the Spatially Resolved Spectroscopy (SRS) method to
look at relative changes in deep tissue oxygenation. The second was the ISS Oxiplex
TS (Imagent, USA), a FD system using multi-distant, AC intensity, measurements, along
with phase, to determine quantitative scatter and absorption coefficients. The ISS system
was also used in healthy volunteer investigations where the level of superficial contamina-
tion was artificially lowered through the use of vasopressor injections to the forehead, in
order to investigate the effect on the fNIRS signals when skin blood flow is reduced and
therefore the potential for signal contamination.
4.2 Sensitivity simulations on existing fNIRS probe
geometries
4.2.1 Jacobian Analysis
As described in Chapter 2, the Jacobian matrix is the differential of the surface measure-
ments with respect to the optical properties of a model at a given point. Therefore, it can
be referred to as a sensitivity matrix, describing how much influence a change in optical
properties, at a particular point in the model, will have on the overall detector measure-
ments. Thus, analysis of the Jacobian matrix is a good way to assess the sensitivity of
different probe geometries to absorption changes in the brain. As the main aim of this
work is to develop fNIRS for use in TBI, the sensitivity of the probe geometries will be
assessed at a depth of 21 ± 4 mm from the surface of the head as this is the average depth
of the white-grey matter interface as measured from patient CT scans [42].
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Methodology
For the simulations five commercially available fNIRS probe geometries (details in Ap-
pendix .1) were positioned centrally on the forehead region of the ICBM152 Atlas model
[58, 110, 111], 3 cm above the nasion point (the air sinus was not included in the model).
The ICBM152 Atlas model is based on the average of 152 segmented head MRIs, and was
designed for use in brain activation studies [111]. The Atlas model was processed using
NIRVIEW [112] to create a series of masks that were imported into NIRFAST [63] and
used as a basis for volumetric mesh creation. The node spacing in the meshing process
was set to 1.5 mm, which gave a total of 574,999 nodes. To decrease the reconstruction
times the Atlas model was cropped to a smaller forehead region and re-meshed at the
same node spacing so the number of nodes was reduced to 111,840 (Figure 4.1A and B).
The internal structure of the Atlas model consisted of 5 layers, 1 - Skin, 2 - Bone, 3 -
Cerebral spinal fluid (CSF), 4 - White matter and 5 - Grey matter, as shown in Figure
4.1C, however for the purpose of the simulations, regions 3-5 were grouped into a single
’brain’ region, labelled 3. The optical properties of the mesh used for the simulations were
taken from the literature [113] and are shown in Appendix .2.
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Figure 4.1: Atlas model used for NIRFAST simulations. A - Whole head, B - Clipped
head showing internal structure, C - Cropped forehead region. The region labels are: 1 -
Skin, 2 - Bone, 3 - Cerebral spinal fluid (CSF), 4 - White matter and, 5 - Grey matter.
The 5 probe geometries modelled were the: INVOS 5100C-PB (Covidien; Boulder, CO);
EQUANOX Classic 7600 (Nonin Medical Inc; Plymouth,MN); FORE-SIGHT (CAS Med-
ical Systems Inc; Branford,CT); NIRO-200NX (Hamamatsu, Japan) and ISS Oxiplex TS
(ISS Inc, USA). Figure 4.3 shows the positioning of the EQUANOX probe geometry on
the Atlas model. The probe details are shown in Figure 4.2.
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Figure 4.2: Details and schematics of the five probe geometries being modelled in this
investigation. For the schematic diagrams X represents a detector and O represents a
source.
Usually fNIRS probes would be positioned to the left or right of the forehead in order
to avoid the air sinus located centrally on the forehead above the bridge of the nose.
However, the sinus is not modelled in the Atlas and so the probes were positioned central
for simplicity as the target volume being sample has the same region thicknesses.
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Figure 4.3: Example of fNIRS probe geometry modelled on the Atlas
The Jacobian matrix was calculated in NIRFAST for a continuous wave spectral (at the
given wavelengths for each fNIRS probe) model. The Jacobian, as described in Chapter
2, contains sensitivity values for each node with respect to all the source wavelengths
and measured chromophore (HbO, HHb, Scatter power and amplitude etc.). Therefore
in order to obtain a combined sensitivity the Jacobian was summed over all wavelengths
and chromophores to give a singular sensitivity value per node. Starting at the central
point of the probe in the axial plane, the sensitivity profile was taken as the values along
a path perpendicular to this point in the coronal plane.
Results
It is an inherent part of all fNIRS probes that there will be a majority of the sensitivity
in the shallow depths just underneath the sources and detectors. This leads to recon-
structed parameters being heavily weighted towards superficial changes. Therefore, the
ideal probe geometry would have an even sensitivity with depth, however as this is an
unrealistic aim the probe sensitivities are assessed by locally normalising each Jacobian
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so then we can look at the sensitivity of the probe geometry as a function of its maxi-
mum sensitivity values, showing which has the most ’even’ response (shown in Figure 4.4).
Figure 4.4: Sensitivity profiles for the 5 fNIRS probe geometries modelled on the Atlas.
Each probe is normalised to its own maximum sensitivity. The region of interest is the
’ideal’ target depth measured from 50 CT scans of TBI patients and has its lower bound
at A - 17 mm and its upper band at B - 25 mm (shown by the black dashed lines).
The locally normalised sensitivity data suggested that the FORESIGHT probe had
the greatest sensitivity to the brain region as a function of its maximum sensitivity value.
This highlights the use of long source-detector separations (50 mm in this case) and the
use of multiple wavelengths. The simulations also showed that all the probe geometries
are capable of sampling at a depth relevant for monitoring usable TBI parameters. Only
sensitivity values greater than the noise threshold of 1% were considered relevant. While
the noise threshold of a system will typically be defined by the dynamic range of the
detectors and will vary based on the source-detector separation, 1% was used as a repre-
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sentative noise floor for the simulations as it is in line with literature values quoting noise
levels of 0.12-1.42 % for separation of 13-48 mm respectively [113]. This is an example
of one probe location on the head model. If the sensitivity was sampled over multiple
probe locations we would expect to see a range differing depth sensitivity values. This is
because the composition of the target volume will change, meaning there will be different
levels of scatter and absorption.
Conclusion
Jacobian analysis has highlighted that the key to increased sensitivity in the brain region
is the use of multiple wavelengths and the use of long source-detector separations (even
though in reality the maximum separation will be defined by the signal-to-noise ratio of the
system and the dynamic range of the detectors). Over all the probe geometries modelled
there was clearly hypersensitivity in the superficial (shallow) regions in comparison to
deep (brain) regions. Despite this all probe geometries showed the ability to sample the
brain at the depth of 21 ± 4 mm, but had sensitivity values of greater than 1% of their
maximum value.
4.2.2 Singular Value Analysis
Singular value analysis of the Jacobian has been used throughout the field of NIR imaging;
used to optimise source-detector locations [114] and as a form of regularisation in the
reconstruction process [115, 116]. The singular value decomposition of a matrix, in this
case the Jacobian, takes the form shown in Equation 4.1.
J = USV T (4.1)
Where J is the Jacobian matrix, U and V are orthonormal matrices that contain the
eigenvectors of J, and S is a matrix containing the singular vales of J [116]. The matri-
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ces U and V can be thought of as the eigenvectors in the detection and imaging space
respectively. The magnitude of S defines the ’importance’ of paired eigenvectors between
U and V. In essence the higher the singular values (with magnitudes over a given noise
threshold) the more information there is to link the detection and imaging spaces, thus
providing better reconstruction detail or resolution.
Methodology
By extending this principle to Jacobian values corresponding to the brain region only,
it is possible to assess the ’information content’ a given probe geometry can provide
for reconstruction of brain tissue changes. Using the same mesh as was used for the
Jacobian analysis in Section 4.2.1, the singular values of the Jacobian nodes corresponding
to brain regions only were calculated using the MATLAB SVD function. The probe
geometries and optical properties from Appendix .1 and .2, respectively, were used to
produce the Jacobian in NIRFAST before singular value decomposition was implemented.
The magnitude of the singular values for each probe was normalised to its own maximum
values in order to give a comparison between probes. As there was no noise in the
simulations the noise level from literature sources was implemented as 1% of the maximum
singular value magnitude [116].
Results
The results in Figure 4.5 show that the probe geometry with the greatest information
content in the brain region was the EQUANOX. This probe has the largest number of
measurement channels and highlights the benefit of collecting overlapping measurements
at multiple wavelengths.
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Figure 4.5: Magnitude of singular values obtain from Jacobian sensitivity values cor-
responding the brain nodes in the Atlas-head model from each of the 5 fNIRS probe
geometries. The magnitude of the singular values are normalised to its local maximum.
The noise threshold is shown as 1% of the normalised maximum.
Figure 4.6 quantifies the locally normalised magnitude of singular values over the 1%
noise threshold. It shows that the probe with the second greatest information content in
the brain is the ISS probe; another probe that uses a series of multi-distant, overlapping
measurements. All of the probe geometries simulated showed information content in
the brain tissue regions; the SVD analysis highlighted the key features of probes, which
maximised brain region information content i.e., multiple wavelengths and overlapping
source-detector pairs.
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Figure 4.6: Magnitude of singular values over the noise threshold for each of the 5 probe
geometries normalised to their own maximum value
Conclusion
Singular value analysis of existing fNIRS probe geometries has highlighted the benefits
of using overlapping and multi-distant measurement channels. The analysis also confirms
that all the simulated probe geometries do provide information in the brain region. This
information is valuable in confirming the validity of current fNIRS systems and also pro-
vides further insight into methods of developing the technology further to allow it to be
used as a TBI monitoring tool. The Jacobian sensitivity studies showed the need for large
source-detector separations for a probe to increase sensitivity to brain tissue; the SVD
analysis shows that to maximise this it must also be combined with the use of overlapping
measurements at multiple wavelengths.
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4.3 Healthy Volunteer Investigation testing method
- The Valsalva Manoeuvre
For a more in depth assessment of fNIRS, in the context of TBI monitoring, a physiological
model is required that will simulate some of the acute changes that clinicians would be
looking for, such as a large desaturation (hypoxia) in the brain. As well as cerebral
changes it is important for the model to have a unique set of superficial changes so as to
provide a test of how well fNIRS devices can separate out cerebral from superficial signals.
This is important because in TBI, systemic measures of blood saturation may not mirror
that of the brain. Considering these criteria the Valsalva Manoeuvre (VM) was selected
as an appropriate model.
4.3.1 What is the Valsalva Manoeuvre?
In its simplest form the VM is straining and occurs often in day-to-day life. Heavy lifting,
coughing and even playing wind instruments are all activities that incorporate some form
of the VM of a varying intensity [117, 109]. The main reason the VM is of interest to
NIRS investigations is that it will induce profoundly different acute responses in cerebral
and somatic tissues. Empirically we know the act of straining can cause people to become
dizzy and pass out, we also can see that people become flushed and red-faced. From
this evidence it can be deduced that there is clearly a lack of oxygen in the brain, hence
the black outs, but at the same time there is clearly a large pooling of blood in the
facial tissues. These observations can be backed up but by a wealth of quantitative data
discussed later in Section 4.3.2.
The technical terminology for a VM is the act of forced respiratory expiration against
a closed glottis, raising intra thoracic pressure (Figure 4.7A and B). During the initial
∼2-3 seconds, perfusion pressure is elevated, which is associated with an acute increase in
blood flow in the cerebral and systemic circulations [118], this is what causes the subject
to go red in the face (Figure 4.7B). As the VM continues, venous return to the heart
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is impeded by the raised intra thoracic pressure. This produces a marked reduction in
cardiac output and thus blood pressure. The increased intra thoracic pressure also impairs
venous outflow from the brain, causing an increase in intra-cranial pressure and venous
pooling within the brain and systemic tissue (Figure 4.7C). On release of the VM, the
pooled blood is released (Figure 4.7D). It has been used previously as a tool for checking
cerebral auto regulation [119, 120, 121] and observing changes in intracranial pressure
[122]. The use of the VM has not been limited to brain studies, it has also be used to
detect changes in blood pressure response [123], fluid responsiveness [124] and congestive
heart defects [125]. Despite its range of use, some research has questioned whether with all
the changes induced by a VM, it may be too complex for assessing cerebral autoregulation
[126].
Figure 4.7: Diagrammatic representation of the stages in a Valsalva from A to D
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The body’s response to a VM has been categorised into 4 phases, which relate to the
changes in mean arterial pressure (MAP) and which are outlined in Figure 4.8 [127, 109].
The 4 phase response in Figure 4.8 is for a supine VM, performing a VM while in a supine
position will decrease the magnitude of the response in comparison to a standing VM.






Figure 4.8: Four phases of the VM in terms of mean arterial pressure blood response
[124].
1. Phase I - increase in MAP as intrathoracic pressures force blood towards the head.
2. Phase IIa - decrease in MAP as the return of systemic blood to the heart is impeded.
3. Phase IIb - arterial baroreflex responds to drop in MAP, resulting in heart rate
increasing.
4. Phase III - As the VM is released the MAP drops rapidly as venous congestion is
removed.
5. Phase IV - The MAP overshoots to compensate for the phase III drop.
Maximal Valsalva Manoeuvre - It is possible to grade a VM by measuring
the expiratory pressure with respect to a maximal expiratory effort. The model of the
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VM implemented for this PhD research was termed a ’maximal’ effort, standing, VM
where expiratory pressure was at the subjects maximum. The predicted haemodynamic
responses shown in the next section are based on a maximal effort VM held for 10 s; a
model design to invoke the most dynamic changes in cerebral and somatic tissues. The 10
s maximal VM is capable of causing a subject to faint i.e., the levels of cerebral hypoxia
are sufficient to cause dysfunction.
4.3.2 Predicted Haemodynamic changes during a Valsalva Ma-
noeuvre
The following section constructs the basis for the predicted changes in haemodynamics
occurring over a 10 s, maximal effort, standing VM. While there exists a wealth of in-
formation of VM-based changes from a wide variety of monitoring modalities (discussed
below), there is no ’gold standard, which can be used to tell us, exactly what changes in
haemoglobin concentration and oxygen saturation will occur. Therefore this section aims
at deriving the most likely set of changes from the available data, however they are still an
estimate. As the Atlas model being used for fNIRS/DOT simulations and reconstructions
has three tissue layers (i.e., skin, bone and brain) a set of responses are devised for each
layer starting from optical properties used in the literature [113]; one adjustment to these
baseline values was the increase in skin saturation from 80% to ∼ 95% to reflect the lower
metabolic demand in somatic tissue. Only changes to the skin and brain haemodynamics
are predicted, the assumption is made that the bone will show no dramatic change during
a VM due to its already low HbT concentration.
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Figure 4.9: Blood pressure response during a 10 s VM over 9 subjects recorded as part
of the preliminary investigations into using the VM for fNIRS testing (Average over all
subjects).
Immediately after the onset of the VM there is a blood pressure spike (Figure 4.9),
indicating that blood is being force upwards into the head via increased perfusion pressure
and thus causing an increase in HbT concentration. The skull essentially makes a sealed
box around the brain, so there is a limit to how much blood can be forced in during
this initial phase, before the reduction in the driving force due to the impaired cardiac
output associated with the reduced venous return (phase IIa). Figure 4.10 illustrates this
flow response to a VM as measured via blood flow velocity in the middle cerebral artery
[118]; and this initial peak response is further supported by the fact that ICP will increase
during a VM [122].
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Figure 4.10: Percentage change from mean flow velocity in the middle cerebral artery mea-
sured with transcranial Doppler over a 10s VM [118]. The triangle, square and diamond
markers represent 30 %, 60 % and 90 % maximal VMs.
The skin however contains blood vessels that can expand and accommodate blood through
pooling, so the HbT concentration in somatic tissue can still climb until being limited by
the impaired cardiac output (Figure 4.11).
Figure 4.11: Percentage change in cardiac output during a 15s (non maximal) VM [117].
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Drawing together all of this information allows prediction of the changes in HbT for the
modelled VM as displayed in Figure 4.12. The VM is modelled over a 32 s period split into
2 s sample points, allowing for a 10s VM with a 10/12 s baseline before and after (longer for
recovery). The choice to use 2 s samples point was to speed up the reconstruction process
in the later simulation studies. Even with a wealth of blood pressure and blood flow
metrics available there is currently no gold standard method that can map the changes in
HbT during a VM. Therefore, to predict a model for the VM, the focus was on the large-
scale changes. Over the course of the VM we know that initially we expect an increase in
the amount of blood being forced into the head through increased intrathoracic pressure.
This is seen in the blood pressure, middle cerebral artery velocity and cardiac output
data (Figures 4.9-11 respectively) that all show an increase of ∼20-40 % within the first
second of the VM. Therefore, we chose to model the initial increase in HbT concentration
as a 30 % increase in both the skin and the brain within the first 4 s. From here until the
release of the VM the predicted changes are more qualitative. We can see that the blood
pressure and cardiac output drop, so we know blood is trapped in the head. In the brain
the volume is fix and thus the concentration of HbT maintains a constant level. The skin
and facial tissues however can increase in volume; this is why we predict a more gradual
increase in HbT initially, which can then start to decrease in the final few seconds of the
VM. After the release of the VM we can see from the blood pressure that there is a spike
of much smaller magnitude than the initial increase at the VM onset. This we model as
a ∼ 10 % increase in skin HbT, and then both skin and brain HbT return to baseline
values.
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Figure 4.12: Predicted changes in total haemoglobin concentration over a 30 s period
including 10 s baseline, 10 s maximal VM and 10 s of recovery. Values are show for three
different tissues, Skin, Bone and Brain.
Given the predicted HbT concentration changes, the next consideration is how the








The skin on the forehead, where this response is being modelled, does not have a
high metabolic rate and therefore the assumption can be made that the saturation of
the pooling blood in the skin, during the VM, will closely match the pressure-driven
changes in flow across the VM. Specifically, there will be a small increase in saturation
that comes with blood being forced into the facial tissues by the raised intrathoracic
pressure at the onset of the VM, then on release of the VM the blood pressure response
(i.e., Phase IV) causes a (slightly delayed) influx of oxygenated blood into the head in a
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drive to compensate for the VM effects causing a further small spike in skin saturation
∼2 s after the release (Figure 4.12). Overall changes in skin HbT concentration are fairly
profound, however, the associated change in saturation ranges over ∼5 %. This skin
response is supported by data collected with fMRI using BOLD measures during a VM
[129]; wherein these data demonstrated that there was a correlation between fMRI and
fNIRS saturation in the two facial areas assessed (fNIRS probes placed on facial somatic
tissue - the zygoma). The trends shown in these data (Figure 4.13) match the predicted
haemodynamics of the VM model used within this thesis. While these normalised data
do no allow for the absolute quantification of haemodynamic changes, they do confirm
the expected pattern of change across the VM.
Figure 4.13: Normalised average change in fMRI BOLD (ROI in extracranial tissue in the
same field of view as the fNIRS probe) and fNIRS oxygen saturation data from somatic
tissue on the zygoma during a 10 s maximal, supine VM [129].
The brain response during a VM was also mapped in the same study along with fNIRS
oxygen saturation data (probes on the forehead). These data demonstrated that both
modalities show a profound drop in cerebral saturation from the onset of the VM, which
then rebound upon release, overshooting the initial baseline saturation before recovery
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(Figure 4.14). This pattern of saturation change in the cerebral tissue is consistent with
the blood flow data from the middle cerebral artery described above, which showed that
blood is initially ’forced’ into the brain, then as the ICP increases and venous return
is impaired, blood pools within the brain. Therefore, given the high metabolic demand
of cerebral tissue, brain saturation will decrease steadily as the oxygen bound to the
haemoglobin is extracted and used to meet this metabolic demand.
Figure 4.14: Normalised average change in fMRI BOLD (region of interest at white/grey
matter junction of the middle frontal gyrus (brodman area 10)) and fNIRS signal from
cerebral tissue during a 10 s maximal, supine VM [129].
Predicting how much the saturation drops, however, is another challenge. It is known
that holding a maximal VM for too long (e.g., 10-15 s) will result in a loss of consciousness
[109], so clearly the saturation drop in the brain is profound. The predicted cerebral
saturation drop was estimated using data on the rate of oxygen metabolism in the brain
as obtain via fMRI, that being 125.1 ± 11.4 µ mol/100g per minute [130]. Making the
assumption that the active tissue mass in the brain is roughly constant over all subjects
and that the ratio of oxygen metabolism to HbO and HHb is 1:1, then it can be calculated
that the drop HbO over a 10 s VM is ∼ 20 µ mol and the corresponding rise in HHb is
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also ∼ 20 µ mol. Applying these values to the baseline optical properties used for the
brain (Appendix .2), the maximum saturation change is ∼ 20 %, which when projected
onto the changes observed in fMRI give the cerebral saturation changes shown in Figure
4.15.
Figure 4.15: Predicted changes in oxygen saturation over a 30 s period including 10
s baseline, 10s maximal VM and 10 s of recovery. Values are show for three different
tissues, Skin, Bone and Brain.
The shape of the predicted saturation values shown in Figure 4.15 model the saturation
changes seen in the fMRI data during a VM (Figures 4.13 and 4.14) and the HbT pre-
dictions in Figure 4.12. The changes are again modelled over a 32 s VM at 2 s intervals
in order to reduce computation time in simulations. The magnitude of the drop in brain
saturation is modelled quantitatively on the values of oxygen metabolism in the brain
(125.1 ± 11.4 µ mol/100g per minute) mentioned previously. Taking this rate of oxygen
metabolism the saturation was steadily decreased at 2 s intervals to the maximum pre-
dicted drop of ∼ 20 %. Then on release of the VM the saturation values was modelled
as returning to baseline and overshooting by ∼ 8 % due to a secondary spike in blood
pressure (Figure 4.9, which occurs within a 10 s time frame. The saturation changes skin
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are estimated based on the predicted HbT concentration changes. Working on the basis
that the HbT will spike by ∼ 30 %, and we do not expect the HHb component of the
blood in the skin to increase due to low metabolic demand, the HbO concentration was
adjusted to give the required HbT change and hence the saturation spikes seen in Figure
4.15.
4.4 Spatially Resolved Spectroscopy - Simulation Stud-
ies
Spatially Resolved spectroscopy (SRS - described previously in Chapter 2) is a method
of weighting fNIRS data reconstruction to look only at deep tissue changes. As this is
a relatively simple technique already available commercially on fNIRS devices like the
NIRO-200NX (Hamamatsu, Japan), it is an ideal starting point for TBI monitoring. The
SRS method does not claim to be able to quantify deep tissue oxygenation, it only maps
relative saturation and total haemoglobin, known as the tissue oxygenation index (TOI)
and tissue haemoglobin index (THI) respectively. In this respect a normative baseline
reading is still required to map changes, a limitation of application in TBI, however
assessment of the technique is a good starting point from which to progress. In order
to test the accuracy of the SRS method, a series of simulations designed to mimic the
VM were tested. Specifically, these simulations were used to determine the accuracy of
the technique for measuring cerebral changes and the determine how much influence the
superficial signals were having on the derived TOI and THI parameters.
Methodology
As described in Section 4.2, the probe geometry of the NIRO-200NX (details in Appendix
.1) was modelled on the 3-layered (skin, bone and brain tissue regions) ICBM 152 Atlas,
and the predicted haemodynamic changes for a 10 s maximal VM from Section 4.3 were
applied to the model and forward data produced for each set of values using NIRFAST.
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Using the modelled intensity, the TOI and THI values were calculated using Equations
3.13 and 3.14. In the original validation paper for the SRS method [76], the accuracy of the
techniques was confirmed using models that were homogeneous in scatter and absorption
properties. Therefore, as application to cerebral monitoring is inherently heterogeneous,
for completeness, the SRS methods was tested under a series of conditions:
1. The forward model used to produce a set of simulated detector intensity values
was given homogeneous brain scattering values and the global absorption changes
mapped the predicted brain changes.
2. The forward model used to produce a set of simulated detector intensity values was
given homogeneous brain scattering values. Absorption was heterogeneous, skin and
bone properties were kept constant and absorption properties were changed in the
brain region only.
3. The forward model used to produce a set of simulated detector intensity values was
given fully heterogeneous scatter and absorption changes in skin, bone and brain
regions.
The effect of superficial contamination was assessed further by simulating the hetero-
geneous VM haemodynamics while lowering the HbT concentration in the skin region
to assess the influence on derived TOI and THI parameters. As the SRS method only
shows relative chromophore concentrations, the results were offset to start from the same
baseline saturation in order to assess the accuracy of the derived changes.
Results
As the SRS does not assess quantitative level of HbO and HHb the analysis criterion for
these results is the magnitude of the recovery saturation (TOI) drop in comparison to
the simulation VM values. The saturation drop in the brain being simulated is ∼22 %,
and therefore the closer the SRS method is to accurately mapping this change the more
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potentially beneficial it will be as a TBI monitoring tool. For the fully homogeneous model
saturation changes were made globally (Figure 4.16 - green line) the recovered TOI values
were seen to dramatically overshoot the predicted saturation changes giving ∼ 48 % drop
instead of the simulated 22 %. This is most probably due to the fact that while the SRS
method is designed to weight reconstruction towards the deep tissue changes there is still
influence from shallow signals, which as seen in Section 4.2.1, fNIRS devices are known
to be hypersensitive to shallow changes and thus it is enough to cause overestimation
of the TOI. This sensitivity issue will be discussed later on in this section. This theory
is supported by the results of the simulation where the forward mesh had homogeneous
scattering properties and absorption changes were applied to the brain region only (Figure
4.16 - blue line). When there were no changes in the shallow (skin/bone) regions the SRS
method mapped the saturation drop in the brain accurately, obtaining a drop of 20 %.
This indicates that there is still an oversensitivity to shallow changes even with SRS. The
third simulation example with fully heterogeneous scattering and changes in absorption
over all regions, showed a much lower response to the drop in cerebral saturation (Figure
4.16 - red line). Collectively, these findings demonstrate that the changes in the skin are
having an influence on the recovery TOI parameters. For example, the increase in TOI
seen just after the onset of the VM is a response that was modelled for the skin region
only; the brain saturation was only simulated to decrease during the VM. While there is
clear superficial influence in the derived parameters, the SRS method does still observe a
drop in the cerebral saturation, albeit at a reduced magnitude ( ∼12 %). This reduction
in recovered magnitude for the heterogeneous model is not entirely unexpected as the
equations for calculating the relative HbO and HHb concentrations for SRS (Equation
3.13) are derived for a medium with homogeneous scattering parameters.
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Figure 4.16: Recovered TOI values during a simulated 10 s VM using the SRS method
on homogeneous and heterogeneous head models. Results are all offset to start at the
simulated baseline level
To further assess the amount of influence the superficial signals have on the recovered
TOI values, the simulations were repeated for the heterogeneous model with varying
concentrations of HbT in the skin region. The HbT concentrations were taken to be 100,
70, 50, 30 and 10 % of the standard skin value. The results (Figure 4.17) show that
as the superficial HbT concentration decreases the magnitude of the recovered cerebral
desaturation becomes closer to the true simulated value, until at 10% the magnitude of
the change is mapped correctly. The concentration change however does not appear to
influence the saturation spike (from the skin region at the VM onset) to the same extent,
suggesting that while we can improve the magnitude of the observed cerebral changes
there will always be a constant level of superficial contamination. This again may be a
side effect of the homogeneous scatter assumptions and residual sensitivity to superficial
signals.
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Figure 4.17: Recovered TOI values during a simulated 10 s VM using the SRS method
on a heterogeneous head model with varying concentrations of superficial haemoglobin.
Results are all offset to start at the simulated baseline level
With reference to the ’sensitivity’ of the probe to different regions as discussed in Section
4.2.1 the Jacobian matrix for a model can give a measure of the probes sensitivity to
changes occurring at a given point in the model. As an example, the Jacobian for the
NIRO-200NX for a 2D heterogeneous rectangle is shown in Figure 4.18. This 2D model
has 3 different regions; skin for the first 10mm, bone for the next 10mm and the remainder
of the model is brain, the optical properties used where the same as the heterogeneous
baseline properties used in the Atlas-head model. The Jacobian, summed over all wave-
lengths and chromophores, shows that the sensitivity of the probe geometry is focused in
the superficial (shallow) regions (more negative values indicate higher sensitivity), as is
expected.
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Figure 4.18: Example Jacobian sensitivity plot for NIRO-200NX probe geometry on a
heterogeneous 2D model for one source-detector pair.
As the SRS method looks at the difference between two detector measurements, we can
build a SRS sensitivity profile by finding the difference between the Jacobians to the two
detectors in the NIRO-200NX probe geometry. The results of the SRS sensitivity plot
on the same 2D rectangle model are shown in Figure 4.19. It is apparent that there is a
section of high and low sensitivity in the superficial region, which may cancel out when
the sensitivity is summed over the entire region leaving a low sensitivity to superficial
changes and a higher sensitivity to deeper signals.
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Figure 4.19: Example SRS (difference between Jacobians from each detector) sensitivity
plot for NIRO-200NX probe geometry on a heterogeneous 2D model.
When the sensitivity profiles are averaged over the region the percentage of the overall
sensitivity in each region can be calculated (Figure 4.20). These data show that even
though the SRS method is dramatically decreasing the sensitivity of superficial influences
on the recovered TOI, it is not removing it entirely, which explains why there are still
superficial changes visible in the VM simulations. Despite this, the sensitivity profile of
SRS is significantly more even over the model than the standard fNIRS sensitivity, and
therefore represents a profound improvement to the accuracy of recovered deep tissue
changes.
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Figure 4.20: Comparison of sensitivity to different tissues (skin, bone and brain) with and
without the SRS-method employed on the NIRO-200NX geometry modelled on a 3-layer
heterogeneous head Atlas.
4.4.1 Conclusions
The SRS method does provide a more even depth sensitivity profile in comparison to
a standard fNIRS probe, allowing changes in cerebral saturation to be obtained with
higher confidence of the signal origins. While the SRS method is clearly measuring sat-
uration changes in the brain, even with its more level depth sensitivity profile there is
still an element of superficial contamination in the derived TOI values when using a fully
heterogeneous model. A potential source for this is the fact that SRS is based upon
a homogeneous scatter model, which is an inaccurate model for photon migration in a
heterogeneous medium. Collectively, these simulation studies indicate that in its current
form SRS is not suitable for TBI monitoring without a normative baseline reading.
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4.5 ISS Oxiplex TS Vasopressor Studies
To further investigate the effects of superficial contamination on fNIRS parameters, phar-
macological intervention, through use of a vasopressor injection, was used as a means
of reducing the overall concentration of haemoglobin in the superficial tissue above the
target area of the cortex (similar to simulations performed with the SRS method). The
vasopressor acts to constrict the blood vessels to the skin and hence reduce the amount
of blood supply to the target region. This will result in a lower volume of blood at the
site and therefore subsequent changes in its saturation will have a decreased influence on
the fNIRS detector signals and theoretically reduce the contamination from skin changes.
While the bone region is still considered as a superficial tissue, there is no practical way of
infiltrating it with vasopressor, however as the haemodynamics of bone are insignificant
in comparison to the skin and brain, the levels of signal contamination from the region
will be generally lower. For comparison, the probes used in the vasopressor study were
modelled on the ICBM152 Atlas and the effect of the vasopressor simulated by decreasing
the quantity of superficial HbT.
4.5.1 Methodology
Eight healthy volunteers performed a series of 10 s, standing VMs under controlled lab-
oratory conditions, pre and post injection of a potent vasoconstrictor (∼1.5-2 mL of
2%xylocaine, with 1:100,000 epinephrine). The magnitude and consistency of the VM
was assessed using contemporaneous, beat-to-beat blood pressure monitoring (Portapres,
Finopres Medical Systems, The Netherlands). The NIRS monitoring was done using
the ISS Oxiplex TS (ISS Inc, USA) with two frequency domain probes positioned on
either side of the forehead, centred 2 cm above the superior orbital ridge, with the field
of acquisition centred 3 cm from the mid-line. A minimum of 2 satisfactory VMs (i.e.,
maximal and near identical blood pressure patterns) were recorded for each volunteer for
each series of VMs performed. Laser Doppler (Moor Instruments, UK) was also used to
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measure blood flow (as indexed by flux) in somatic tissue along the line of the zygoma
during forehead NIRS measures. In addition, a repeat set of VMs was completed with
laser Doppler measures of the forehead somatic tissue. This protocol was then repeated
following injection of the vasoconstrictor into the forehead tissue. Post-injection testing
began after capillary refill was observed to be at least 4 s (usually 1-2 s). The ensure that
there were no order effects in the repeating of the VM pre and post injection, the blood
pressure of the subjects was recorded continuously as a way of gauging the strength of the
VM performed. A VM was considered acceptable if the blood pressure dropped to ∼40
mmHg before release. The blood pressure data for each subject is shown in Appendix .4.
The study conformed to the Declaration of Helsinki and was approved by the University
of Birmingham Research Ethics Board (Ref.: ERN 30-1031). Individuals recruited had
no significant prior medical history.
Simulations of the ISS probe geometry (Appendix .1) were modelled using NIRFAST
on the ICBM 152 Atlas model shown in Figures 4.1 and 4.3 (baseline optical properties
show in Appendix .2). The Atlas model was separated into 3 tissue layers with the CSF,
white matter and grey matter being combined into a single ’brain’ region. The effect of the
vasopressor was simulated as a 50 % reduction in HbT concentration (chosen from prelim-
inary work) in the skin region modelling the same VM concentration changes outlined in
Figure 4.15. Simulated data was then produced in NIRFAST with a 110-MHz frequency
modulation to match that of the ISS system. It is important to note that the reconstruc-
tion method for the frequency domain data produce in simulation will not directly mimic
the output of the ISS system, it is designed as an indicator for how the vasopressor may
alter the recovered parameters. The optical properties of the simulated datasets pre and
post vasopressor were recovered using the analytical fitting routine outlined in Section 3.1
to find absorption and scatter values, the chromophores were then calculated using the
modified BLL (Section 2.2.1). The absorption and scattering properties recovered are a
global representation of the haemodynamics in the target volume.
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4.5.2 Results and Discussion
The VM simulations (Figure 4.21) predicted that even without the vasoconstrictor injec-
tion a frequency domain reconstruction based on the ISS cerebral probe geometry would
be capable of observing changes in brain saturation. The magnitude and quantitative ac-
curacy of these changes however is noticeably obscured by the superficial saturation. As
mentioned above, the effect of the vasoconstrictor injection acts to decrease the amount
of obstruction from the superficial tissues. The main finding of this experiment was that
while the magnitude of the change remains constant before and after the vasoconstrictor
injection, the quantitative accuracy of the recovered saturation values show a marginal
shift towards the simulated brain values when the vasoconstrictor is introduced. The sim-
ulation results therefore indicate that the limiting factor in the quantitatively accurate
recovery of the brain saturation values is the global nature of the parameter reconstruc-
tion.
Figure 4.21: Recovered saturation values from frequency domain reconstruction using
ISS Oxiplex TS probe geometry before and after a 50 % reduction in skin haemoglobin
concentration (Left). Simulated VM saturation values in skin and brain (Right)
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The effect of the vasopressor can be seen in Figure 4.22, which shows the Laser Doppler
readings taken on the forehead (in the same position as the fNIRS probes) before and
after the injection during a 10 s standing VM. Laser Doppler measures flux, which can be
taken as a surrogate for flow and only gives a superficial tissue measure. Thus it is clear
that the vasopressor injection is dramatically decreasing the blood flow in the skin and
also reduces the flow rate induced by the VM. This provides evidence that the vasopressor
is working as expected and confirm that the predicted 50 % drop in HbT concentration
is valid.
Figure 4.22: Average change in forehead flux measured with laser Doppler during a 10 s
VM over 4 subjects.
A two-tailed Wilcoxon signed rank test (MATLAB signrank function) was used to
look for statistically significant changes in total haemoglobin and saturation values in
both fNIRS probes (left and right) before and after the vasoconstrictor injection; a P-
value of less than 0.05 was considered significant. Results from the two-sided hypothesis
test showed that the injection did not elicit an alteration in the changes in saturation
observed during the 10 s VM, with a P-value of 0.2065 (z = -0.646 , N = 16) and 0.6813
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(z = -0.8015, N = 16) for right (channel A) and left (B) side, respectively (Example
results plot in Figure 4.23). The fNIRS parameters are sensitive to the probe positioning,
therefore care was taken to ensure the probes were placed in the same place before and
after the injection. There is also the possibility that the injection itself caused bleeding,
and while any blood was cleaned from the probes and the target area before the completing
the protocol, there is still a possibility that minor bleeds below the skins surface (in the
region of a source or detector) could cause anomalous results.
Figure 4.23: Single subject example of recovered saturation (Top) and total haemoglobin
concentration (Bottom) values from the ISS Oxiplex TS probe during a 10s VM before
(Left) and after (Right) a vasopressor injection to the forehead.
Using a right-tailed hypothesis test (MATLAB signrank function) the total haemoglobin
(HbT) showed a statistically significant drop on both channels, with P-values of 0.00003
(z = 2.6889, N = 16) and 0.0004 (z = 3.3611, N = 16) for right (A) and left (B) side
respectively after the vasoconstrictor was introduced (example data in Figure 4.23). This
observation is consistent with the laser Doppler findings and also with the prediction
that the vasopressor would decrease the HbT concentration within the probes target vol-
ume. The significance of this results confirms that the changes observed were more than
90
variations due to probe positioning, which was a possibility when looking solely at the
saturation data. The drop in HbT over, while not significant in terms of the VM, did
prove the effectiveness of the vasopressor injection.
The average saturation and HbT response from all subjects is shown in Figure 4.24.
There is a large variation in the baseline measurements (Table 4.1) as was found in
other parallel studies conducted within our group [54]. Having a highly variable baseline
between patients makes it very difficult to put a number of what constitutes a ’healthy’
reading, which is an essential part of TBI monitoring. Despite this, the trend in the
saturation changes over the VM is consistent with the shape of predicted changes, further
validating the model. This would imply that the fNIRS instrument being used is definitely
observing cerebral changes with the superficial contamination only sufficient to obscure
the magnitude of the cerebral haemodynamics, with drop in saturation during the VM
ranging from 2 - 12 % (Table 4.1), significantly lower than the predicted 24 %. This is
also confirmed by the simulation studies where the quantitative accuracy of the recovered
saturation as well as the magnitude of the changes was not sufficient to reflect VM changes.
It is worth noting that the HbT concentration recovered from the fNIRS data does not
follow the trend predicted for a VM, which predicted that the HbT concentration should
rise slightly in both the skin and the brain; instead the observed results showed that
there is a small drop in HbT during the VM. While this does not fit with the biological
prediction there is no obvious reason for it although it could potentially be due to cross
talk between wavelengths as both the 690 nm and 830 nm wavelengths used are absorbed
by HbO and HHb, perhaps showing the benefit of having additional source wavelengths



























3 → 11 4 → 12 2 → 8 2 → 11
Table 4.1: Recovered saturation changes from the ISS probe during a 10s standing VM,
before and after vasopressor injection to the forehead. The table shows the average
baseline across all subjects and the average desaturation during the 10 s VM with the
error shown as 1 standard deviation from the mean. The range of changes in the baseline
and the VM desaturation are also shown.
Figure 4.24: Group average of recovered saturation (Top) and total haemoglobin concen-
tration (Bottom) values from the ISS Oxiplex TS probe during a 10 s VM before (Left)
and after (Right) a vasopressor injection to the forehead across 14 subjects.
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4.5.3 Conclusions
Currently fNIRS has not progressed into the clinic as a gold-standard method of monitor-
ing TBI patients. This is despite its apparent advantages (e.g., cost, portable, non-invasive
and non-ionising) as there are still concerns as to the origins and quantitative accuracy
of the results being obtained.
The results presented from both simulation and healthy volunteer trials conclusively
show that a frequency-domain fNIRS probe can detect neurological changes, in both
haemoglobin content and haemoglobin saturation, when positioned on the forehead. The
effect of superficial contamination in this instance appeared to be insignificant in the
healthy volunteer trials. Even with a significant drop in superficial haemoglobin due
to the vasoconstrictor there was no significant change in measured saturation over the
volunteer pool. This is supported by simulation findings that showed only a small increase
in quantitative accuracy following injection. However, this could be misleading to say
that superficial contamination is not affecting the recovered parameters. In terms of
quantitative accuracy of the fNIRS, simulations showed that recovered parameters could
not be taken as an absolute measure of haemoglobin concentration or oxygen saturation.
While the superficial signals do not inhibit fNIRS from being used to measure relative
brain changes, the global parameter recovered used by fNIRS effectively give average
values that will to some extend include the superficial layers, regardless of the logistical
and computational methods used to reduce it.
In order to achieve quantitative accuracy needed for TBI monitoring without a nor-
mative baseline measurement, a high-density fNIRS probe with multi-layered parameter
recovery could offer a potential solution. Here, instead of a globally reconstructed set of
parameters, the reconstruction could take into account the different layers of the head, a
topic that will be explored in later Chapters.
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4.6 Summary
Simulations and testing of fNIRS geometries and devices has shown they are definitely ca-
pable of measuring changes in cerebral haemodynamics, despite inherent limitations from
superficial contamination. It would appear that the issue is not necessarily to do with the
probe but more to do with the reconstruction process. Frequency domain devices, while
providing quantitative chromophore concentrations are not accurate for cerebral values
because the concentrations are an average over the whole target volume, a combination
of the brain and superficial tissues. Regardless of the fact that Jacobian and singular
value analysis confirmed the sensitivity and information content of the simulation probe
geometries were detecting cerebral haemodynamic changes, the values were always sig-
nificantly higher for the superficial regions making depth-related unmixing of the signals
untenable. A tomographic reconstruction is ill posed even with the large over lapping
datasets of DOT probe, making it an unobtainable goal for small fNIRS probes with CW
or FD sources.
Using spatially resolved spectroscopy (SRS) the sensitivity profile of a fNIRS probe
can be evened out (with respect to depth) so that not as much weighting is given to
superficial regions. A direct comparison between the FD reconstructions and the SRS
reconstruction for the same set of simulated VM values showed that the SRS method
observes a cerebral saturation change of 12% where as the FD model only observed a
5 % change, with the model predicted change estimate at ∼ 20%. While this should
not be considered a direct comparison between the two probes, it does highlight that
the SRS is providing improvements to obtaining cerebral saturation values. Despite the
improvement to the observed change, the SRS method is still far from quantitative and
is still not accurate enough to be used as a stand alone monitoring modality in TBI.
Considering a more advanced reconstruction method is required to differentiate the
depth of signal origins, it is clear that a high-density probe similar to the DOT devices
discussed in Chapter 2 is required in order to obtain the necessary data. However, as the
DOT devices to date have been large scale and relatively importable in relation to the
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fNIRS devices, a compromise must be reached on the design of the NIR device. Chapter 5
explores the use of a hybrid fNIRS and DOT probe in order to improve upon the current






The aim of this chapter is to address the current limitations of fNIRS application to
TBI monitoring by assessing an Atlas-based reconstruction model and algorithm in or-
der to move towards a more quantitative and depth-resolved parameter recovery. The
reconstruction algorithm is designed to work with a small scale DOT probe, obtaining
overlapping spectral (multiple wavelengths) data from multi-distant source-detector pairs;
a probe that has the potential to be made portable and affordable to application to TBI
monitoring in the clinical and pre-clinical settings.
This chapter is split into two sections, the first is a simulation study to assess the feasi-
bility of the Atlas reconstruction process with a model DOT probe. The second section
entails healthy volunteer investigations, applying of the Atlas model to data obtained on
a functioning small scale DOT system (designed by Nalecz Institute of Biocybernetics
and Biomedical Engineering Polish Academy of Sciences) during a series of standing VMs
in order to assess its current ability to provide clinically beneficial measurements.
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5.1 Introduction
As discussed in previous chapters, the current quantitative accuracy of fNIRS devices is
currently insufficient for it to progress as a monitoring modality in TBI. The progression
of NIRS towards a more quantitative assessment of cerebral oxygenation can come in one
of two ways. The first is to move to a time domain (TD) NIRS system that maintains the
real-time and portable advantages of standard NIRS, however, such systems require the
use of significantly more expensive components capable of individual photon counting.
By measuring both intensity and arrival time of the photons, TD NIRS has intrinsic
information about photon flight path, and therefore deep and shallow probing photons
can be selected that allows greater quantitative accuracy and increased depth resolution
(although still global in the lateral plane) [55].
An alternative method is an adaptation and use of diffuse optical tomography (DOT),
which, with a denser array of sources and detectors allows use of multiple sets of overlap-
ping measurements that can improve both the spatial resolution and quantitative accuracy
[22]. Most reconstructions in DOT are model-based, typically using finite element mod-
els (FEM) for which spatial priors and initial optical property estimates can be used to
increase the accuracy of derived optical properties. The limitation of DOT systems is
their size and parameter recovery time, which makes them less practical for TBI mon-
itoring. Although relative changes in chromophore concentrations from a baseline can
be measured in real time, the quantitatively accurate results (of oxygen saturation, for
example) require a non-linear and iterative reconstruction approach to hone in on the best
solution. To date, however, truly quantitative results have only been obtained with DOT
of the breast [56]. The lack of known baseline optical properties in the brain is currently
a limiting factor in achieving quantitative result even when using DOT.
Providing spatial priors regarding the tissue layers of the head, namely the skin, bone
and brain in a reconstruction algorithm has shown to help constrain the ill-posed nature
of the problem and improve parameter recovery accuracy [57]. Such spatial priors can
be obtained from patient MRI or CT scans, which can be segmented and formed into
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subject-specific models, however in the clinical and pre-clinical setting this is not always
a feasible option [22, 57, 58]. Alternatively, the use of Atlas-based models has shown
good promise to overcome cases where subject-specific MRI/CT data are not available
[57, 58, 59].
Although the application of a DOT-based system can produce the data required to mon-
itor TBI patients, in its current format it is not ideal. The first issue is size and expense
of the equipment, which may have a relatively simple solution; the sampled area could be
scaled down. Although this would imply a smaller region of interest from which spatially
varying parameters would be recovered, such small target regions would be suitable if the
results were quantitative. It is worth noting that the invasive ICP probes only target a
small area of the brain also. Therefore, if a small DOT probe is used to give overlapping,
multi-distant measurements over a small area, it could be used to reconstruct depth-
resolved spectroscopic parameters. A smaller probe is also more portable and cheaper to
produce and will also help with the second issue of reconstruction time. Specifically, the
smaller the number of voxels (spatially varying locations) being reconstructed, the faster
the iterative reconstruction will complete [58]. In addition, having multiple overlapping
measurements obtained over a smaller sample area will also improve the ill-posed nature
of the inverse problem [60]. With parallel computing and GPU acceleration becoming
more prevalent, reconstruction times will only get faster [61], providing additional bene-
fits. The final obstacle in the way of quantitatively accurate DOT reconstructions is the
availability of spatial priors. A subject-specific reconstruction model will not typically be
available in clinical and pre-clinical TBI cases, hence the utilisation of an Atlas model,
using the average spatial priors over a multitude of segmented heads, could be registered
to match a patient head and used as a substitute for specific priors [57, 58].
Finally, while portable high-density NIRS system designs are already available and
routinely used (e.g., NIRSport, NIRx Medical Technologies and fNIRS300B, BIOPAC
System, Inc), the key feature that is currently lacking is the non-trivial baseline parameter
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recovery needed to obtain information with a reasonable degree of quantitative accuracy.
At the other extreme, systems such as the Washington University DOT array [62] uses
a large-scale probe design, focusing on mapping cerebral activation and connectivity,
which incorporates Atlas-guided recovery into their reconstruction routines. Thus, there
are already system designs available that are suitable in terms of hardware. A NIR
system suitable for the monitoring of TBI lies somewhere between these aforementioned
designs, hybridising the portability of the smaller DOT arrays with the more enhanced
reconstruction algorithms of the large scale probes. While this is something that has
been explored [59], there has been limited expansion of the Atlas-guided techniques to
produce quantitatively accurate results. Therefore this chapter is aimed at investigating
the suitability of a small scale DOT probe, designed for use on the forehead, for producing
quantitatively accurate cerebral oxygen saturation values, using a registered Atlas model
for spatial priors.
5.2 Methodology - Simulation Studies
In order to assess the quantitative accuracy of DOT reconstruction using registered Atlas
models, simulations were designed using NIRFAST [63] and a series of simulated brain
conditions were constructed to mimic a Valsalva Manoeuvre (VM). As discussed in Section
4.3, the VM produces dramatic alterations in ICP, a key parameter monitored in TBI
cases, which combined with the fact that the VM will produce very different superficial
and cerebral haemodynamic responses, makes it an ideal method to test the suitability
of the proposed NIRS/DOT probe and Atlas reconstruction algorithm for use in TBI
monitoring. This method section is split into the following areas:
1. Production of patient specific models for modelling forward data.
2. Registration of Atlas models to match patient models for use in data reconstruction.
3. Probe design and positioning on head models
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4. Simulation of forward data
5. Atlas and Tomography based reconstructions
5.2.1 Production of Patient Specific head Models
The process of data simulation and image reconstruction starts with the creation of
subject-specific models, the basis of which is a T1 weighted MRI scan (Figure 5.1A). The
MRI scan provides accurate structural information of features within the head, which can
be translated into an FEM to accurately predict the propagation of NIR light through
the target volume. From this the MRI scans were segmented into 5 separate regions:
skin, bone, cerebral spinal fluid (CSF), white matter and grey matter (Figure 5.1B), us-
ing the statistical parametric mapping (SPM) software package [58, 131] based on a pixel
intensity probability function distribution.
Figure 5.1: Flow chart of model generation from a patient MRI scan. A Original T1
weighted MRI scan. B MRI scan segmented into skin, bone, CSF, white matter and grey
matter. C Masks created in NIRVIEW using the segmented MRI scan. D Mesh created
in NIRFAST using masks.
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Following the segmentation of the MRI scans, NIRVIEW [112] was used to create masks
of the segmented scans (Figure 5.1C), which the final meshing process can be based on.
NIRVIEW provides a vital checking step to ensure the segmentation process was correct,
where any gaps of unassigned pixels can be filled to reduce the risk of holes in the final
head model. Small gaps in the segmentation can be rectified using the iterative hole-
filling algorithm built into NIRVIEW, which uses a voting algorithm at each iteration to
determine where each pixel will be assigned based on the assignment of its surrounding
pixels [112]. Large holes that were not filled using the automated routine were filled in
manually through inspection of each segmented image slice. The end result of NIRVIEW
processing was a stack of segmented masks that could be imported into NIRFAST and
used as a basis for volumetric mesh creation (Figure 5.1D) [112, 63]. Once meshing in
NIRFAST was complete, the models could be checked for consistency to ensure there were
no holes present in the target forehead region.
5.2.2 Production of registered Atlas models
A widely used Atlas model in DOT studies is the ICBM152 [58, 110, 111], in which studies
were primarily designed to look at brain activations and therefore segmentation accuracy
was focused on the brain rather than superficial (skin and bone) regions. Preliminary
data for the current study showed that there exists a large mismatch between the relative
thicknesses of skin and bone within this Atlas and subject-specific models (see for example
Figure 5.2), with this difference in layer thickness being enough to substantially reduce
the accuracy of the model used. Therefore, for the purpose of this work a new Atlas
was developed based on a tenth subject-specific MRI, which was segmented (as described
in Section 5.2.1 and used as the new Atlas. While the layer thicknesses on the new
Atlas were more representative of the 9 other models, future work will require a more
comprehensive Atlas. The mismatch may not purely be due to the ICBM Atlas, there
is also the possibility that the segmentation process used to create the patient specific
models is also inaccurate in the superficial regions, thus selecting a new Atlas that would
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also contain this error is a potential method to reduce its influence on the reconstructions.
Figure 5.2: Comparison of the ICBM152 Atlas (Left) and the new Atlas used for the
simulations (Right).
The registration of the Atlas model to each of the 9 subject-specific models was achieved
using 687 evenly distributed landmarks based on a non-iterative point-to-point (nP2P)
algorithm, to minimise the difference between the subject and the Atlas. This method
has previously been shown to give a maximum surface registration error of 4.5 mm [58].
While this may appear as a large registration error based on the ∼1 mm resolution of the
initial MRI scans, it has been shown to be a successful method to provide an alternative
to cases where subject-specific models are not available [132].
5.2.3 Proposed continuous wave probe design
The DOT probe being modelled (Figure 5.3) consisted of 8 triple wavelength LED sources
(for example, L735/805/850-40C32, Ushio Epitex Inc., Japan) with peaks at 735, 805 and
850 nm with a bandwidth of 40 nm. There were 7 detectors (FDS100, Thorlabs) inter-
spersed within the grid of sources and the spacing between each adjacent source/detector
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was 15 mm, giving a total of 168 measurements with a minimum source-detector sep-
aration of 15 mm and a maximum of 62 mm. In real practical settings the maximum
source-detector separation would probably be limited to ∼40 mm, depending on the dy-
namic range of the detectors and the systematic noise levels. The modelled probe was set
up to produce continuous wave intensity data only.
Figure 5.3: Design of high-density NIR spectroscopy probe
The probe pad was positioned relative to a user defined reference at the nasion point, as
identified during the segmentation of MRI data (a process covered in Section 5.2.1). From
this reference point a positioning algorithm was used to reduce the Euclidean distance
between every source and detector to the desired 15 mm over an iterative cycle. From
this point inbuilt routines within NIRFAST were used to move the sources one scattering
distance beneath the surface of the model to account for the boundary conditions in the
diffusion approximation (DA). For the simulation studies, the probe was positioned on
the left hand side of the subject’s for forehead (Figure 5.4) with first point being place 25
mm up and 1 mm left of the reference nasion point.
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Figure 5.4: High-density NIR spectroscopy probe positioned on the forehead
5.2.4 Simulation of Forward Data
Forward (boundary) data for the VM (Section 4.3) was produced for 9 unique subject
models using the FEM-based software package NIRFAST [63], with each time point on
Figure 5.5 providing an individual dataset for a specific set of skin, bone and brain optical
properties (Appendix .1). The simulation was designed to represent a continuous wave
(CW) system, meaning that the forward dataset consists of a single boundary intensity
measurement for each source-detector pair over three wavelengths.
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Figure 5.5: Predicted changes in oxygen saturation over a 30 s period including 10 s
baseline, 10 s maximal VM and 10 s of recovery. Values are show for three different
tissues: Skin, Bone and Brain.
5.2.5 Reconstruction Routines - Simulation Studies
Reconstruction of the simulated data was performed using NIRFAST, which uses FEMs
and the DA to produce data for the forward model within the reconstruction regime. The
DA has been shown to be valid in mediums where scatter is the dominant interaction
process and the source-detector separations are large enough to allow for multiple scat-
tering events [63]. It may be argued that the use of the DA may not be the most accurate
model for application in tomographic imaging of the brain, as there may exist regions
where scattering does not dominate absorption (for example Cerebral Spinal Fluid), but
the methodologies for parameter recovery outlined here are independent of the model of
light propagation utilised. A full explanation of the basic reconstruction process used
by NIRFAST is given in Chapter 2, any additional changes made for the purpose of the
simulation studies will be cover in this section.
Several different reconstruction regimes were investigated for comparison, including
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inverse crime and Atlas-based reconstructions, both utilising spatial priors for either full
tomographic or region-based (one value for each layer) parameter recovery. The inverse
crime involves using the same FEM for the forward and inverse modelling, which rep-
resents an idealised situation in which there is no error in source/detector positioning,
the exact scattering properties are known and the spatial information in the model is
accurate; whereas the Atlas-based reconstruction provides a more realistic setting. The
tomographic reconstructions produce a set of spatially varying optical properties for ev-
ery node in the FEM, which could then be averaged to give global parameter values per
region (skin, bone, brain etc.) post reconstruction. However, the regional reconstructions
produce a singular set of optical properties per predefined region, assuming each region
is homogeneous. The region-based reconstruction uses a mapping function to make the
values of the Jacobian matrix for each region the same value, this has the effect of re-
ducing the number of unknowns in the inverse model, however, it is based heavily on the
assumption that each region is homogeneous. Further details on the region-based recon-
struction algorithm can be found elsewhere [133].
The inverse crime reconstructions had the most accurate prior information in terms of
spatial and scattering properties; this was designed as a proof-of-concept. Atlas-based re-
constructions, however, were designed to assess the ability to reconstruct brain saturation
with only an estimate at absorption, scattering and spatial priors. NIRFAST allows for a
reconstruction basis to be chosen in order to increase computational efficiency instead of
using the original forward mesh (in this case the Atlas of subject-specific models). A re-
construction basis allows the model to be subdivided into sections (reconstruction pixels),
reducing the number of unknowns in the matrix inversion process (further details found
here [134]). Additionally, an increased computational efficiency was obtained by imple-
menting a method of reducing the Jacobian calculation to utilise only sensitivity values
greater than 1% of the total sensitivity for parameter recovery [135]. For this study the
reconstruction basis was kept as the Atlas or subject-specific mesh (depending on the re-
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construction type) with the starting values kept constant regardless of the reconstruction
type for consistency. The 3 regions used the same scattering and water percentages as
shown in Appendix .1, however the haemoglobin concentrations were set to be homoge-
neous at 0.0560 mM (Oxyhaemoglobin -HbO) and 0.0140 mM (Deoxyhaemoglobin - HHb)
equating to a saturation of 80%.
The reconstruction process itself was split into two steps: (1) a global fit of optical
properties based on boundary data for the whole model (i.e., assuming a homogeneous
single layer model), which was limited to 20 iterations with a regularisation parameter
of 10, and (2) using the bulk average value from the previous step as a basis for either
the tomographic or regional reconstruction, which was limited to 40 iterations with a
regularisation parameter of 0.01, the stopping criteria due to projection error change was
a difference of less than 0.01 %.
For full tomographic-based reconstructions, in order to obtain an average value from
each layer, the region of interest for each layer was define as those with a minimum of 2.5%
sensitivity, and the reconstructed saturation values were then averaged over these regions
of interest. This value was initially chosen based on prior knowledge of photon penetration
for the initial homogeneous model, but the importance of model-based, subject-specific
modifications are discussed below. For the regional reconstruction, a single saturation
value was produced for each layer.
5.3 Results and Discussion - Simulation Studies
5.3.1 Registration Process
The principle of using a registered Atlas model for reconstruction requires that the reg-
istration methods applied are capable of giving an accurate fit to the patient-specific
models, from which the simulated data are obtained.
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Figure 5.6: Heat map showing average registration error between each subject-specific
and the corresponding registered Atlas model (Left). Cropped and rescaled heat map to
show registration error on the desired region of interest (forehead) (Top Right). A zoom
in on the region of the forehead where DOT pad is positioned (Bottom Right).
The registration accuracy was assessed for each of the 9 models used by measuring the
Euclidean distance between nearest neighbour points on the original and registered Atlas
models and averaging over all the models (Figure 5.6). The maximum registration error
over the entire head was found to be 22 mm; however this takes into account anomalous
regions such as large differences in nose features. Since the main focus of the study was
the forehead, the calculated average results confined to the forehead region was found to
be less than 10 mm, with errors in the pad region not increasing over 4.53 mm.
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Figure 5.7: Average coordinates positions of the DOT pad on the original subject-specific
models (red) and on the registered Atlas models (blue).
With confidence in the accuracy of the registered Atlas-models, the next step was to
assess the positioning and layout of the DOT probe on the forehead region. The pad-
positioning algorithm developed for this work uses a user defined reference point, at the
nasion, from which the optode positioning initiates at a fixed x, y and z distance from
the nasion. Figure 5.7 shows the average position of the pads from all models before and
after registration, and it can be seen that although the conformity of the pad is correct in
the x and z axes, the positioning in the y axis (as controlled by the user defined reference
point) is not optimal. This has resulted in a shift of ∼5 mm of the pad down the forehead
towards the nose, which is not ideal as the probe will be sampling a different region of the
cortex. Nevertheless, since the reconstruction averages over the whole pad area, a small
change in sample area would be considered negligible in this study, and which represents
a more realistic clinical situation where pad orientation and position will vary between
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patients.
The more important issue, however, is the accuracy in layout of the sources and
detector positions. If the spacing between sources and detectors used for the reconstruc-
tion model is different to that of the original model, there will be inaccuracies that will
propagate through to the final reconstructed parameters. Figure 8 shows a contour plot
of positioning accuracy for each source and detector across all the registered models,
which was produced by stacking all the pads for all models, aligning their central point
and calculating the spread in Euclidian distances between the original location of each
source/detector and their position on the registered Atlas models. This gives a 2D rep-
resentation of a 3D error. From the plot it can be seen that all the sources and detectors
fall within 2.5 mm of their desired position.
Figure 5.8: Maximum error in individual source/detector positioning across all the
registered-Atlas models. This is a 2D representation of a 3D error.
Considering the system as a whole, the combination of errors in positioning of the pad
and registration of the Atlas models produces a maximum mismatch of 7.5 mm. This
is an area where refinements can be made, however, for the scope of the current study
this mismatch provides a baseline level of numerical noise (error) for the reconstruction
process, posing a worst-case scenario as a proof-of-concept. In a clinical situation, there
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will be other confounding factors to reduce the accuracy of the reconstruction, such as
detector noise, source variability, poor coupling between the head and probe, as well
as human error in pad positioning. Human error in pad positioning has been observed
in published literature observing the effect of test-retest NIRS studies [136]. Potential
optimisation of the probe positioning through the use of a full head cap is impractical
in the context of TBI, as there are often bandages and injuries, as well as other invasive
probes obstructing the head. These factors are hard to reproduce in simulation; hence the
baseline numerical noise from the registration is a good starting point from which future
investigations can build and improve upon. With regard to the coupling efficiency between
the probe and the scalp, as this simulation is designed as a proof-of-concept, the effect
of coupling efficiency has not been considered, however it has been illustrated in other
published literature that data can be calibrated to account for intensity and measurement
variation effects [137, 14], as well as the recovery of these unknown coefficients as part
of the image reconstruction [138]; both of which will be subject of further work when
considering experimental data.
5.3.2 Reconstructions
After the registration process, the next step was to assess the reconstruction algorithms
and its ability to provide quantitative measures of modelled changes from modelled mea-
surements. The overall quality of the reconstruction was assessed on the accuracy of the
recovered saturation values in the brain region, and while ideally all regions would be
recovered to the same level of accuracy, in the interest of TBI the main concern is the
quantitatively accurate reconstruction of brain saturation. All presented data are the
average across all models with error bars showing the standard deviation calculated for
the means of all models.
Reconstructed parameters from all models were analysed in terms of the recovered tem-
poral changes of oxygen saturation for each layer of tissue, as shown in Figure 5.9. This
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figure illustrates the recovered values as a function of time shown for the three layers
under investigation (skin, bone and brain), prior to, during and immediately following a
simulated VM. This reconstruction was an inverse crime, where the same model was used
for both data simulation and reconstruction. From the results shown in Figure 5.9 it is
evident that the region-based reconstruction (where a single parameter is recovered for
each tissue type) has given the most accurate results in all three layers of the head. This
result demonstrates the validity of the regional reconstruction algorithm (0.04% error for
simulated values with a standard deviation of 0.07%), using a set of homogeneous starting
properties and given accurate spatial priors.
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Figure 5.9: Inverse crime reconstructed saturation values for the skin (top), bone (centre)
and brain (bottom) regions (outlined in Figure 4.15) using both regional (green) and
tomography (blue) algorithms prior to, during, and immediately following a VM (time
points 6-11) . The plotted results are the average over all models with the error bar
showing the standard deviation of the dataset. The simulated saturation line (dashed)
in the Brain results graph (bottom graph) is not visible as it overlaps the Inverse Crime
Regional Reconstruction (Green) line.
The results when utilising spatially varying tomographic reconstruction are also shown
in Figure 5.9 (blue line), and demonstrate that these do not perform to the same level of
accuracy as the region-based reconstructions (green line). Recovered oxygen saturation
in the skin, while showing the correct trend, is not quantitatively accurate. Bone region
reconstructions show a closer resemblance to the expected changes in the brain rather
than for the bone. Finally the brain reconstructions, while showing the correct trends (like
the skin), lacked the desired quantitative accuracy, with maximum percentage difference
between the average brain parameters and the simulated values of 15.7% (values quoted
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are percentage error between recovered and simulated values as opposed to a change in
oxygen saturation) with a standard deviation of 1.2%.
While these tomographic-based results are of lower accuracy, they are not unexpected
for this set of simulations, since tomography gives a spatially varying saturation value
throughout the model in comparison to the region-based reconstructions (Figure 5.9)
that give a single saturation value for an entire region.
Figure 5.10: Graph illustrating how the sensitivity of DOT in the brain region alters as
the saturation in all regions is varied during the VM. The sensitivity is a summation of
the Jacobian values corresponding to brain nodes. More negative values indicate higher
sensitivity.
To further analyse the tomographic reconstruction, the inaccuracy in the recovered param-
eters has two main potential factors; firstly, the simulation is biased to regional recovery
as the simulation itself is for changes that are global to each region. Based on this in-
formation it can be speculated that in a clinical situation where changes in each region
is heterogeneous, tomography may outperform the regional reconstruction. The second
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source comes from how each FEM node and its optical properties are selected for aver-
aging. The nodes as discussed earlier are selected in a pre-reconstruction step, where the
Jacobian is calculated for the initial homogenous optical properties of the reconstruction
model by thresholding to a minimum (at least 2.5%) sensitivity value. A retrospective
view would show that this is not the most accurate way to define nodal region of inter-
est. Instead a better method would be to reassesses the Jacobian matrix and the region
assignments at the end of each time point reconstruction, and then look at an objective
method of thresholding the Jacobian to determine a more accurate region of interest. This
way the tomographic reconstruction would be better suited to keep up with any localised
changes in sample area due to changes in optical properties. For example, Figure 5.10
shows that as the saturation in the brain decreases the overall sensitivity to the brain
region itself is being decreased due to the increased concentration of deoxyhaemoglobin.
This is why a decrease in the accuracy of the reconstruction at the peak desaturation
of the VM is observed. It would also explain why the bone region is inaccurate around
the VM; the change in sensitivity causes cross talk between the brain and bone regions
as the region assignment becomes less accurate. In terms of improving the thresholding
for region selection, defining a range of values based on a percentage (top 60-95%) of the
maximum sensitivity value instead of a simple cut-off sensitivity at 2.5% could offer ad-
vantages. As evident in Figure 5.11, is it clear that by setting only a minimum sensitivity,
and not a maximum, the average saturation in the superficial (skin and bone) regions will
be inaccurate due to the hot spots of hyper sensitivity.
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Figure 5.11: Plot of Jacobian (sensitivity) matrix values on the surface of a subject-
specific model showing the hot spots of hyper sensitivity under each of the sources and
detectors. A smaller sensitivity value represents a higher sensitivity.
While the studies to date utilising the inverse crime models demonstrate that a small
scale DOT probe can be used to obtain quantitatively accurate brain saturation values, it
is imperative to investigate the accuracy and validity of using the registered Atlas models
as the basis for the reconstructions, bringing the simulations more in line with clinical
conditions where there is no prior information about the internal structure of the head.
For the regional reconstruction based on registered Atlas models (Figure 5.12), the
recovered saturation for both skin and bone are subject to poor quantitative accuracy
and a large standard deviation. It is evident that fixing spatial priors, by giving absolute
spatial information for each region (layer), the reconstruction is not able to accurately
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recover the superficial saturation values. This indicates that despite the utilisation of
the new Atlas model, the variation in superficial layer thickness between subjects and
the Atlas is still confounding the reconstructions. Evidence of this cross talk within the
superficial layers can also be seen with a simple comparison of the trends in the skin and
bone regions, which both appear to follow the same trends as the simulated skin satura-
tions, thus implying that the skin layer is too thin in the utilised Atlas model. Despite the
mismatch in superficial layers, the region-based reconstruction recovered the brain satu-
ration values with an average percentage difference of 11.2% (standard deviation 5.0%)
between simulated and reconstructed values. While this does not seem overly accurate,
in comparison to some of the existing NIRS techniques such as SRS reconstructions ex-
plored in previous work [139, 140, 54] and data from Chapter 4, region-based DOT shows
a marked improvement.
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Figure 5.12: Atlas reconstructed saturation values for the skin (top), bone (centre) and
brain (bottom) regions using both regional (green) and tomography (blue) algorithms.
The plotted results are the average over all models with the error bar showing the standard
deviation of the dataset
Unlike the inverse crime reconstructions, once the Atlas is employed, the quality of
the tomographic reconstruction surpassed that of the regional in all layers, other than the
skin (see Figures 5.12 and 5.9) in terms of both quantitative accuracy and the standard
deviation of the recovered saturation values. The average percentage difference between
the simulation and reconstructed brain values was 10.1% with a standard deviation of
1.8%. While the fixed region sizes posed an issue for the regional reconstructions, the
tomographic process was not constricted in the same way. The Atlas tomography even
performed better than its inverse crime counterpart, again highlighting issues with region
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of interest (ROI) selection. The limiting factors in grouping nodes into a ROI via Jacobian
thresholding still apply, however because of the mismatch in superficial layer size these
errors appear to average out over the course of all the head models, smoothing the results.
The main consideration when assessing the quality of the registered-Atlas reconstruc-
tions is that the results were more quantitatively accurate than the current NIRS-based
recovery techniques. While absolute quantification was never anticipated, the main goal
of this study was to show the potential of DOT to improve on current NIRS limitations,
which is clearly visible from the above results.
5.3.3 Conclusions - Simulation Studies
Currently the NIRS technology that is available in the clinic lacks the quantitative accu-
racy to monitor saturation changes in TBI patients. The global measures of saturation
provided by NIRS probes mean that the target changes in the brain are often confounded
by the haemodynamics of superficial layers such as skin and bone. While brain haemo-
dynamic changes are observable, the saturation values obtained are not reliable enough
to allow NIRS to be used as a clinical gold standard for TBI monitoring.
In the context of measuring quantitatively accurate brain saturation measurements
in TBI patients, the technique of Atlas-guided reconstructions has shown significant po-
tential. While there are many refinements to both the reconstruction algorithms and
the realism of the simulations, which can be made, the data in this study present a first
step towards clinical DOT measurements for TBI monitoring. Where previous studies
implementing NIRS into the clinic have found that the superficial saturation changes can
obscure accurate brain observation, current simulations for DOT have shown the potential
benefits. Due to the iterative recovery process of DOT it is inherent that more prior in-
formation can be provided. Even though this information has proved inaccurate in terms
of superficial layer size, the known depth of the cortex surface (roughly constant over all
heads) has allowed for significant improvements in brain parameter recovery.
The next progression of this work comes in two forms. The first needs to focus on the
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refinement of the reconstruction techniques. This will come in the form of redeveloping
the Atlas so that the superficial layer mismatch provides less of an issue. Also in terms
of improving the tomography reconstructions, thorough investigations into methods of
selecting the correct regions of interest are required. The second is the practical imple-
mentation for a clinical DOT NIRS system. Simulations will never truly mimic clinical
conditions, thus the probe needs to be characterised and tested on a mix of, well defined
phantom models, healthy volunteers and TBI patients.
5.4 Direction Of Future Studies - Healthy Volunteer
testing with existing DOT probe
Having demonstrated that the reconstructions based on registered-Atlas models were
found to provide potential improvements, in terms of quantitative accuracy, when re-
covering cerebral saturation changes during a simulated VM, the following experiment
aimed to extend this method for testing in a series of healthy volunteer studies. As well
as extending the Atlas model reconstruction, where available, the Atlas reconstructions
were compared to reconstructions using a subject-specific model (segmented MRI of the
subject) as the reconstruction basis to improve the structural prior information. In com-
paring the two, the validity of the Atlas models in clinical situations can be assessed,
as well as allowing the effects of superficial layer mismatch to be seen. With healthy
volunteer studies, as well as potential mismatch in tissue layer thicknesses and the shape
of the head, there is now also the possibility of scattering property mismatch. This is
a potential limitation of this technique as continuous wave devices provide no specific
scatter information during data reconstruction.
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5.5 Methodology - In Vivo Testing
5.5.1 High-Density Probe for Data Collection
High-density probe used for these healthy volunteer studies was designed and built by
the Nalecz Institute of Biocybernetics and Biomedical Engineering (Polish Academy of
Sciences). The probe consisted of 8 source positions, illuminating at 750 and 850 nm with
6 detector locations. Each detector measured light from all 8 source positions resulting
in 96 overlapping measurements at source-detector separations of 1.5, 3.4, 4.5 and 5.5 cm
over a 16 cm2 region of interest. The layout of the probe and position on the Atlas model
and subject heads is shown in Figure 5.13
Figure 5.13: Layout of the high-density DOT probe on Atlas Model (A) and actual probe
(B) designed and built by the Institute of Biocybernetics and Biomedical Engineering
(IBIB). Detector positions are shown in blue and source positions in green with the
maximum source-detector separations indicated. C shows the probe in position on a
subjects forehead.
The pad holder was made from a curved and semi-flexible plastic that moulds to the
subject’s head and is held in place with an elasticated strap. The fibre optic cables
channelling light to and from the sources/detectors could be individually moved to ensure
they were all in direct contact with the skin, and as the target region was on the forehead
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there was no risk of hair obstructing any of the fibres. The position of the pad was on the
subjects right-hand side and was positioned such that the right most source/detector was
1 cm from the midline with probe base just above the superior orbital ridge. While this
protocol was used for each of the subjects, variation in the shape and available space on
the forehead meant the angle of the probe did vary, which may cause a mismatch between
the ’real’ probe and the probe positioned on the reconstruction models.
5.5.2 Recording Valsalva Data
Ten healthy volunteers (8 Male, 2 Female aged 35-50) performed a series of three, 10 s,
standing maximal VMs under controlled laboratory conditions. The study conformed to
the Declaration of Helsinki and was approved by the University of Birmingham Research
Ethics Board (Ref.: ERN 30-1031). Individuals recruited had no significant prior medical
history. As no blood pressure readings were available to judge the recovery to baseline be-
tween VMs, a 5 min rest period was taken between each recording. Each data acquisition
consisted of a 30 s baseline reading, the 10 s VM with a 30 s recovery reading. Subjects
were given instruction and practice trials to insure the VMs would be consistent.
5.5.3 Production and Registration of Head Models
The production of both the Atlas and subject-specific head models used the same method
followed for the simulation studies in Section 5.3.1. The Atlas used for the reconstructions
was the ICBM152 model, despite its discovered limitations in the simulation study. The
Atlas and MRIs were segmented in NIRVIEW, where the landmarks for registration were
also positioned. MRI data was available for two of the subjects, which was used to create
subject-specific head models to compare to the registered-Atlas reconstructions. The
meshing process used an average nodal distance of 3 mm and the total number of nodes
in the mesh was 76,925 for the Atlas model
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Figure 5.14: Example of the 4 landmark points used to register the Atlas model to the
geometry of a subjects head.
Instead of the 687 registration point used in the simulations (which are usually collected
with a digitizer pen that maps 3D coordinates), 2 sets of paired points were used to
represent a simple set of measurements that would be easily obtainable in a clinical set-
ting. Although only using 4 points will likely cause the registration accuracy to decrease,
previous research into the use of different registration methods has shown that the basic
4-point registration did not provide a significantly reduced registration accuracy (∼2 mm
reduction in accuracy) [58]. The points used for registration were, nasion to inion (front to
back) and pterion-pterion (side to side) as shown in Figure 5.14 and were measured using
medical callipers. The 4 points were co-registered using the same non-iterative point-
to-point algorithm used in the simulations study (Section 5.2.2). The probe positioning
was done prior to registration using the same iterative algorithm from Section 5.2.5, with
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updated information about the new probe layout. The transformation followed by the
registration was used to deform both the head model and the source/detector coordinates
at the same time. The baseline optical properties of the models were set to the values
defined in Appendix .1.
Data exclusion - In the previous studies using the VM to induce superficial and
cerebral changes the validity of each data set for inclusion in statistical analysis was assess
by monitoring blood pressure during the VM to insure enough effort was exerted by the
participant to stop venous return. However, in this study blood pressure monitoring was
not available and thus the assessment of the VM had to be performed empirically through
inspection of the raw data before processing, as well as subjective notes taken during the
data collection on the apparent visible effort (facial flushing, shaking etc). In order to
increase the reliability of performing the maximal VM, each participant was shown an
example maximal VM by an experience maximal VM performer. As well as being used as
a demonstration, this performance was used for the subjective grading and was arbitrarily
given a grade of 5. A maximal VM should cause strong facial flushing, shaking from the
strain of force expiration and finally a fast audible release of breath as the glottis is
opened. Using the example participant as a model, each subsequent volunteer was given
a VM grade based purely on these physical attributes. Then once the VMs were complete
the raw detector data was checked against the physical gradings. Only participants who
showed both poor visible VM signs as well as poor detector response were excluded (see
Figure 5.15 for examples of VM data grading).
While these metrics are no substitution for blood pressure monitoring there was cor-
relation between the observed effort and the level of changes seen in the raw data. Figure
5.15 shows examples of how the VM data was graded from 1 to 5, with one being a poor












































































































































































The reconstruction regime for the healthy volunteer study was altered from the original
methodology used in the simulation studies as an additional step was required in terms
of data processing and reconstruction sequence. Only the region reconstruction method,
providing a single set of recovered optical properties for each region was used, with no
’global’ reconstruction to provide an initial guess. The global reconstruction was removed
as preliminary studies showed that it tended to force the reconstruction into a local
minimum and finish with a high projection error after only 2 iterations. The outline of
the reconstruction sequence for the healthy volunteer study are as follows:
1. Calibration of raw VM data.
2. Averaging of data into two time points. A) baseline and B) peak VM.
3. Three-region reconstruction for baseline and VM data
Data Calibration - The data calibration process used data obtained from a large
homogeneous cylindrical phantom using the high-density probe (FEM shown in Figure
5.16). The phantom data was fitted to an analytical solution to the diffusion approxima-
tion, which is based on a infinite homogeneous medium (full details given in Section 3.1)
using a 25 stage iterative fitting algorithm (Newton-Raphson). The calibration process
fits the gradient of ( δln(rI)
δr
), where r is the source-detector distance and I in the detected
intensity. The fit minimises the difference between the calibration dataset and a set of
forward data produced by the analytical solution for the same probe geometry given a
set of initial starting properties (µa = 0.01 mm
−1 and µ′s = 1 mm
−1 ). This process is
repeated for the 750 nm and 850 nm data.
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Figure 5.16: Surface point representation of cylindrical phantom mesh used for VM data
calibration process.
To further improve the fitted optical properties, a second fitting process over 10 iterations
was used in conjunction with the FEM (Figure 5.16) fit instead of the infinite medium
solution. The result is an offset value for each source-detector pair for each wavelength
that could be directly applied to the raw VM data, this is also a calibration for detector
responsivity and source intensity.
Data Averaging - The data were recorded by the probe at 10 Hz so there were
10 data points available for each second of recording time. For the reconstruction, two
sections of the recorded data were averaged to produce two data points, one for the baseline
measurement and another for the peak desaturation just before the VM is released (Figure
5.17). The baseline was an average over a 20 s period (200 data points) and the peak
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VM data were averaged over a 1 s (10 data points) period. Each data set was checked
manually to make sure the data points taken for each section were in the correct location.
Grade 1 VMs were removed from statistics on peak VM desaturation changes, however,
the data were still valid for assessment of the baseline variation between participants.
The assessment looked at the magnitude of the change as well as in which channels it
occurred. For example, a poor VM has no response even in the short (15 mm) source-
detector separations (channels); even a weak VM caused facial flushing that was enough
to exhibit a change in detected intensity, therefore without this change the VM was not
counted as a maximal effort.
Figure 5.17: Illustrations of the sections of the recorded data used for the baseline and
peak VM data sets.
Reconstruction - The reconstruction process consisted of a region-based recon-
struction recovering a set of optical properties for 3-tissue layers of skin, bone and
brain. The reconstruction basis for both the baseline and VM datasets was set to be
the registered-Atlas model (or subject-specific model) with scattering properties and wa-
ter content values shown in Appendix .1. The concentrations of HbO and HHb were
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initially set as homogeneous being 0.0560 mM and 0.0140 mM, respectively. The recon-
struction was allowed to run for a series of 40 iterations with the stopping criteria for
the projection error being a change of less than 0.01 % between the current and previous
model data. The regularisation value used for the reconstruction process was 1000. The
use of this value was based on preliminary results what showed the reconstruction ran for
a large number of iterations with a lower final projection error when the regularisation
parameter was higher.
5.5.5 Results and Discussion
Valsalva Reconstructions - Atlas model
The Atlas-based regional reconstructions showed that the variation in baseline readings
over the 10 participants was significantly higher than expected, with the standard de-
viation of the brain saturation across the group being 24% (Figure 5.18). This was a
significantly higher variation than was seen with existing fNIRS probes testing in previ-
ous work where the NIRO-200NX and the ISS Oxiplex TS were found to have a mean
baseline variation of 8.4 % and 9.7%, respectively. These results are not encouraging for
the high-density probe as the large variation in brain saturation makes it very difficult to
quantify what saturation value constitutes a healthy subject in the TBI monitoring con-
text. It is unlikely that the results given are quantitatively accurate as some participants
had recovered cerebral saturation values as low as 39%, a value that would be considered
extremely dangerous in the clinic. The variation in the baseline is most likely due to mis-
matches between layer thickness and scatter properties from the Atlas to the participant,
as was seen in the simulation studies. An explanation for this is that in the making of
the reconstruction model more complex to improve its accuracy, this may have inherently
left the process more open to influence these sources of error. The subject of mismatch
between layer thickness and scatter between the Atlas model and the participant head is
discussed later on in this section.
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Figure 5.18: Baseline variation in saturation for the skin, bone and brain regions over all
10 participants.
Despite the lack of quantitative accuracy there are areas where the high-density probe
showed improvements over the conventional fNIRS devices. The high-density probe was
significantly better at mapping the magnitude of the desaturation expected during the
VM. The predicted drop in saturation was approximately ∼20% yet data recorded on
the ISS Oxiplex TS fNIRS device during the experiments in Chapter 4 where a maximal
effort VM was performed showed there was only a drop in saturation of 7±3%, less than
half of the drop predicted in the VM model. The high-density probe on the other hand
showed an average drop in saturation of 20±7%. So while the high-density probe still
lacked the quantitative accuracy required to monitor TBI patients without a normative
baseline measurement, they appear better at separating out changes between different
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tissues on the head and recovering the magnitude of changes in the brain. The results
of the reconstructed VM data are shown in Figure 5.19, where the average reconstructed
values for each region are plotted for the baseline and the peak of the VM. Due to the high
variability in the baseline the error bars overlap between the baseline and the peak VM
values which makes the data hard to interpret, however there is a statistically significant
desaturation over all the participants (Wilcoxon Signed rank test: p<0.001, z = 3.49,
number of samples - 16).
Figure 5.19: Average reconstructed saturation values for the skin, bone and brain regions.
It is clear that even though reconstructions using the Atlas model and high-density probe
data are able to accurately map the cerebral changes occurring due to the VM without
influence from the superficial tissues (as was seen with conventional fNIRS), there are
still flaws in the model that are preventing it from being fully quantitatively accurate. As
discussed in the simulation results, this is most likely due to a mismatch in the tissue layer
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thickness between the Atlas model and the participant, or that the scattering properties
in the model are different to the actual scatter properties of the participants head. As the
probe only provides intensity measurements there is no way for scatter to be accurately
updated in the reconstruction, for this a frequency domain device with phase measure-
ments would be required. However, the layer mismatch, which would mean the spatial
priors given to the reconstruction were inaccurate, is a theory that can be tested. For two
of the participants who underwent the VM protocol there was MRI data available, which
was segmented and used to create two subject-specific models that could be compared to
the registered Atlas models when used as the reconstruction basis.
Valsalva Reconstructions - Patient Specific Models
The two participants for whom the MRI data were available showed a marked difference in
the saturation values reconstructed using the registered Atlas models. The reconstructed
data for these participants are compared alongside the predicted saturation values in Table
5.1. While both of these participants show a large drop in saturation over the course of








Scalp Baseline 99.99 94.53 95
Skull Baseline 78.67 58.92 80
Brain Baseline 94.83 39.10 72
Scalp VM 99.99 91.67 95
Skull VM 72.90 57.54 80
Brain VM 66 18.80 50
Table 5.1: Comparison of reconstructed regional saturation values using registered Atlas
models for two participants.
132
From the simulation studies the source of this error was thought to be the mismatch
in superficial layer thicknesses. Figure 5.3 shows a comparison of the layer thicknesses
and depth to the cortex for the Atlas and both the subject-specific MRI models. The
measurement plane was taken as the central sagittal slice of the models, 4 cm above
the nasion point. The measurements show that there is an difference between the layer
thicknesses in the models with the Atlas having a thicker scalp layer and a greater depth
to the cortex, however, as the resolution of the models is 3 mm, it is hard to draw any
firm conclusions from this data, it can only be taken as a guideline. Measurements taken
from the MRI data using specialised clinical software (AGFA, Impax) showed that the
distance from the skin surface to the grey matter surface to be 16.0 ±1 mm and 15.6
±1 mm for participants 1 and 2 respectively. While this cannot be directly compared to
the measurements taken on the models it confirms that there may be limitations to the
segmentation process and the meshing resolution being used to translate the MRI data
into the reconstruction models.
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Figure 5.20: Comparison of superficial layer thicknesses between the Atlas model and
two subject-specific models made from segmented MRI data. All distances are measured










Scalp Baseline 99.99 99.92 95
Skull Baseline 79.65 60.31 80
Brain Baseline 86.54 55.20 72
Scalp VM 99.99 99.14 95
Skull VM 74.54 57.70 80
Brain VM 71.76 39.15 50
Table 5.2: Comparison of reconstructed regional saturation values using registered MRI
models for two participants.
When the reconstructions were reprocessed using the MRI models as the reconstruction
basis, the results showed a marked improvement with the average values becoming closer
to the predicted saturation values and the standard deviation between the two models
decreasing, as shown in Figure 5.21, dropping from 39% to 22%. The average desaturation
during the VM changed from 25±6 % with the Atlas models to 15± 1% for the MRI
models, showing a much smaller variation and on average closer to the predicted 22%
drop (when considering the variation). This showed that even though the measurements
of superficial thickness did not show much variability (when considering measurement
accuracy) there were clearly differences between the Atlas and MRI models within the
layer sizes or the surface geometry. Overall, the saturation in participant 1 still higher than
expected and the saturation in participant 2 was still lower than expected despite the use
of accurate spatial priors (Table 5.2). Therefore, it can be hypothesised that the superficial
mismatch in tissue layer thickness is not the limiting factor in achieving quantitatively
accurate results as the two tested healthy participants should not show this degree of
variation at baseline. The most significant other factor capable of affecting the light
propagation in tissue is the scattering properties; a parameter that is not reconstructed
for when using continuous wave systems. So, it is possible that although the correct
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spatial prior information is being used the light propagation in the forward model is not
representative of the true model as scatter is being incorrectly calculated through under
or over estimation of scatter. This is entirely possible as the scattering values being used
were average values taken from literature sources [113], and hence may not represent all
heads sufficiently to get quantitative accurate data.
Figure 5.21: Comparison of average reconstructed saturation for all tissue layers using
the registered Atlas models and the subject-specific models for 2 participants. A and B
show the baseline values for the Atlas and MRI models, respectively, and C and D show
the VM values for the Atlas and MRI models, respectively.
5.5.6 Conclusions - Healthy Volunteer Testing
Testing on healthy volunteers with a high-density probe showed that the registered-Atlas
model-based reconstructions is not currently capable of quantitatively accurate cerebral
oxygen saturation values using continuous wave measurements. The standard deviation
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in the baseline cerebral saturation between subjects was 24%, which is greater than the
variation seen in testing on commercial fNIRS devices of 8.4% and 9.7% [54]. It is apparent
that increasing the complexity of the reconstructions to give regional values rather than
just global changes, as with conventional fNIRS, has opened up the potential for both
improvements and further inaccuracies in reconstructed results. Despite the increased
variability and the lack of quantitative accuracy, the high-density probe along with the
Atlas-based reconstruction has shown potential improvements over conventional fNIRS
techniques, in the sense that it can more accurately map the predicted magnitude of
saturation changes during a VM. There was a statistically significant desaturation over
all the participants, with an average drop in saturation of 20±7%, almost double that
of the 7±3% drop shown with a conventional fNIRS probe in Chapter 4. This result
is also more in line with the predicted 22% drop in saturation predicted during a VM.
Therefore, even though the results are not quantitatively accurate, the knowledge that
the magnitude of the change can be more accurately mapped is an advantage for TBI
monitoring.
The inaccuracies in the healthy volunteer reconstructions are greater than in the sim-
ulation studies as there are now errors due to the scatter and spatial errors in the Atlas
models, as well potential differences in the magnitude of patient effort during the VM.
While future testing on the patient effort could be monitored with beat-to-beat blood
pressure monitoring, scatter and spatial mismatches in the models require a different
approach. The use of segmented MRI data to provide subject-specific models in two
participants showed that the accurate spatial information did bring the reconstructed
saturation values more in line with the predicted values, however the variation between
the two subjects was still too high to indicate the results were quantitatively accurate.
Therefore, it can be concluded that as well as errors in the spatial accuracy of the models
(tissue layer thickness), there must also be a difference in the scatter properties of the
head between participants that are confounding results, an issue that was not present in
the simulation studies. As the continuous wave measurements with this probe cannot be
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used to accurately update scatter and absorption properties simultaneously, there is no
way to improve this error unless a more representative set of baseline scatter properties for
the skin, bone and brain regions can be found. Alternatively, if frequency-domain data
could be obtained phase measurements could be used to update the scatter properties
during the reconstruction.
The two main issues highlighted by this study have been inaccuracies in the spatial in-
formation given by the Atlas model and the scatter properties being used. Therefore,
to improve the quantitative accuracy the following section will explore the use of fre-
quency domain measurements in updating scatter properties as part of the Atlas-based
reconstruction. Also, the spatial errors in the Atlas model are clearly having an influence
on the reconstruction accuracy, thus further investigation is required into the creation of
more representative Atlas models.
5.6 Frequency Domain Simulations
One of the primary aims of this research was to design and build a high-density con-
tinuous wave probe that was capable of obtaining the quantitatively accurate saturation
measurements needed for monitoring TBI patients in the clinical and pre-clinical setting.
The combination of the simulation studies and the healthy volunteer studies indicate
that while cerebral haemodynamics are being more precisely mapped, the quantitative
accuracy of the results is still confounded. While superficial mismatch has been shown
to have an influence on results in both cases, it is clearly not the overriding source of
error. The scatter parameters in the simulations were kept constant and therefore were
not present as a source of error, however in the healthy volunteer studies it has become
apparent its effects are more pronounced. Research by Michaelsen et al showed that if the
scatter estimate was out by 20%, then the error in the reconstructed HbT concentration
could be out by up to 22.6% or 35.1%, for over or under estimating scatter respectively
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[141]. The same study also showed that using phase data from a frequency-domain de-
vice, to recover scatter information, allowed for more accurate reconstruction of optical
properties as scatter estimates were being updated in reconstruction data from human
breast imaging. Therefore to extend this theory the concept of using phase data to re-
cover scatter information and thus improve the quantitative accuracy of the Atlas-based
reconstructions is explored in a preliminary set of frequency domain simulations.
5.6.1 Methodology
The probe used for the frequency domain simulations was the one described in the previ-
ous simulations (Section 5.2.3), utilising the same absorption changes to simulate a VM.
The difference was the use of different scattering properties and spatial prior informa-
tion between the data simulation and the reconstruction basis model. Three scenarios
were tested to assess the contribution from superficial layer thickness mismatch (spatial
mismatch) and scatter property mismatch.
1. Layer mismatch - Example MRI used to simulate data and Atlas model used for
reconstruction with the same scatter properties
2. Scatter mismatch - Atlas model used for both data simulation and reconstruction
with different scatter properties
3. Scatter and Layer Mismatch - Example MRI model used for both data simulation
with ’Original’ scatter and reconstruction performed using the Atlas model with
’New’ scatter properties
Frequency-domain data was modelled at 100 MHz modulation frequency and both
frequency domain and continuous wave reconstructions were carried out on the data sets
for comparison, the ’New’ and ’Original’ scatter properties are shown in Table 5.3 with









Original - 735 nm 0.33 2.20 0.68
Original - 805 nm 0.26 1.93 0.64
Original - 850 nm 0.22 1.78 0.61
New - 735 nm 1.74 2.66 2.49
New - 805 nm 1.63 2.34 2.19
New - 850 nm 1.56 2.17 2.03
Table 5.3: New ([142]) and Original ([113]) scattering properties used for the frequency
domain simulations.
The reconstruction of the data followed the same outline as the VM data with the IBIB
high-density probe (detailed in Section 5.5).
5.6.2 Results and Discussion
The results of the frequency domain simulations were variable, however, there were areas
where the more complex reconstruction process proved superior to the previous continuous
wave results. Figure 5.22 shows the saturation values reconstructed for the baseline and
VM datasets for the skin, bone and brain regions over the 3 different simulation conditions.
As these are a preliminary set of simulations, there is not enough data for a rigorous
assessment of the technique, however, there are a number of deductions that can be made
to inform future studies.
For the first set of reconstructions the reconstruction basis had the correct scatter
properties however the shape of the mesh and the internal layers was different (spatial
mismatch). The results are shown as the red line on the graphs in Figure 5.22, and show
a poor correlation with the simulated saturation values (dashed black line) over all three
regions of the head. Even though the FD reconstructions used phase to calculate updates
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to the scatter properties of the model, the quantitative accuracy of the reconstructed
saturation values showed no improvement over the CW reconstructions of previous simu-
lations and healthy volunteer testing. This could be due to the region-based nature of the
reconstruction, where even though the scatter properties are being updated for a more ac-
curate estimate, the fact that the parameters are being ’forced’ into the inaccurate spatial
layers of the model is undoing any improvements the scatter information may provide.
Future investigation in this area could reassess the use of the tomographic reconstructions
explored in the first set of simulations so the reconstruction process is less constrained.
Figure 5.22: Reconstructed saturation values for the 3 different frequency domain simu-
lations.The blue line representing the FD reconstructions with on a scatter mismatch and
the black line representing the simulated values overlay each other.
The second set of reconstructed values (shown by the green line) use a reconstruction
basis that has both inaccurate scatter and spatial properties and theoretically should have
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the least quantitative accuracy, however, the saturation values obtained were similar to
the reconstructions with just a spatial mismatch. This would indicate that the mismatch
in scatter properties are not causing the inaccuracies in the frequency domain reconstruc-
tions and it is still the spatial mismatch causing a majority of the errors. This theory is
confirmed by the third set of FD results that used a reconstruction basis containing only
scatter property mismatch; these results are shown by the blue line and show an almost
perfect match to the simulated saturation values.
While the overall results of the frequency-domain simulations showed that the quantitative
accuracy is still limited, the results were compared to a set of continuous wave simulations
based on the same parameters to check the magnitude of change of the desaturation seen
during a simulated VM. This comparison aimed to see if FD reconstructions maintained
this advantage, which showed in the previous CW testing in this Chapter.
The continuous wave results indicate that in the situations where scatter and spatial
mismatch were simulated, the magnitude of the desaturation was ∼ 17%, which is much
more significant than the ∼5% seen in the FD reconstruction and much closer to the
simulated 22%. The reconstructions with spatial inaccuracies only showed the magnitude
of change was under estimated in the FD reconstructions and over estimated in the CW
reconstruction. The only time when FD reconstructions outperformed the CW recon-
structions in all metrics was when scatter mismatch was the only form of inaccuracy in
the reconstruction model.
This would suggest that in a situation where the Atlas model could be improved, so
as to be more representative of a subject’s internal tissue layer thickness, the FD recon-
struction would theoretically improve the quantitative accuracy of the reconstructions,
and make the technique more viable for use as a TBI monitoring modality. There is also
the possibility that if a frequency domain probe was used it would have better results if
it was combined with a tomography-based Atlas rather than a fixed layer-based region
142
reconstruction.
5.6.3 Conclusions - Frequency Domain Simulations
From the simulations explored with frequency-domain reconstructions, the inclusion of
phase data only increased the quantitative accuracy of the reconstructed saturation val-
ues when the only inaccuracy in the reconstruction model was scatter mismatch. How-
ever when the reconstruction model includes inaccuracies in spatial information, the fre-
quency domain reconstruction does not provide any improvements over the continuous
wave methodology, in fact, in the example tested here the continuous wave reconstruction
provides a better insight into the magnitude of cerebral saturation changes, although they
are still quantitatively inaccurate.
The data indicates that a frequency-domain device could have the ability to make
the Atlas reconstruction method more quantitatively accurate if the Atlas model itself
could be improved, to be more representative of the patient tissue layer thicknesses.
If this could be achieved then a frequency-domain probe could provide the additional
quantitative accuracy needed for TBI patient monitoring. The probe designed as part of
this research (covered in Chapters 6 and 7) is controlled by an Arduino Due, which has
the ability to modulate its LED output signal and therefore theoretically be adapted to
make a low cost frequency domain probe to provide a cheap and portable form of TBI
monitoring.
5.7 Summary
The overall findings from this Chapter show that the current state of high-density mea-
surements and the Altas-based reconstruction are not yet sufficient to achieve quantita-
tive accuracy in the context of TBI patient monitoring. Despite this, the technique does
provide a more accurate mapping of cerebral saturation values during a VM than con-
ventional fNIRS probes and thus the use of tomography can be considered a step in the
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right direction.
The initial simulations with the high-density probe showed that the continuous wave
measurements were capable of semi-quantitative accuracy even when there is a spatial
mismatch of the internal layers between the subject and the Atlas model. However, when
a different high-density probe was tested on healthy volunteers, the semi-quantitative ac-
curacy of reconstructed parameters seen in simulations broke down. This was down to the
addition of scatter mismatch as well as the spatial mismatch to the Atlas models, which
is confounding the continuous wave reconstructions and limiting them to observing only
accurate changes in cerebral saturation values. Another explanation for the reduction in
the quality of the reconstructions in healthy volunteers is the design and features of the
probe being used. The probe being simulated (the one built as part of this research -
Chapter 6) theoretically provides a higher measurement density (168 for a 18 cm2 region)
and number of wavelengths (3), which could improve on the quality of the reconstructions
obtained using the IBIB probe, which only had 2 measurement wavelengths (96 measure-
ments for a 16 cm2 region). This suggests that the high-density probe simulated does
contain enough data for semi-complex reconstruction, however, the accuracy of the Atlas
models is clearly still a limiting factor in terms of both its spatial and scattering proper-
ties. There is a large amount of variation in the literature values of scatter properties for
skin, bone and brain tissues, which means that the values being used cannot necessarily
be trusted in all situations, which was the basis for the preliminary testing with frequency
domain simulations.
Initial testing with the frequency-domain measurements obtained on the high-density
probe designed in this research indicate that the use of phase data can lead to improved
quantitative accuracy of the reconstructed saturation values in the situation where there
is only scatter mismatch and not spatial mismatch. In the event that both mismatches
are present, the frequency-domain reconstructions provide no improvements over contin-
uous wave results and in some cases could potentially be less accurate in observing the
magnitude of cerebral changes. Therefore, a key area for further research in this area
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is improving the spatial accuracy of the Atlas model so it is more representative of the
internal structure of patient heads. Improving the spatial accuracy could then poten-
tially provide the additional information required to improve the scatter estimates with




SPECTROSCOPY PROBE DESIGN AND
VALIDATION STUDIES
The overriding aim of this research was the adaptation and development of high-density
NIR devices for use in monitoring patients with a traumatic brain injury (TBI), in both
clinical and pre-clinical settings. While Chapter 5 explored potential algorithmic develop-
ments during data reconstruction to improve the suitability of high-density near infrared
spectroscopy (HDNIRS) as a TBI monitoring modality, it is not the only area the tech-
nique needs further research and development. The cost and portability of the devices is
a key consideration if they are to be used for widespread patient monitoring. The aim
of this chapter is to show that a small scale HDNIRS device can be built from off the
shelf components such as silicon photodiodes (SPDs) and light emitting diodes (LEDs),
designed specifically for use with the Atlas-based reconstruction algorithm outlined in
Chapter 5. As mentioned in Chapter 5 there are probes available that could be used for
this purpose, however this study is a proof of concept to demonstrate it can be achieved
at minimal cost, increased portability and increased measurement density.
In this Chapter the design and building of the new probe is outlined and testing carried




The probe design is the same as the one outlined for the simulation studies in Chapter
5, which is a simple rectangular, high-density grid (Figure 6.1), a design which has been
shown previously to be have high sensitivity and localisation errors when reconstructing
cerebral data [88]. The probe consists of 8 triple wavelength LED sources ( L735/805/850-
40C32, Ushio Epitex Inc., Japan) with peaks at 735, 805 and 850 nm with a bandwidth
of 40 nm.
Figure 6.1: Design of high-density NIR spectroscopy probe
The wavelengths are similar to those used in the NIRO-200NX. The choice of wavelengths
is essential for unmixing spectral signals as 805 nm is at the isobestic point in the HbO and
HHb spectra (Figure 6.2), the point at which absorption is equal for both chromophores.
Then 735 nm is to the left of this point being more strongly absorbed by HHb and 850
nm is to the right and is more strongly absorbed by HbO.
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Figure 6.2: Absorption spectra for oxyhaemoglobin (HbO−2, deoxyhaemoglobin (HHb),
and water, showing the relatively low absorption levels in the NIR region and the location
of the LED wavelengths used in the probe [18].
There were 7 photodiode detectors (FDS100, Thorlabs) interspersed within the grid
of sources and the spacing between each adjacent source/detector was 15 mm, giving a
total of 168 measurements with a minimum source-detector separation of 15 mm and a
maximum of 62 mm. These components along with the printed circuit board and the
Arduino Due (Arduino, USA) give the probe a cost of ∼ £300.
6.1.1 Electronics
The electronic setup of the probe was made as simplistic as possible consisting of a grid
of LEDs and SPDs controlled directly via an Arduino Due board. Each LED consisted
of a single anode and three cathode pins, one for each wavelength, therefore, to control
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each LED and wavelength individually, would have required at least 25 output ports on
the Arduino. To reduce the number of Arduino pins required to drive the LED sources,
the LEDs were arranged in a grid where each of the columns shared a common anode and
each of the rows shared a common cathode. By multiplexing the LEDs in this way all 24
source positions/wavelengths could be activated individually using only 12 output pins
on the Arduino as shown in Figure 6.3. As the current available from the Arduino ports
was less than the maximum forward current over the LEDs, no current limiting resistors
were required in the circuit.
Figure 6.3: Circuit diagram for the LED and SPD grids and their connection to the
Arduino Due control board.
The SPDs were connected directly to the analogue input ports of the Arduino that con-
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tains a 12 bit analog to digital converter in zero bias (photovoltaic) mode (Figure 6.3).
In photovoltaic mode the current flow in the diode is restricted so a voltage builds up,
this is the basis of solar panels and is used here in order to decrease the dark-noise level.
Operating the photodiode with a reverse bias voltage applied across it will increase the
sensitivity of the detector however it comes at the cost of high dark noise. Photovoltaic
mode allows the SPD to become a voltage source where the anode is connected to ground
and the voltage can be measured by the Arduino at the cathode. In this configuration
there should be an exponential relationship between voltage and incident light intensity.
It is common practice to connect SPDs in series with a resistor or as part of a pre-amplifier
circuit to linearise the response of voltage with light intensity, however as the detector
response could be calibrated with this setup it was therefore was not necessary for the
prototype probe as it is being assessed as a proof of concept device. As the maximum
input to the Arduino ports was 3.3 V the minimum observable change by this system is
a change of 3.3V
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= 0.8mV . The output from the Arduino ADC is simply a value from
0 to 4096 that can be translated into a Voltage reading using the value of 0.8 mV per unit.
For this probe to be used for monitoring the brain, the components would need to be
soldered onto a flexible circuit board and encased in a flexible silicon or plastic casing,
however for the initial testing of the device a rigid version was built using a solid circuit
board and case with the view to testing on solid phantoms and a human arm where no
curvature is present. The circuit was printed on a 2 layered board to allow for the complex
LED circuit wiring and the components soldered in place as shown in Figure 6.4. The
circuit board was then connected to the Arduino using flexible 1.6 mm coated wire.
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Figure 6.4: Circuit board for probe with component soldered in place.
The Arduino was programmed to illuminate each source in sequence, wait 5ms (integration
time per detector) and then take a recording from each of the 7 detectors. The detector
data at each source was then concatenated and set as a string of data via USB to a
PC where the data were formatted in MATLAB, using inbuilt serial function, ready for
processing. One read cycle consisting of 7 detector readings for 24 source wavelength
could be transferred into MATLAB at a rate of 1.3 Hz (773 ms total acquisition time per
read cycle).
6.1.2 Probe Casing
The design for the case sections that made up the circuit board housing are shown in
Figure 6.5, the sections were designed using OpenSCAD (Freeware CAD package). The
designs were translated into .stl format so they could be manufactured using a 3D printer
(Mendel - RepRapPro) in solid black plastic.
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Figure 6.5: Sections of probe casing that fit together to house the circuit board. The top
curved section is removable to allow for data collection of curved or flat target media.
The finished probe housing is shown in Figure 6.6. This version of the probe was designed
for use on flat targets, however, a curved light guide was constructed to allow preliminary
measurements to be made on curved surfaces such as the head.
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Figure 6.6: Fully assembled prototype probe with flat top.
6.2 Probe Characterisation
In order to test the validity of the probe setup a series of characterisation experiments were
carried out that will be covered in Sections 6.2.1 - 6.2.8, data from these measurements
can then be used to calibrate the probe before experimental use.
6.2.1 Dark Noise
A silicon photodiode consists of two types of semiconductor material placed alongside
each other, one will be an electron rich N-type semiconductor and the other will be an
electron deficient, P-type semiconductor. At the interface between the two semiconductor
a depletion region forms with electrons and electron holes being drawn towards their
respective sides of the junction as seen in Figure 6.7, the depletion region sits in a state
of dynamic equilibrium. When a photon with sufficient energy (3.62 eV for Silicon [143])
is incident on this region it is absorbed and an electron-hole pair is produced with both
drifting to their respective sides of the junction, this causes a build up of positive charge in
the N region and a negative build up in the P region giving and overall increased potential
difference (voltage). However it is possible for thermally excited electrons to drift across
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the depletion region and induce a current flow irrespective of incident light, this is known
as dark current and the associated change in detector signal due to this current is known
as dark noise.
Figure 6.7: Illustration of the P-N junction of a Silicon Photodiode and the depletion
region formed between them. The left of the figure shows the component symbol for a
SPD and how it orientates with the P and N type junction.
Correction for dark noise is relatively simple however it can be complicated if the tem-
perature of the detectors is changing over time; the higher the temperature the more
thermal electrons will have the energy to drift across the depletion region. This is one
of the reasons why photovoltaic mode was selected to minimise the dark current so the
effect of temperature change from influences such as contact with the skin, would have a
smaller effect on the overall readings. As the experiments done with the probe were short
in duration the dark noise correction factor was based on the assumption that dark noise
levels would remain constant over the course of the data collection process.
Method - The dark noise was assessed by averaging the response from each detector
over a series of 7 reads (a total of 2200 read cycles) under blackout conditions. The LED
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sources were set to remain off while the rest of the acquisition process remained constant.
Then a solid homogeneous phantom (ISS calibration phantom A - details in Appendix
.3) was placed on the probe and was further covered in a black out cloth (Figure 6.8),
all readings were performed in a dark room, care was taken to shield the detectors from
outside light sources such as the acquisition laptop.
Figure 6.8: Setup used for dark measurements as well as phantom and repeatability
measurements for later sections.
Results - Figure 6.9 shows the average dark noise (in mV) for each detector. These
data are used at the first form of calibration for the raw detector measurements and can
be applied through direct subtraction.
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Figure 6.9: Top - Graph showing the dark noise of each detector along with the standard
deviation from the average measurement. Bottom - Table of numerical values of Dark
correction factors.
6.2.2 Silicon Photodiode responsivity
The response from each detector with respect to the wavelength of incident light should
be equal, however due to differences in the manufacturing process it is possible that
detectors being used will respond differently to the same incident light. This could be due
to aspects such as small changes in the size of the detector or changes in the uniformity
of the semiconductors materials making up the photodiode. Therefore, the response of all
the detectors was measured in order to provide a calibration factor that would normalise
the response for all detectors prior to the data reconstruction process.
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Method - The response of the detectors in the probe was measured while being
illuminated by a single LED source at each of the source wavelengths. Even though the
LED being used as the reference source is not calibrated, it is sufficient to normalise the
response of all the probe detectors with respect to each other.
Figure 6.10: Setup of SPD responsivity test for probe.
The setup of the responsivity experiment is shown in Figure 6.10, light from the LED
was channelled to each of the detectors in turn using 1
4
”, 91cm optical fibre. A diffuser
(Thorlabs) was placed between the source and the optical fibre to account for any small
variations in the positioning of source between data acquisition cycles. The fibre optic
was held in place using a series of clamps and the opposing end of the fibre was placed
directly on top of the target SPD.
A series of 5 repeat reads for each detector were recorded with 29 read cycles in each,
resulting in 3625 measurements per detector for calculation of the responsivity.
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Results - The results showed that there was a maximum variation in the detector
responsivity of 3.5% from the maximum reading, with the response consistent across
all three wavelengths on each detector. The average responses for each detector, after
dark noise correction, is shown in Figure 6.11, the calibration factor was calculated by
dividing each average response by the maximum detector response at each wavelength.
The calibration can be applied after the dark correction by dividing each detector reading
by the wavelength specific correction factor.
Figure 6.11: Results of detector responsivity testing with calibration factors shown below
the graph.
6.2.3 Light Emitting Diode intensity variation
The light output of each LED in the probe is not identical and can therefore influence
the detector readings and propagate through the reconstruction process as an error. The
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changes in LED intensity can be due to small differences in the semiconductor material
making up the LED, small changes in supply current (due to position in the multiplexed
LED grid), and the mounting angle of the LED on the circuit board.
There LED intensity has an angular dependence, with a zero angle providing the
maximum intensity. Therefore if the LED has been soldered into the board at a slight
angle then the apparent intensity of the LED will appear lower.
Method - To assess the intensity of each LED in the probe an EMCCD (Hama-
matsu, Japan) camera was used to measure the photon counts per second at each source
wavelength so all the LEDs could be calibrated to the maximum value.
Figure 6.12: Setup of LED intensity testing for probe.
Figure 6.12 shows the setup of the experiment used to measure the intensity the probe
LEDs. The front face of the probe was positioned 20 cm from the front of the camera and
then the probe was raised so the central point on the front face lined up with the centre
of the camera lens.
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Figure 6.13: Image taken of 735nm sources using EM CCD.
Six repeat readings were taken for each LED position and wavelength. Each source was
captured individually with the exposure times set to 1 s for the 735 nm wavelength and
0.03 s for the 805 and 850 nm sources. Figure 6.13 shows the combined images of all
the 735 nm sources. The source images were dark corrected by subtracting a dark image
taken over the same exposure time. The peak intensity, measured in photon counts,
was extracted by fitting a 2D Gaussian to the source image in MATLAB. The intensity
readings were translated into counts per second so they could be plotted on the same axis.
Results - The results of the LED intensity calibration test (Figure 6.14) showed
that the largest variation in LED intensity is 54% from the maximum value. The pat-
terns in the intensity variation were also consistent across the three wavelengths. The
calibration factor to normalise the LED intensity can be applied to the detector read-
ings simultaneously through division, as it maps a percentage change and can therefore
be used interchangeably regardless of the detector being used. As a separate set of cal-
ibration factors was calculated for each source wavelengths, the spectral response and
quantum efficiency of the EMCCD did not need to be considered. The calibration factor
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was designed only to normalise across sources of the same wavelength.
Figure 6.14: Results of LED intensity testing with calibration factors shown below the
graph.
6.2.4 Light Emitting Diode spectra response
Since the probe detectors have been calibrated for their response at the specified source
wavelengths of 735, 805 and 850 nm, it is important to confirm that each source is emitting
light around these peak wavelengths. As well as having effects on the detector response
a large change in the peak wavelength of the sources has a knock on effect in the recon-
struction of data as the extinction coefficients used will be specific to a given wavelength.
By measuring the true peak wavelengths of each source the reconstruction models can be
updated to match, improving the overall accuracy of the reconstruction.
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Method - The emission spectra of the probe LEDs was measured using a spec-
trometer (BSR112E-VIS/NIR CCD Spectrometer, Edmund Optics) and the setup shown
in Figure 6.15. Light was channel through a 1
4
”, 91 cm optical fibre, held in place with a
series of clamps, from each of the source LEDs to the detector of the spectrometer. Three
spectra were taken for each LED (and source wavelength) in the probe.
Figure 6.15: Setup of LED Spectral testing for probe.
The measured spectra were recorded over a 75 ms integration time and were dark corrected
for the given exposure time within the spectrometer software. The spectral data were
imported into MATLAB for processing where the response was averaged over all 8 LEDs
at the 3 different source wavelengths. The peak wavelength was found by extracting the
maximum value from each spectrum.
Results - The peaks wavelength of the LEDs were found to be 728±1 nm, 803±2
nm and 850±1 nm for the advertised source wavelengths 735, 805 and 850 nm respec-
tively (shown in Figure 6.16). Within the bounds of the standard deviation only the 735
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nm sources did not match up with the results showing that the peak wavelength was
potentially 7 nm lower than expected.
Figure 6.16: Average spectral response over all LEDs in the probe compare to the expected
peak wavelengths.
As the spectra response across all LEDs in the probe was mainly consistent (Figure
6.17), the calibration of the detector responsivity performed earlier in this section is still
valid as the tested LED was from the same batch.
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Figure 6.17: Peak wavelengths for all the sources in the probe.
6.2.5 Voltage - Intensity Calibration
As discussed in Section 6.1.1, the detected voltage from the SPDs is not linear with the
incident light intensity as the photodiodes are connected directly to the Arduino without
the use of a preamplifier. Therefore, to estimate the intensity of light being observed
by each detector a calibration factor between the output voltage of the detector on the
Arduino and the input light intensity is beneficial. It will also confirm that the detectors
are responding as expected.
Method - To assess the detector response to different input light intensity a source
of known intensity, a Thorlabs High-Intensity Halogen Lamp Light Source (OSl-1-EC),
with a maximum light output of 40,000 foot candles that is equivalent to ∼ 0.064 Wcm−2
was used. This process is not exact as the light source itself is not calibrated, however it is
possible to take relative, intensity change, measurements. The intensity of the input light
is altered through the use of neutral density filters. The intensity of the light transmitted
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(I) through the neutral density filter (of value nd) from initial intensity I0 is calculated
using Equation 6.1. The neutral density filters used had values of 0 (no filter), 0.1, 0.2,




The setup on the experiment is shown in Figure 6.18. Light from the source was directed
to a single detector on the probe using a 1
4
” optical fibre held in place using a clamp stand.
The neutral density filter was applied above the light guide positioned over the detector.
Figure 6.18: Setup of voltage-intensity calibration experiment using an external light
source.
A series of 5 repeat measurements with each neutral density filter were obtained for
processing.
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Results - The average detector intensity readings from the Arduino (in mV) were
plotted against the log of input light intensity and showed a linear relationship (Figure
6.19). This confirmed the expected exponential relationship between light intensity and
SPD response (in mV).
Figure 6.19: Voltage - Intensity calibration plot with fitted equations to convert mV
detector readings into intensity for using in NIRFAST reconstructions.
To obtain a conversion factor between voltage and intensity the polyfit function in MAT-
LAB was used to fit the data plotted in Figure 6.19 and provide the conversion equations
for each wavelength (shown under the plot). Although the intensity of the light source is
known approximately because the source is not calibrated we can only produce a ’relative
intensity’ value for the photodiode response, which is unitless.
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6.2.6 Probe repeatability tests
It is essential that the response of the probe is consistent over a number of read cycles
with detector readings remaining constant (within a certain margin). A constant set of
detector readings would mean that data recorded in different sessions on different days
would be directly comparable.
Method - To test the probes repeatability a series of 20 acquisitions consisting of
30 read cycles each taken over a 2-day period. The data were taken using the probe and
a solid homogeneous phantom (ISS phantom A - details in Appendix .3) using the setup
shown previously in Figure 6.8.
Results - The average results over the 20 reads (Figure 6.20) showed that the
maximum variation in detector measurements was 0.67%, which is an acceptable amount
of variation as it is below the variation in dark noise measurements found in Section 6.2.1
Figure 6.20: Percentage variability in detector measurement over 20 independent read
cycles on a solid phantom
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To further assess the variation data the percentage variation was grouped by source-
detector separation (Figure 6.21). These data showed that the variation in the detector
signals increases with increasing source-detector separation. This is expected as the lower
the incident light intensity the higher noise level in comparison to the signal (signal-to-
noise ratio) with the error on photon counting (intensity α number of photons) scale with
√
n, where n is the number of photons.
Figure 6.21: Average percentage variation in 735 nm detector measurements, separated
by source-detector distance, over 20 repeat reads on a solid phantom
6.2.7 Solid phantom measurements
With the components of the probe now individually calibrated the response of the probe
as a whole system must also be assessed to ensure that the correct response is seen on
a homogeneous phantom model. The detected intensity of light recorded on a reflection
geometry should decrease exponentially with increasing source-detector separation.
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Method - The data were taken using the probe and a solid homogeneous phantom
(ISS phantom A - details in Appendix .3) using the setup shown previously in Figure 6.8.
The data acquisition was run over 60 cycles and averaged into a single dataset as the
phantom is homogeneous and not changing over time. The calibration factors calculated
previously in this Chapter were applied to the data before processing.
Results - To check the detector response matches the expected exponential drop
off with increasing source-detector separation, a box plot of intensity vs source-detector
separation is shown in Figure 6.22. To make the results easier to interpret the intensity
axis is given a logarithmic scale so the ideal response is a linear drop off in intensity with
increasing distance. The first 3 source-detector separation, 15, 33 and 45 mm follow a
linear decrease, however at 54 mm and 62 mm the linearity breaks down. This indicates
that the large source-detector separations are not useable in the data reconstruction pro-
cess as they are clearly subject to high noise levels that are limiting their accuracy. As
well as the noise effects at the higher source-detector separations there is also the issues
of the boundaries of the phantom itself. At this separation the source and corresponding
detector are within 2cm of the edge of the phantom, this could lead to photon loss through
the edges of the phantom and potentially contamination from external photon sources.
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Figure 6.22: Plot of detector intensity (on logarithmic scale) vs source-detector distance
on solid phantom A for 735 nm wavelength
The quality of the data was further assessed by running it through the data calibra-
tion process outlined in section 3.1 where the log of source-detector distance multiplied
by intensity is plotted against source-detector separation and fitted to expected values
generated from an analytical model. This response should again show a linear decrease
with increasing source-detector distance. The results of this calibration, seen in Figure
6.23, confirm that the 54 and 62 mm data points are inaccurate and should not be used
in reconstruction processes.
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Figure 6.23: Example of a calibration plot fitting homogeneous phantom data (from
735nm source) to an analytical model to estimate absorption properties - Process ex-
plained in Section 2.
6.2.8 Pre-amplifier testing
The break down of the relationship between detected intensity and source-detector sep-
aration is due to the limited dynamic range and sensitivity of the detector configuration
being used, as mentioned previously in Section 6.1.1. The lack of pre-amplifiers and the
direct connection of the detectors to the Arduino result in a exponential relationship
between voltage and intensity which limits the dynamic range of the setup and reduces
sensitivity to low light levels. As this probe was built a proof of concept the limitations of
the detectors were not a major hindrance however to prove that the low cost components
used in the system were capable of more accurate measurements the SPDs were tested
with a ready built pre-amplifier.
171
Method - The pre-amplifier testing was carried out in preliminary tests before the
probe was built, thus the LED light source used was a 780nm (Thorlabs LED780E) with
a similar optical power to those used in the prototype probe (∼9mW). The pre-amplifier
used was the PowerLab 16 channel analog-to-digital converter (ADC). The setup of the
experiment is shown in Figure 6.24. The SPD was held in place by a black plastic holder,
then there were 6 different slots for the LED to sit in at 10, 20, 30, 40, 50 and 60 mm from
the detector, with measurements being taken across a solid homogeneous phantom (ISS
phantom A - details in Appendix .3). The LED source was powered using an Arduino
Due and the PowerLab data were recorded using LabChart software.
Figure 6.24: Setup of preamplifier testing experiment using PowerLab pre amplifier for a
single detector while measuring sources at varying distance along a solid phantom.
Results - The results of the pre-amplifier testing are plotted in Figure 6.25 alongside
a set of example detector measurements from the prototype probe. Intensity is plotted
against source-detector separation distance on the intensity axis that was given a loga-
rithmic scale. Although the results are not directly comparable as the source LEDs are
different, the data shows that the pre-amplified detectors have a much greater dynamic
range and sensitivity to low intensity light. The prototype probe detector setup under
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responds to changes in light intensity and therefore it can be theorised that the probe will
be less sensitive to absorption changes within a given target medium.
Figure 6.25: Plot of detector intensity vs source-detector separation distance recorded us-
ing a PowerLab pre-amplifier. The error bars on the pre-amplifier detector measurements
are ±0.03 mV which was the smallest measurable change in voltage.
While these data shows that the current probe design will function with a reduced sen-
sitivity to chromophore concentration changes, it will still function as a proof-of-concept
device and the testing with the pre-amplifier has shown that the components are capa-
ble of producing good data. Upgrading the probe to use pre-amplifiers in the future is
achievable at a low cost so the aim of a low cost probe would still be feasible.
6.2.9 Curved probe calibration
The prototype probe was designed for use on solid flat target volumes, however, a curved
plastic mould was produced to act as a light guide so measurements could be made on a
curve surface such as the forehead. With the curved mount on the probe the sources and
detectors were no longer in direct contact with the target medium. To account for this
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and any decrease in detected intensity due to the curved surface a coupling calibration is
required.
Method - The solid homogeneous ISS phantoms have a curved side for calibration
of flexible probes. This feature was used to provide a comparison between the detector
measurements when the phantom was imaged on the flat probe and the measurements
when the curved probe was used. An average of 30 read cycles were taken for the curve
and flat probes on the solid phantom (ISS phantom A - details in Appendix .3) - detailed
in Figure 6.26.
Figure 6.26: Setup of curved probe phantom testing.
Results - The percentage difference between the detector readings on the flat and
curve side of the phantom was calculated in order to give a calibration factor to account for
any changes in detector intensity. As the same phantom was used for both measurements
the only external change is the non-contact nature of the curved probe, hence it can be
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concluded that any change in measurement data is a result of the curvature.
Figure 6.27: Plot of correction factor to compensate for intensity drop due to curvature
in the probe mount.
The variation in detector intensity varies from +8.5 to -12.5 % (Figure 6.27), and the
percentage change is converted into a decimal so a calibration factor can be applied to
each source-detector measurement taken on the curved probe.
6.3 Conclusions
The data in this Chapter has demonstrated that a low cost high-density probe, produced
for approximately £300, can use Arduino Due controlled LEDs and SPDs to measure
changes in detected light intensity from a solid homogeneous phantom that follow the
predicted patterns of an exponential drop off in intensity with increasing source-detector
separation.
The probe built was a simplistic prototype built as a proof-of-concept device and
is therefore limited in terms of its sensitivity. Despite this, the probe was calibrated
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for dark noise and detector responsivity as well as peak LED wavelength and intensity.
Investigations into the use of pre-amplifiers with the SPD showed that the current probe
setup has a limited sensitivity and dynamic range. This will have an effect on data
reconstruction as the probe will under respond to changes in absorption, however changes
will still be observed, but they will just be blunted, this will be explored in Chapter 7.
Although the prototype probe was designed for use on flat surfaces only, the addition
of the curved mount allows for data collection on a curved surface. The effect of the non-
contact nature of the curve probe was assessed by direct comparison of phantom data
taken on the flat and curved probes to provide a calibration for each source-detector pair
in order to allow preliminary data to be taken on different geometries such as the forehead.
Assessment of the prototype probe has shown the potential of a low cost high-density
probe to provide meaningful data for semi-complex reconstructions. While the current
probe may lack the sensitivity and ergonomics to provide cerebral measurements required
for TBI monitoring, it has shown the technology is available in a much more cost effective
form than current commercially available NIR devices. The ability of the probe to provide
meaningful oxygen saturation values under in vivo conditions will be explored in the form





Registered Atlas-based reconstructions have shown improvements in terms of observing
the magnitude of changes in cerebral haemodynamics when tested using an existing high-
density DOT system. While the variation in baseline measurements between subjects
was too high to yield the quantitatively accurate chromophore concentrations required
for monitoring traumatic brain injury (TBI) patients, the correct mapping of cerebral
desaturation during a Valsalva showed potential improvements over existing fNIRS tech-
niques.
Improving the reconstruction methods is only half of the challenge in developing NIR
techniques for TBI monitoring. The second issue is making the high-density probe small,
cost effective and portable so they can be used on a large scale in both the clinical and
pre-clinical settings. To date the high-density probes that have been produced that would
be suitable to provide the measurement data needed for the Atlas reconstruction method
have either lacked the low cost, compact nature or portability required for TBI moni-
toring. The probe built and calibrated in Section 6 was designed to fulfil the low cost
and portable requirements needed for a TBI monitoring device. Preliminary calibration
of the prototype device showed that the system followed the expected response trends,
however, the configuration of the electronics requires fine tuning for the probe to match
data reconstructions performed on the IBIB probe in Section 5.
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The following chapter assesses the prototype probe under in vivo conditions by measuring
oxygen saturation on the forearm and the forehead during physiological procedures that
changed oxygen saturation within the targeted tissue. If the prototype probe can obtain
meaningful data in its current form then there is potential for the probe to be developed
further for more accurate measurements. This combined with the progress in the Atlas-
based reconstruction is a step forward for NIR TBI monitoring. These experiments were
only a preliminary assessment of the high-density probes’ performance, and were only
carried out on 3 healthy volunteers. Further, while a protocol was followed for the data
acquisition they were not rigorous in terms of repeat measurements due to time constraints
and the suitability of the prototype probe for this manner of such testing.
7.1 Arm Cuff Studies
Arm cuff experiments are a fast and simple way of inducing large changes in blood oxygen
saturation for assessment via NIR. There are experiments within the literature where
arm cuff/occlusion studies have been used to test or compare fNIRS devices (Examples -
[144, 145, 146]). The effect of clamping blood flow at the top of the arm (with pressure
high enough to restrict both arterial and venous flow) results in a steady reduction in the
oxygen saturation of the blood over time. When the clamp is release there is a hyperaemia
response, which floods the occluded tissues with blood giving a sharp rise, or rebound in
oxygen saturation.
By acquiring the fNIRS data on the forearm the region of interest can be considered
roughly homogeneous as the target area will be skeletal muscle, therefore the fitting of
blood concentration parameters is theoretically more accurate as there is no influence
from superficial contamination all changes are global in the target volume.
Within the context of assessing the prototype probe, arm cuff experiments are a sim-
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ple way to illicit large saturation changes as a measure of how well it is functioning in
comparison to conventional fNIRS devices.
7.1.1 Methodology
The following arm occlusion protocol was carried out on 2 healthy volunteers. The cus-
tom high-density probe was tested along side the NIRO-200NX (Hamamatsu, Japan) as
a reference fNIRS device.
Figure 7.1 shows the position of the probe and the cuff on the subjects arm. A blood
pressure monitoring cuff was positioned around the bicep on the upper section of the
subject’s left arm. The probe was positioned over the brachioradialis muscle on the
underside of the forearm just below the elbow joint. As it was the larger probe, the
position of the high-density probe was marked so the NIRO probe could be positioned at
the centre of the acquisition area.
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Figure 7.1: Setup for taking arm cuff measurements on the NIRO-200NX and the in-house
high-density probe.
Once positioned, a baseline reading of 60 s was recorded, at the end of the baseline
the cuff was inflated to a pressure of 220 mmHg over a 10 s period. Once fully inflated
the cuff pressure was maintained for 5 min. After 5 min of cuff occlusion the pressure was
released using the quick release function on the pressure monitor and the recovery process
was recorded for a further 60 s at which point the data acquisition was terminated.
This process was repeated for both the custom probe and the NIRO probe. A reference
reading was taken with a second NIRO-200NX probe on the right forearm to show there
were no other systemic influences on the occluded arm measurements.
Parameter Reconstruction - The data from the NIRO comes in the form of
chromophore changes (HbO, HHb and HbT) and also the tissue oxygenation index (a
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surrogate for deep tissue oxygen saturation). Therefore, to provide a comparison the
high-density probe data was processed in the following ways.
1. Difference Data using the modified Beer-Lambert Law.
2. Spatially Resolved Spectroscopy.
3. Spectral minimisation of difference data - FEM basis.
Before the data were processed the calibration factors calculated in Chapter 6 were ap-
plied, starting with the dark noise subtraction and then dividing through by the LED
intensity and SPD responsivity factors. As discussed in Chapter 2, there are several
sources of physiological noise present in all fNIRS data, such as mayer waves (blood pres-
sure) and cardiac changes that will cause small, predictable fluctuations in detected light
intensity. Therefore, to smooth the raw data a frequency domain filtering process was
used to removed signals with frequencies of 1 Hz (cardiac) or 0.08-0.12 Hz (Mayer) [107].
After the noise filtering, a secondary smoothing process consisting of a 5-point moving
average was also applied. After the smoothing process the intensity data for the 60 s base-
line measurement was averaged to provide a reference measurement (Θref ) from which
changes could be measured.
The modified Beer-Lambert law can be used to calculate changes in chromophore (HbO
and HHb) concentration with reference to a set of reference baseline measurement inten-
sities (Θref ). Using the relationship Θanom −Θref , the change in optical density (∆ OD)
at a given time point can be found, where Θanom is a non-reference measurement point
[107]. Using the OD from each wavelength (λ) and the extinction coefficients (ε) of the













As the differential pathlength factor (DPF) at the source wavelengths is not known, an
average literature value of 5.5 was used based on forearm data [147] and L is the distance
between the source and detector.
As the high-density probe has multiple measurements at a range of source-detector
separations, they were grouped and averaged by separation distances of 15, 34, 45, 54 and
62 mm for reconstruction.
Spatially resolved spectroscopy is discussed in detail in Chapter 2. For the arm cuff













where k is an unknown constant, λ is wavelength, µa is the absorption coefficient, A is
the detector measurement, ρ is the distance between detectors, and ε is the extinction
coefficient. From the relative concentrations of HbO and HHb the TOI can be produced












The SRS method is only valid for small changes in detector separation, ρ, the high-density
dataset could not be combined to reconstruction in one value. Instead the detector mea-
surements were separated into their nearest neighbour groups, 15-34 mm, 34-45 mm, 45-54
mm and 54-62 mm, with the 34-45 mm pairing the closest to the NIRO detector setup
of 37-43mm. All the detector pairs over the high-density grid were averaged in order to
calculate a single TOI value at each time point for each of the detector distance groupings.
The spectral minimisation of the data was done using a rectangular FEM produced using
NIRFAST measuring 60x100x60 mm (Height x Width x Depth) with 15417 nodes (shown
in Figure 7.2). The model was set to have homogeneous scatter and absorption properties
with HbO concentration at 0.0560 mM, HHb at 0.0140 mM, a water percentage of 50%
(mimicking the properties of muscle tissue found in [113]) and scatter power and amplitude
values of 1.
Figure 7.2: Mesh used for spectral minimisation of arm cuff data.
The minimisation process uses the difference data between a give time point and the
average baseline measurement intensity (Θanom − Θref [19]) and the inverted Jacobian
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matrix (J) to calculate the nodal changes in chromophore concentration (∆C) as shown
in Equation 7.4






As the minimisation provides a change at all nodes, a small region of interest central
in the probes acquisition field was chosen over which the chromophore changes could be
averaged. The region of interest was take 5 mm below the surface to avoid the hyper-
sensitivity spots under each source and detector and was 5x10x10 mm in size (Height x
Width x Depth).
7.1.2 Results and Discussion
The following data was from a single subject and is aimed at proving the prototype probe
is observing sensible signals. An example of the raw data from a single source-detector
pair in the probe at 735 nm is shown in Figure 7.3. The raw data is also plotted along
side the filtered and smooth data, which can be seen to remove a proportion of the high
frequency noise in the signal. The data shows that there is a large change in detected
intensity over the course of the arm occlusion followed by a large rebound in the signal
strength on release of the cuff. As 735 nm is most strongly absorbed by HHb this is the
pattern that would be expected to be seen as more HHb will be present over the occlusion
as saturation decreases then as HbO returns after the cuff is released, the HHb absorption
decreased and more light is detected again.
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Figure 7.3: Raw data from built high-density probe before and after moving average, and
frequency domain filtering.
A noticeable feature of the raw data is the obvious drift in the baseline measurement
before the cuff was inflated. It is possible that this change is due to the photodiode being
in direct contact with the skin and hence the temperature change is affecting the response.
To test this, the drift of the probe was measured on a solid homogeneous phantom over
20 minute period so the change in intensity over time could be calculated to provide a
calibration factor for the raw data. Figure 7.4 shows the drift data for the same source-
detector pair as the raw data in Figure 7.3. Given that the change in intensity over the
entire 20-minute period is ∼ 12% and the baseline drift is ∼ 20% over a 60 s period it is
likely that it is body heat affecting the detectors which is an issue that will need to be
addressed in future probe development. Calibration factors for the intrinsic probe drift
were applied to all raw data measurements for processing after this point, however it did
not make a significant impact because ∆I (intensity change) measurements were being
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used.
Figure 7.4: Data from measurement of probe drift over a 20-minute period with fitted
line used to calculate a correction factor for drift.
Figure 7.5 shows the average change in optical density from the baseline measurement.
The results follow the expected trends with the 735 nm data showing an increase in density
from increasing HHb during the occlusion, 805 nm data shows a minimal change as the
total amount of HbT is not changing and the 850 nm data shows a decrease in optical
density during occlusion as HbO concentration is decreasing. Then on release of the cuff
the optical density in all channels rises due to the influx of blood back to the arm. The
data are separated by source-detector distance and indicates that the 3 mm channels are
showing the greatest changes, representing a depth of approximately 2 cm into the target
tissue. As discussed in the previous chapter, the dynamic range and sensitivity of the
current detector setup is suboptimal the correct level of change may not be seen over all
the detectors.
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Figure 7.5: Graphs of optical density change from baseline over the duration of data
collection for each respectively source-detector distance and wavelength.
The changes in optical density and the modified Beer-Lambert Law were used to estimate
the changes in HbO and HHb over the arm cuff acquisition, with the results being displayed
in Figure 7.6 along side the data set obtained using the NIRO-200NX under the same
conditions. While all the data channels show the correct trends in comparison to the
NIRO probe, it is clear that on the whole the probe response between channels is not
consistent. For a homogeneous medium such as forearm muscle, it is expected that the
changes with depth are roughly similar however the results show a distinct drop in the
magnitude of change as the source-detector separation increases. It is also clear that
the 54 and 62 mm readings are noisier. Using the 34 mm channel as an example, the
concentration change of approximately 12 uM in both HbO and HHb over the course of
the occlusion and assuming the literature values for baseline chromophore concentrations
at correct at 56 uM for HbO and 14 uM for HHb [113], the saturation change on the
high-density probe would be 80-63 % which is a more realistic value than the ∼ 400uM
change in HbO and HHb shown by the NIRO, however this is likely due to the use of
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literature values for differential pathlength factor used in the current reconstructions. All
channels also showed a slight increase in HbT over the course of the occlusion, which is
theoretically not possible as the blood supply is blocked and so HbT should stay constant
as it does in the NIRO data. A slowly increasing HbT can be explained by the intensity
drift discussed earlier in this section, where the intensity slowly decreases over time and
propagated through the reconstruction as a small increase in absorption uniform over all
wavelengths. This highlights a limitation of the current probe electronics.
Figure 7.6: Changes in chromophore concentration calculated using the modified Beer
lambert law for each source detector separation.
The results of the SRS reconstruction are shown in Figure 7.7, where it can again be
seen that there is one channel outperforming the rest. The 34-45 mm channel shows the
greatest change in TOI over the course of the arm occlusion with a drop of approximately
7% observed. All channels follow the expected trend of steadily decreasing saturation
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during the occlusion followed by a saturation spike when the cuff is released. This is
supported by the trends shown in the NIRO TOI data shown in Figure 7.8.
Figure 7.7: Reconstructed spatially resolved spectroscopy parameter - tissue oxygenation
index during arm cuff measurement. Results are shown for each pair of source-detector
separations.
The magnitude of the desaturation over the course of the arm occlusion is significantly
greater in the NIRO TOI data (Figure 7.8), with a TOI drop of approximately 35% which
is similar to previous literature values [144]. However, simulations using the SRS method
on homogeneous models presented in Chapter 4 showed that the method overestimated
saturation changes in the medium under homogeneous, globally changing, conditions.
This would indicate that even though the prototype probe is clearly underestimating
saturation changes, the NIRO data may also be an overestimate of the true saturation
change. The over response could be due to the scatter assumptions that are made in the
SRS equation, which would lead to the constant ’k’ value not cancelling out correctly
when calculating TOI.
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Figure 7.8: Tissue oxygenation index values obtained from the forearm with a NIRO-
200NX probe.
The final form of data reconstruction is spectral minimisation of the data using the
Jacobian matrix from the FEM shown in Figure 7.9. The reconstructed chromophore
changes are based on the entire set of high-density measurements providing 3D tomo-
graphic changes, which have been averaged into a singular concentration value based on
the assumption that the medium is homogeneous. While the reconstructed data appear
noisy, it is still following the same trends as the previous data. Considering that the
predicted HbT concentration in the forearm is 70 uM, the changes in HbO and HHb of
approximately 80 uM seem to be overestimates of the actual change, however this is as-
suming the literature values are correct and the medium is homogeneous. The raw data
for the FEM results were processed with a 20-point moving average in order to smooth
the data, which is why the plot in Figure 7.9 is more ’stepped’ than the previous results.
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Figure 7.9: Changes in chromophore concentration during arm cuff study obtained
through minimisation of spectral data.
7.1.3 Conclusions
The results of the arm cuff measurements confirmed findings from the previous chapter
that the detector setup is not sensitive enough to monitor the true changes in absorption
within a medium and therefore cannot accurately detect the magnitude of haemodynamic
changes. The drift in the intensity measurements over time and the effects of body heat
on detector readings are a significant limitation for the prototype probe, and will need
development if the probe is ever going to be a viable TBI monitoring device.
Despite the apparent limits in the probe sensitivity and issues with long-term drift,
these arm cuff studies show that the prototype probe is capable of observing sensible
changes in haemodynamics on simple homogeneous media (muscle tissue), which is an
important first step in the development of a low cost probe.
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7.2 Valsalva Studies
The second stage in the prototype probe testing recording data on the head, the protocol
for this assessment was the same Valsalva Manoeuvre used to test the IBIB probe and the
Atlas reconstruction process. While the data on the probe so far indicates it is limited
in its sensitivity, if the prototype is capable of tracking the haemodynamics of a VM and
differentiating between the superficial and cerebral changes then it will be a significant
step forward in the development of a low cost, portable probe with a more spatially
assessment of saturation than that provided by conventional fNIRS devices.
7.2.1 Methodology
For the VM testing of the probe the curved attachment was used to improve the fit of
the probe to the curvature of the forehead. As these were again preliminary tests data
were recorded for 2 repeat VMs over 2 healthy volunteers following the protocol for a 10 s
maximal VM outlined in Chapter 5. The probe was positioned on the left hand side of the
subjects head (Figure 7.10) and held in place manually for the duration of the recording
due to the size of the prototype, meaning a physio bandage wrap (as used in a clinical
setting) could not be used to secure it to the head. The data were recorded first on the
high-density probe and then after a minimum of 5 minutes recovery time the experiment
was repeated with the NIRO-200NX probe in the same position for comparison. The
acquisition consisted of 60 s of baseline readings, 10 s of maximal effort VM followed by
a further 60 s of recovery measurements.
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Figure 7.10: Position of high-density and NIRO probe of the subjects head.
Before reconstruction of the data, the calibration factors were applied to the raw data
to correct for dark noise, detector responsivity, LED intensity, and to convert the data
into intensity units. As the curved probe was being used, the coupling correction factor
was also applied. As the time scale of the VM was over 10 s, performing the normal
frequency domain removal of Mayer waves resulted in the response to the VM being
blunted. Therefore, the frequency filtering was only performed on 1 Hz signals from
cardiac noise. The smoothing of the data was done with a 3-point moving average as to
not affect the signal drop in the VM.
Parameter Reconstruction - For comparison to the NIRO-200NX and previous
experimental results using the VM, the data were reconstructed using 2 different routines.
1. Spatially Resolved Spectroscopy.
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2. Spectral minimisation of difference data - FEM basis.
The spatially resolved spectroscopy method used was identical to the procedure fol-
lowed in the arm cuff reconstructions with the detector measurements being separated
into their nearest neighbour groups, 15-34 mm, 34-45 mm, 45-54 mm and 54-62 mm. All
the detector pairs over the high-density grid were averaged in order to calculate a single
TOI values at each time point for each of the detector distance groupings.
Figure 7.11: Mesh used for spectral minimisation of high-density VM data. Left - Surface
mesh showing the position of the sources and detectors on the model. Right - Internal
tissue structure of the head model, region 1 is skin, region 2 is bone and regions 3-5 are
brain.
The spectral minimisation for the VM data used a more spatially accurate model than
the arm cuff data. Instead of having a homogeneous slab model, the Atlas model was
used as the basis for the minimisation so the chromophore changes could be separated
into the skin, bone and brain regions. The scatter and absorption properties of the model
are based on literature values for muscle shown in Appendix .2. The model consisted of
131,545 nodes and the minimisation process is outlined by Equation 7.5. This is the same
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minimisation method used for the arm cuff studies for consistency, no regularisation was
included.






The 60 s baseline reading was averaged into a single reference dataset, (Θref ), then each
time point after the baseline was taken as the ’anomaly’ measurement, (Θanom), from
which the change in intensity could be found in order to calculate changes in chromophore
concentration over time.
7.2.2 Results and Discussion
The following data gives example measurements from a single subject during a VM to
show the prototype probe is capable of obtaining useful data when positioned on the
head. As the probe was solid, even with the curved head piece the coupling with the head
of the subjects was not ideal. The following dataset was for a subject where the probe
made the best contact with the forehead and therefore represents a best case scenario for
the prototype probe; a successful reconstruction of the data will prove that the concept
of the low cost probe is viable and will form the basis for progression of the design and
electronics.
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Figure 7.12: Raw data recorded on the forehead during a 10 s VM plotted alongside
moving average and frequency domain filter data.
Figure 7.12 shows a set of raw data from a single source-detector pair over the course of
the VM measurement. The data comes from a 735 nm source and the separation between
the source and detector is 34 mm. There is a large drop in detected light intensity after
the onset of the VM, which quickly recovers to baseline when the VM is released. Given
that this data is at 735 nm, the drop in intensity indicates an increase in the concentration
of HHb and which would be consistent with the predicted decrease in oxygen saturation
in the brain. The raw data is also shown alongside the frequency filtered and smoothed
datasets, showing that the noise removal process is not obscuring the dynamics of the VM.
The results of the reconstructed TOI values are shown in Figure 7.13 for the 4 different
source-detector gradient pairs. Unlike the arm cuff measurements, the pair showing the
greatest change in the VM data is the 15-34 mm. This make sense conceptually as the
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15 mm detector readings will be mainly sampling skin and the 34 mm readings will be
sampling both skin and the surface of the brain, therefore the difference between them will
be mainly brain changes. Also, as these are the two shortest source-detector separations
the sensitivity of the probe is less of a limiting factor as it is with the other measurement
pairs. The data from the second participant is shown in Appendix .6.
Figure 7.13: Reconstructed TOI for 10 s VM using high-density probe.
The maximum reconstructed drop in TOI over the course of the VM was 3%, which is
significantly lower than the predicted 22% drop expected in a VM. However, considering
the current limitation of the prototype probe in terms of detector sensitivity the TOI drop
is comparable to the 6% seen on the same subject using the NIRO-200NX probe (Figure
7.14). Regardless, the probe is clearly detecting cerebral changes during the VM, which
is a promising step for the low cost probe that could be easily improved upon with design
changes to improve contact with the subjects head, for example.
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Figure 7.14: Tissue oxygenation index values obtained from the forehead with a NIRO-
200NX probe during a 10 s VM.
The spectral minimisation of the data aimed to provide a semi-complex form of data
reconstruction, as the Atlas model used as the basis for the Jacobian can be separated into
distinct tissue regions of skin, bone and brain in order to assess chromophore concentration
changes in the different regions. However the data taken using the curved probe during
a VM proved too noisy to provide meaningful results using this form of semi-complex
reconstruction.
7.3 Conclusions
The purpose of this chapter was to verify whether the prototype high-density probe was
capable of observing sensible changes in haemodynamics from measurements taken on the
forearm and forehead. For development of NIR techniques for monitoring TBI patients
there are changes necessary in both the hardware and the reconstruction algorithms. The
results of the Atlas-model based reconstructions in Chapter 5 showed the potential bene-
fits of the semi-complex reconstruction method underpinned by high-density overlapping
measurements. The experiments in this chapter represent the testing of a low cost and
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portable high-density probe that could, with further development and refinement, provide
the measurement data required for the semi-complex Atlas-based reconstructions.
From the probe characterisation work performed in Chapter 6 it was known that the
prototype probe did not have the sensitivity to perform quantitatively accurate measure-
ments and as the dynamic range of the detectors was narrow, the chances of observing
accurately the magnitude of changes within a target medium were also low. Therefore,
the success of the prototype probe was measured by its ability to map qualitative changes
in superficial and cerebral haemodynamics.
Arm cuff studies confirmed that even under homogeneous conditions the prototype
probe lacked the sensitivity to accurately map changes in TOI, with only a 7% drop over
5 minutes in comparison to the 35% drop seen on the NIRO-200NX. Nevertheless, the
34 mm data channels showed that when the data was reconstructed using the modified
Beer-Lambert law, a more realistic change of 17% was observed. Spectral minimisation of
all the data measurements also showed the correct desaturation trends. Consequently, the
results do indicate that the probe is definitely capable of observing saturation changes,
however, the detector sensitivity is the limiting factor as the probe is failing to match the
results from commercially available fNIRS probes.
The VM measurements of TOI were at the very limit of the prototype probes capabil-
ity due to the inflexible nature of the head piece, which prevented complete contact with
the forehead. Despite this major limitation and the sensitivity issue highlighted above
the high-density probe was still able to map the expected trends in TOI during the VM.
The Atlas-based spectral minimisation however was unsuccessful even the noise level in
the data and the more complex form of reconstruction relative to the SRS method used
to calculate TOI.
While the prototype probe is clearly in need of further development in terms of pre-
amplifiers for the detectors and flexible circuit boards for conforming to curved surfaces
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it has shown the potential for a low cost and portable probe to be built that could be
applied in a TBI monitoring environment.
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CHAPTER 8
CONCLUSIONS AND FUTURE WORK
8.1 Conclusions
The validity of NIR spectroscopy as a monitoring modality for patients with traumatic
brain injury has been investigated and presented. Within the context of traumatic brain
injury the following hypotheses have been addressed as stated in Chapter 1.3:
1. Signals from superficial tissues are not preventing fNIRS from measuring haemody-
namic changes in the brain that would be necessary for guiding TBI patient therapy.
2. Contamination from superficial tissues is limiting the quantitative accuracy of fNIRS
measurements and thus it cannot currently by used as a standalone TBI monitoring
modality when no normative baseline measurements are available.
3. A small scale hybrid fNIRS/DOT probe and Atlas-based reconstruction algorithm
can be used to recover superficial and cerebral haemodynamics simultaneously and
thus produce quantitatively accurate results.
4. A low cost, portable, fNIRS device capable of producing these measurements can
be built using off-the-shelf components.
Investigations into existing fNIRS probes, in both healthy volunteer studies and numerical
simulations, confirmed that despite the presence of superficial contamination from facial
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tissue, they still have the capability to observe the changes in cerebral haemodynamics. It
was demonstrated that a maximal VM was a good method of inducing profound changes
in cerebral haemodynamics in healthy volunteers; similar to those that would be expected
in brain trauma patients, making it suitable for validation of fNIRS probes and recon-
struction algorithms. Using this technique it was shown that while the fNIRS devices that
were tested identified the anticipated changes, the magnitude of the change, as well as
the quantitative accuracy of the reconstructed data, was not sufficient to support clinical
decisions on trauma patients. Specifically, without first obtaining a healthy normative
baseline reading from which to reference changes against, fNIRS alone cannot currently
be used to guide patient therapy. Furthermore, the high variation in measured oxygen
saturation at baseline between participants makes it difficult to put a firm number on
what saturation level constitutes a healthy brain.
In reference to the first two hypotheses, superficial contamination does not prevent
fNIRS from observing cerebral changes however, its presence obscures the ability to pro-
duce quantitatively accurate results. Hence it was concluded that in order to develop
fNIRS as a monitoring modality for traumatic brain injury, a high-density probe and
more complex recovery process was required. A more complex dataset and reconstruction
algorithm allows the move from a global parameter recovery over a region of interest,
to a more spatially resolved parameter recovery, capable of separating out changes from
different tissues within the region of interest.
With regards to the third hypothesis posed, using an Atlas-model registered to the
measurements of subject’s head, the reconstruction algorithm for parameter recovery can
be enhanced to provide more quantitative results. The Atlas model gives more accurate
structural prior information as a basis for the reconstruction so that changes from differ-
ent tissue regions (skin, bone and brain) can be separated.
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In simulations, the use of a high-density fNIRS probe utilising multiple overlapping
measurements, at three wavelengths, showed an improvement in terms of quantitative ac-
curacy and also in the magnitude of the recovered saturation changes when compared to
the fNIRS geometries tested previously. Even with this improvement, however the results
could still not be considered to be truly quantitative and findings showed that mismatches
in the internal tissue thicknesses and scattering properties between the subject and the
Atlas were now contributing factors to the quantitative inaccuracies. As such, making
the reconstruction process more complex is a double-edged sword, as there is clearly an
improved ability to separate out signal contributions from different tissue regions in some
cases, however, this also introduces additional error sources; including inaccuracies in
scatter properties and internal tissue structure within the Atlas model that have the po-
tential to obscure recovered parameters.
This was confirmed in the healthy volunteer studies where the recovered cerebral satu-
ration data were found to not be quantitatively accurate. Despite this the probe mapped
drops in cerebral saturation (20±7%) that were much more representative of the expected
values (22%) than current fNIRS devices (7±3%). Extending this probe and reconstruc-
tion process to frequency domain measurements (in simulation) showed that in situations
where the Atlas model was accurate, then the new phase data was sufficient to update
the scatter properties and provide much more accurate cerebral saturation values.
Finally the fourth hypothesis was covered by the work presented in Chapters 6 and 7.
Finding indicate that it is possible to build a portable high-density fNIRS probe for less
than £300. The prototype probe using triple wavelength LEDs (735, 805 and 850 nm)
and SPD detectors provided 168 measurement channels over an 18 cm2 region of interest.
While the prototype did not have sufficient sensitivity to provide a dataset that could be
used for the semi-complex Atlas-based reconstruction algorithm it was shown to be able
to qualitatively map the expected changes in oxygen saturation during arm cuff occlusions
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and Valsalva Manoeuvre studies. Further development of such a probe and reconstruction
algorithms could potentially lead to a viable TBI monitoring device.
Overall this research has shown the benefits of using Atlas models for providing semi-
complex reconstruction of high-density NIR spectroscopy data. While the quantitative
accuracy of the results is not sufficient to guide TBI patient therapy, it can more accurately
map cerebral changes than a standard fNIRS setup.
8.2 Future Work
While this project has provided a basis for the application of high-density fNIRS to mon-
itoring patients with traumatic brain injury, the lack of quantitative accuracy means that
further improvements are needed in order to make it a viable tool for clinicians. The re-
search on Atlas-based reconstruction process can progress in multiple directions. Firstly,
there is the accuracy of the model itself; the model being used currently was produced
for brain activation studies and hence the focus was put on accuracy of segmentation in
the brain region, not the superficial skin and bone regions. It was found that there was a
marked difference between superficial tissue thicknesses in segmented subject MRIs and
the Atlas model, indicating that the Atlas is not truly representative. Therefore, investi-
gating the use of the technique with other Atlas models, such as the Colin27 MRI Atlas,
to assess the impact on the results would be beneficial. There is, however, no guarantee
that the Colin27 Atlas would be any better. The Atlas models could also be extended to
cover different age ranges as this can also lead to different average head structures. The
ideal situation would be to produce a model specific to each TBI patient, however this
is only possible for the clinical environment where CT and MRI scans can be produced.
Therefore as we also require pre-clinical monitoring the best way to approach the Atlas
problem could be to use the ’big data’ approach. If thousands of 3D CT/MRI head images
could be processed along with other demographic data, such as age and gender, it may
be possible to build up a new set of generalised head models to use, instead of the Atlas
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models that are currently available. The high-density probe and reconstruction methods
also need to be tested on TBI patients in the clinic. Running a clinical trial where a
high-density fNIRS probe is used alongside current invasive monitoring modalities (ICP
and oxygen tension monitor) for an extended period (e.g. 24 hours) would provide an
ideal opportunity to validate the reconstruction technique and Atlas models. The clinical
trial scenario would mean that CT scans of TBI patients could also be segmented and
used to create models for the reconstruction. This way the registered Atlas could also be
compared to patient specific models.
In addition to the need for testing on different Atlas models, the choice of baseline optical
properties (both absorption and scatter) in the model needs to be addressed. Currently
these are based on a single set of literature values with no guarantee they as representative
of the general population. There is also a large variation in scattering properties for the
given tissues types (skin, bone and brain) across the literature (reviewed by Jacques et al
[142]). Consequently, combining incorrect scattering properties with poor structural priors
in a reconstruction based on continuous wave measurements, where no information about
scatter can be accurately reconstructed, is a large potential error source. Therefore if the
Atlas model can be improved to make the internal structure more representative, then
progression on the scattering properties can be made by extending the high-density probe
to take frequency domain measurements that could allow for scatter to be reconstructed
as well as absorption. Although this may provide advantages to the reconstructions, this
would need to be balanced against the likely increase in cost of the probe.
One of the differences between the Atlas-model simulation studies and the healthy vol-
unteer testing was the number of wavelengths in the probe. The simulations used the
design of the in-house probe that was constructed during this project, which used 3 wave-
lengths instead of the 2 that the Institute of Biocybernetics and Biomedical Engineering
(IBIB) probe used. Therefore, the Atlas-reconstruction method should be tested on a
high-density probe, which uses more than 2 wavelengths.
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Finally, the high-density probe built in this project was a proof-of-concept and is
subsequently in need of further development. The first issue is its lack of flexibility.
Printing flexible circuit boards and low profile LEDs and SPDs would allow the probe to
conform to the shape of a subject’s forehead and minimise the contact error. Also much
greater sensitivity could be obtained from the detectors if pre-amplifiers were incorporated
into the circuits.
While the Atlas-based reconstructions provided a step in the right direction for fNIRS
as a TBI monitoring tool, there is another aspect on top of the quantitative accuracy
that was not addressed in this project. The reconstruction time for the Atlas-based
reconstructions in not yet real time, however there is on-going work within the University
of Birmingham group that aims to use the multiple processing cores on graphics cards
to speed up the matrix calculations performed in the reconstruction (within NIRFAST)
in a move towards real time reconstruction. This will also add significant value and
increase the likely translation of this advancement in fNIRS technology into the clinical
and pre-clinical setting for TBI care.
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ISS 690,830 30,35,40,45 4 1 8
INVOS 730,810 30,40 1 2 4
EQUANOX 730,810,880 20,40 2 2 12
Foresight 690,780,805,850 15,50 1 2 8
NIRO-
200NX
735,810,850 37,43 1 2 6
Table 1: Information about the five commercial probes being modelled. Note - Due to the
curvature of the head the Euclidean distance between a given source-detector pair with
vary by approximately ± 1-2 mm














Scalp 1 0.0560 0.0140 50 0.14 2.82
Skull 2 0.0392 0.0098 15 1.40 1.47
Brain 3-5 0.0540 0.0220 78 0.54 0.76
Table 2: Optical properties for scalp, skull and brain used for simulations [113]
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Table 4: Optical properties of ISS calibration Phantom B
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.4 Appendix 4 - Blood pressure comparisons from
Vasopressor studies
Figure 1: Comparison of blood pressure during the VMs pre and post injection for subject
1.
Figure 2: Comparison of blood pressure during the VMs pre and post injection for subject
2.
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Figure 3: Comparison of blood pressure during the VMs pre and post injection for subject
3.
Figure 4: Comparison of blood pressure during the VMs pre and post injection for subject
4.
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Figure 5: Comparison of blood pressure during the VMs pre and post injection for subject
5.
Figure 6: Comparison of blood pressure during the VMs pre and post injection for subject
6.
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Figure 7: Comparison of blood pressure during the VMs pre and post injection for subject
7.
Figure 8: Comparison of blood pressure during the VMs pre and post injection for subject
8.
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.5 Appendix 5 - Reconstructed arm cuff data from
second participant
Figure 9: Reconstructed concentration values and TOI values (using SRS) for second
participant in arm cuff studies with the prototype high-density probe.
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.6 Appendix 6 - Reconstructed VM data from second
participant
Figure 10: Reconstructed TOI for 10 s VM using high-density probe for second participant
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